INSERT INTO `micro_posts` VALUES (4709,2,'2020-04-07 17:43:15','2020-04-07 17:43:15','Porvair Sciences reports on increased demand for the 3D moulded intake filters and vent diffusers it supplies to GCE Healthcare - manufacturer of the Zen-O lite&#x2122; Portable Oxygen Concentrator.\r\n\r\nZen-O lite&#x2122; is an ultra-lightweight portable oxygen concentrator from GCE Healthcare  that weighs just 2.5 kg (5.5 lbs). <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106574/\">The device is designed for active people suffering from respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease)</a></span> that require long term oxygen therapy. With its advanced breath detection technology, the Zen-O lite automatically responds to breathing rate and will adjust to a person’s specific needs to ensure that their lungs are receiving effective oxygen saturation.\r\n\r\n<span style=\"text-decoration: underline;\"><span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://www.cphi-online.com/advanced-porous-plastics-for-medical-life-science-news075252.html\">Alan Hughes - Porous Plastics Accounts Manager for Porvair Sciences said</a> </span>\"Governments worldwide are calling upon engineering and healthcare companies to help patients infected by COVID-19 to increase output of respiratory assistance devices. In response to this call for humanitarian aid - Porvair Sciences has prioritised manufacturing capacity to enable us to respond quickly to GCE Healthcare\'s urgent request for quick turnaround on the critical Vyon® porous plastic filters we supply for their Zen-O lite&#x2122; device\".</span>\r\n\r\nHe added \"The air intake filter we supply for the Zen-O lite&#x2122; device eliminates blockages and ensures that there is a flow of oxygen to the required specifications. Vyon® porous plastics provide an ideal material for gas filtration as their tortuous path ensures excellent depth filtration. As specialists in porous plastics we have the knowledge, experience and manufacturing capacity to quickly produce components in a variety of pore sizes and thickness enabling filtration of a large range of different particulate. Our materials are also effective at bacterial filtration and preventing microbial ingress\".\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdn.thomasnet.com/ccp/30231258/173536.pdf\">Proprietary to Porvair Sciences - Vyon® is a highly versatile porous plastic</a></span> which can be modified give hydrophilic or hydrophobic properties, or enhanced to achieve specific chemical and biochemical separations.\r\n\r\nVyon® can also be combined with other materials to create a composite product. These and other desirable properties have made Vyon® the material of choice of porous plastic for medical device / healthcare companies looking to produce drug filters, vents for catheters and medical fluid collection vessels with a competitive advantage. Vyon® is available in a range of shapes and sizes to suit your needs.\r\n\r\nTo discuss how a bespoke ultra-pure Vyon® component can help improve your healthcare products performance and competitiveness, please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.\r\n\r\nPorvair Sciences are global leaders and original manufacturers and developers of cutting-edge porous plastics technologies.\r\n\r\nWith patents dating back to the 1950’s, our porous plastics continue to evolve, adapt and respond to changes in technologies, markets and customer needs. Empowered by 50 years of industrial experience, we strive to continue delivering world class, high performing products while providing superior customer service, every step of the way. Our diverse team of scientists, engineers and creative thinkers are committed to providing expert solutions that brings value and integrity to our customers. For further information please visit<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vyonporousplastics.com/medical-and-healthcare/.\"> https://www.vyonporousplastics.com/medical-and-healthcare/.</a></span>','Effective Porous Plastic Filters for Respiratory Devices','','inherit','closed','closed','','4705-revision-v1','','','2020-04-07 17:43:15','2020-04-07 17:43:15','',4705,'https://microbiozindia.com/uncategorized/4705-revision-v1/',0,'revision','',0),(4710,2,'2020-04-07 17:43:45','2020-04-07 17:43:45','Porvair Sciences reports on increased demand for the 3D moulded intake filters and vent diffusers it supplies to GCE Healthcare - manufacturer of the Zen-O lite&#x2122; Portable Oxygen Concentrator.\r\n\r\nZen-O lite&#x2122; is an ultra-lightweight portable oxygen concentrator from GCE Healthcare  that weighs just 2.5 kg (5.5 lbs).\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106574/\">The device is designed for active people suffering from respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease)</a></span> that require long term oxygen therapy. With its advanced breath detection technology, the Zen-O lite automatically responds to breathing rate and will adjust to a person’s specific needs to ensure that their lungs are receiving effective oxygen saturation.\r\n\r\n<span style=\"text-decoration: underline;\"><span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://www.cphi-online.com/advanced-porous-plastics-for-medical-life-science-news075252.html\">Alan Hughes - Porous Plastics Accounts Manager for Porvair Sciences said</a> </span>\"Governments worldwide are calling upon engineering and healthcare companies to help patients infected by COVID-19 to increase output of respiratory assistance devices. In response to this call for humanitarian aid - Porvair Sciences has prioritised manufacturing capacity to enable us to respond quickly to GCE Healthcare\'s urgent request for quick turnaround on the critical Vyon® porous plastic filters we supply for their Zen-O lite&#x2122; device\".</span>\r\n\r\nHe added \"The air intake filter we supply for the Zen-O lite&#x2122; device eliminates blockages and ensures that there is a flow of oxygen to the required specifications. Vyon® porous plastics provide an ideal material for gas filtration as their tortuous path ensures excellent depth filtration. As specialists in porous plastics we have the knowledge, experience and manufacturing capacity to quickly produce components in a variety of pore sizes and thickness enabling filtration of a large range of different particulate. Our materials are also effective at bacterial filtration and preventing microbial ingress\".\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdn.thomasnet.com/ccp/30231258/173536.pdf\">Proprietary to Porvair Sciences - Vyon® is a highly versatile porous plastic</a></span> which can be modified give hydrophilic or hydrophobic properties, or enhanced to achieve specific chemical and biochemical separations.\r\n\r\nVyon® can also be combined with other materials to create a composite product. These and other desirable properties have made Vyon® the material of choice of porous plastic for medical device / healthcare companies looking to produce drug filters, vents for catheters and medical fluid collection vessels with a competitive advantage. Vyon® is available in a range of shapes and sizes to suit your needs.\r\n\r\nTo discuss how a bespoke ultra-pure Vyon® component can help improve your healthcare products performance and competitiveness, please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.\r\n\r\nPorvair Sciences are global leaders and original manufacturers and developers of cutting-edge porous plastics technologies.\r\n\r\nWith patents dating back to the 1950’s, our porous plastics continue to evolve, adapt and respond to changes in technologies, markets and customer needs. Empowered by 50 years of industrial experience, we strive to continue delivering world class, high performing products while providing superior customer service, every step of the way. Our diverse team of scientists, engineers and creative thinkers are committed to providing expert solutions that brings value and integrity to our customers. For further information please visit<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vyonporousplastics.com/medical-and-healthcare/.\"> https://www.vyonporousplastics.com/medical-and-healthcare/.</a></span>','Effective Porous Plastic Filters for Respiratory Devices','','inherit','closed','closed','','4705-revision-v1','','','2020-04-07 17:43:45','2020-04-07 17:43:45','',4705,'https://microbiozindia.com/uncategorized/4705-revision-v1/',0,'revision','',0),(4711,2,'2020-04-07 17:44:31','2020-04-07 17:44:31','The quick spread of the infection that causes COVID-19 has started alert around the world. The World Health Organization (WHO) has pronounced this quickly spreading coronavirus flare-up a pandemic, and nations around the globe are thinking about a flood in affirmed cases. In the US, social separating to slow the spread of coronavirus has made another typical. In the interim, researchers are investigating potential medications and are starting clinical preliminaries to test new treatments and immunizations.\r\n\r\n[caption id=\"attachment_4703\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-4703 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/INFO-300x279.jpg\" alt=\"\" width=\"300\" height=\"279\" /> <em> Image Credit: Vector Stock</em>[/caption]\r\n\r\nUp until this point, most by far of coronavirus diseases have distressed grown-ups. Furthermore, when children are tainted, they will in general have milder ailment. In any case, as a parent, you can\'t resist the urge to stress over the security of your kids. <span style=\"text-decoration: underline;\">Numerous guardians are likewise attempting to discover a harmony between responding to their youngsters\' inquiries regarding the pandemic and upholding wellbeing advancing practices and social separating rules without making an environment of uneasiness. Also keeping kids drew in and engaged with schools shut and playdates dropped.</span>\r\n\r\n<strong>Are kids resistant to the infection that causes COVID-19?</strong>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bbc.com/future/article/20200330-coronavirus-are-children-immune-to-covid-19\">Kids, including little youngsters, can create COVID-19.</a></span> Be that as it may, youngsters will in general experience milder manifestations, for example, second rate fever, weakness, and hack. A few kids have had extreme intricacies, yet this has been less normal. Kids with basic wellbeing conditions might be at expanded hazard for serious ailment.\r\n\r\n<strong>Should guardians take babies for beginning immunizations at the present time? Shouldn\'t something be said about little children and up who are expected for immunizations?</strong>\r\n\r\nThe appropriate response relies upon numerous elements, including what your primary care physician\'s office is advertising. Similarly as with all medicinal services choices, it comes down to gauging dangers and advantages.\r\n\r\nGetting early inoculations in for infants and little children — particularly indulges a half year and more youthful — has significant advantages. It assists with shielding them from contaminations, for example, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994719/\">pneumococcus and pertussis that can be dangerous</a></span>, when their resistant framework is helpless. Simultaneously, they could be helpless against complexities of COVID-19 should their outing to the specialist open them to the infection.\r\n\r\n<strong>Find a way to shield youngsters and others from becoming ill</strong>\r\n\r\nHelp stop the spread of COVID-19 by doing likewise things everybody ought to do to remain solid. Show your kids to do likewise.\r\n\r\n1.<strong>Clean hands regularly utilizing</strong> cleanser and water or liquor based hand sanitizer.\r\n\r\n2.<strong>Avoid individuals</strong> who are wiped out (coughing and wheezing).\r\n\r\n3.<strong>Clean and purify high-contact surfaces</strong> day by day in family unit normal regions (like tables, hard-supported seats, door handles, light switches, remotes, handles, work areas, toilets, and sinks).\r\n\r\n4.<strong>Launder</strong><span style=\"text-decoration: underline;\"> things including launderable extravagant toys varying. Adhere to the producer\'s directions. In the event that conceivable, wash things utilizing the hottest suitable water setting and dry things totally. Filthy clothing from an evil individual can be washed with others\' things.</span>','Is kids are increasingly defenseless for COVID-19 disease??','','inherit','closed','closed','','4701-revision-v1','','','2020-04-07 17:44:31','2020-04-07 17:44:31','',4701,'https://microbiozindia.com/uncategorized/4701-revision-v1/',0,'revision','',0),(4712,2,'2020-04-07 17:45:32','2020-04-07 17:45:32','The quick spread of the infection that causes COVID-19 has started alert around the world. The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">World Health Organization (WHO)</a></span> has pronounced this quickly spreading coronavirus flare-up a pandemic, and nations around the globe are thinking about a flood in affirmed cases. In the US, social separating to slow the spread of coronavirus has made another typical. In the interim, researchers are investigating potential medications and are starting clinical preliminaries to test new treatments and immunizations.\r\n\r\n[caption id=\"attachment_4703\" align=\"aligncenter\" width=\"300\"]<img class=\"wp-image-4703 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/INFO-300x279.jpg\" alt=\"\" width=\"300\" height=\"279\" /> <em> Image Credit: Vector Stock</em>[/caption]\r\n\r\nUp until this point, most by far of coronavirus diseases have distressed grown-ups. Furthermore, when children are tainted, they will in general have milder ailment. In any case, as a parent, you can\'t resist the urge to stress over the security of your kids. <span style=\"text-decoration: underline;\">Numerous guardians are likewise attempting to discover a harmony between responding to their youngsters\' inquiries regarding the pandemic and upholding wellbeing advancing practices and social separating rules without making an environment of uneasiness. Also keeping kids drew in and engaged with schools shut and playdates dropped.</span>\r\n\r\n<strong>Are kids resistant to the infection that causes COVID-19?</strong>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bbc.com/future/article/20200330-coronavirus-are-children-immune-to-covid-19\">Kids, including little youngsters, can create COVID-19.</a></span> Be that as it may, youngsters will in general experience milder manifestations, for example, second rate fever, weakness, and hack. A few kids have had extreme intricacies, yet this has been less normal. Kids with basic wellbeing conditions might be at expanded hazard for serious ailment.\r\n\r\n<strong>Should guardians take babies for beginning immunizations at the present time? Shouldn\'t something be said about little children and up who are expected for immunizations?</strong>\r\n\r\nThe appropriate response relies upon numerous elements, including what your primary care physician\'s office is advertising. Similarly as with all medicinal services choices, it comes down to gauging dangers and advantages.\r\n\r\nGetting early inoculations in for infants and little children — particularly indulges a half year and more youthful — has significant advantages. It assists with shielding them from contaminations, for example, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994719/\">pneumococcus and pertussis that can be dangerous</a></span>, when their resistant framework is helpless. Simultaneously, they could be helpless against complexities of COVID-19 should their outing to the specialist open them to the infection.\r\n\r\n<strong>Find a way to shield youngsters and others from becoming ill</strong>\r\n\r\nHelp stop the spread of COVID-19 by doing likewise things everybody ought to do to remain solid. Show your kids to do likewise.\r\n\r\n1.<strong>Clean hands regularly utilizing</strong> cleanser and water or liquor based hand sanitizer.\r\n\r\n2.<strong>Avoid individuals</strong> who are wiped out (coughing and wheezing).\r\n\r\n3.<strong>Clean and purify high-contact surfaces</strong> day by day in family unit normal regions (like tables, hard-supported seats, door handles, light switches, remotes, handles, work areas, toilets, and sinks).\r\n\r\n4.<strong>Launder</strong><span style=\"text-decoration: underline;\"> things including launderable extravagant toys varying. Adhere to the producer\'s directions. In the event that conceivable, wash things utilizing the hottest suitable water setting and dry things totally. Filthy clothing from an evil individual can be washed with others\' things.</span>','Is kids are increasingly defenseless for COVID-19 disease??','','inherit','closed','closed','','4701-revision-v1','','','2020-04-07 17:45:32','2020-04-07 17:45:32','',4701,'https://microbiozindia.com/uncategorized/4701-revision-v1/',0,'revision','',0),(4713,2,'2020-04-07 17:46:54','2020-04-07 17:46:54','Porvair Sciences reports on increased demand for the 3D moulded intake filters and vent diffusers it supplies to GCE Healthcare - manufacturer of the Zen-O lite&#x2122; Portable Oxygen Concentrator.\r\n\r\nZen-O lite&#x2122; is an ultra-lightweight portable oxygen concentrator from GCE Healthcare  that weighs just 2.5 kg (5.5 lbs).\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106574/\">The device is designed for active people suffering from respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease)</a></span> that require long term oxygen therapy. With its advanced breath detection technology, the Zen-O lite automatically responds to breathing rate and will adjust to a person’s specific needs to ensure that their lungs are receiving effective oxygen saturation.\r\n\r\n<span style=\"text-decoration: underline;\"><span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://www.cphi-online.com/advanced-porous-plastics-for-medical-life-science-news075252.html\">Alan Hughes - Porous Plastics Accounts Manager for Porvair Sciences said</a> </span>\"Governments worldwide are calling upon engineering and healthcare companies to help patients infected by COVID-19 to increase output of respiratory assistance devices. In response to this call for humanitarian aid - Porvair Sciences has prioritised manufacturing capacity to enable us to respond quickly to GCE Healthcare\'s urgent request for quick turnaround on the critical Vyon® porous plastic filters we supply for their Zen-O lite&#x2122; device\".</span>\r\n\r\nHe added \"The air intake filter we supply for the Zen-O lite&#x2122; device eliminates blockages and ensures that there is a flow of oxygen to the required specifications. Vyon® porous plastics provide an ideal material for gas filtration as their tortuous path ensures excellent depth filtration. As specialists in porous plastics we have the knowledge, experience and manufacturing capacity to quickly produce components in a variety of pore sizes and thickness enabling filtration of a large range of different particulate. Our materials are also effective at bacterial filtration and preventing microbial ingress\".\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdn.thomasnet.com/ccp/30231258/173536.pdf\">Proprietary to Porvair Sciences - Vyon® is a highly versatile porous plastic</a></span> which can be modified give hydrophilic or hydrophobic properties, or enhanced to achieve specific chemical and biochemical separations.\r\n\r\nVyon® can also be combined with other materials to create a composite product. These and other desirable properties have made Vyon® the material of choice of porous plastic for medical device / healthcare companies looking to produce drug filters, vents for catheters and medical fluid collection vessels with a competitive advantage. Vyon® is available in a range of shapes and sizes to suit your needs.\r\n\r\nTo discuss how a bespoke ultra-pure Vyon® component can help improve your healthcare products performance and competitiveness, please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.\r\n\r\nPorvair Sciences are global leaders and original manufacturers and developers of cutting-edge porous plastics technologies.\r\n\r\nWith patents dating back to the 1950’s, our porous plastics continue to evolve, adapt and respond to changes in technologies, markets and customer needs. Empowered by 50 years of industrial experience, we strive to continue delivering world class, high performing products while providing superior customer service, every step of the way. Our diverse team of scientists, engineers and creative thinkers are committed to providing expert solutions that brings value and integrity to our customers. For further information please visit<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vyonporousplastics.com/medical-and-healthcare/.\"> https://www.vyonporousplastics.com/medical-and-healthcare/.</a></span>','Effective Porous Plastic Filters for Respiratory Devices','','inherit','closed','closed','','4705-revision-v1','','','2020-04-07 17:46:54','2020-04-07 17:46:54','',4705,'https://microbiozindia.com/uncategorized/4705-revision-v1/',0,'revision','',0),(4714,2,'2020-04-08 07:46:44','2020-04-08 07:46:44','West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President &amp; General Manager for the Asia Pacific region.\r\n\r\n[caption id=\"attachment_4715\" align=\"alignright\" width=\"293\"]<img class=\"wp-image-4715 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/newpic.-293x300.png\" alt=\"\" width=\"293\" height=\"300\" /> <span style=\"text-decoration: underline;\"><em>Stewart Campbell Vice President &amp; General Manger for Asia Pacific Region</em></span>[/caption]\r\n\r\nStewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise.\r\n\r\nHe will be responsible for oversight of West’s Asia Pacific business and will lead regional teams to continue establishing the company\'s leading position. \"I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately benefit our regional customers and the patients they serve,” said Stewart. “Over the past 40 years, West has built a foundation of strong leadership, quality and scientific expertise in the Asia Pacific region. I am confident that, by continuing to work by our customers’ sides, our Asia Pacific team will drive even more momentum and add even greater value across the region.\"\r\n\r\nBefore joining West, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.fmc.com/fmc-acquisition\">Stewart led the FMC Asia Pacific Health &amp; Nutrition business</a></span>, where he built their food division into a $100+ million USD business. Stewart has significant experience in major Asia Pacific economies and has guided organizations, including Research &amp;Development teams,through strategic planning and execution processes to deliver sustainable, profitable businesses. He is also adept at overseeing capital projects, including acquisitions and integration of acquired businesses, and has led manufacturing sites in China and Asia.Stewart received an MBA from the University of Chicago GSB Booth. He also holds Bachelor’s and Master’s degrees in Food Science and Engineering from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unsw.edu.au/\">University of New South Wales.</a></span>\r\n\r\n<strong>About West Asia Pacific</strong>\r\nIn 1983, West established operations in Singapore. In 2009, an injection molding facility opened in Shanghai Qingpu Industrial Zone in China. At present, West has one digital technology center in Bengaluru India, three main production bases located in Singapore, Shanghai China and Chennai India, and seven offices and distributor centers in Australia, China, India, Korea, and Singapore. About West\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/West_Pharmaceutical_Services\">West Pharmaceutical Services, Inc.</a></span> is a leading manufacturer of packaging components and delivery\r\nsystems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West’s 2019 net sales of $1.84 billion reflect the daily use of more than 100 million of its components and devices,which are designed to improve the delivery of healthcare to patients around the world.\r\n\r\nFor more information, please visit www.westpharma.com. West and the diamond logo and By your side for a healthier world&#x2122; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.','West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region','','publish','open','open','','west-pharmaceutical-names-stewart-campbell-vice-president-general-manger-for-asia-pacific-region','','','2020-04-08 08:04:22','2020-04-08 08:04:22','',0,'https://microbiozindia.com/?p=4714',0,'post','',0),(4715,2,'2020-04-08 07:41:56','2020-04-08 07:41:56','','newpic.','','inherit','open','closed','','newpic','','','2020-04-08 07:41:56','2020-04-08 07:41:56','',4714,'https://microbiozindia.com/wp-content/uploads/2020/04/newpic..png',0,'attachment','image/png',0),(4716,2,'2020-04-08 07:46:04','2020-04-08 07:46:04','','west','','inherit','open','closed','','west','','','2020-04-08 07:46:04','2020-04-08 07:46:04','',4714,'https://microbiozindia.com/wp-content/uploads/2020/04/west.png',0,'attachment','image/png',0),(4717,2,'2020-04-08 07:46:44','2020-04-08 07:46:44','West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President &amp; General Manager for the Asia Pacific region.\r\n\r\n[caption id=\"attachment_4715\" align=\"alignright\" width=\"293\"]<img class=\"wp-image-4715 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/newpic.-293x300.png\" alt=\"\" width=\"293\" height=\"300\" /> <span style=\"text-decoration: underline;\"><em>Stewart Campbell Vice President &amp; General Manger for Asia Pacific Region</em></span>[/caption]\r\n\r\nStewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise.\r\n\r\nHe will be responsible for oversight of West’s Asia Pacific business and will lead regional teams to continue establishing the company\'s leading position. \"I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately benefit our regional customers and the patients they serve,” said Stewart. “Over the past 40 years, West has built a foundation of strong leadership, quality and scientific expertise in the Asia Pacific region. I am confident that, by continuing to work by our customers’ sides, our Asia Pacific team will drive even more momentum and add even greater value across the region.\"\r\n\r\nBefore joining West, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.fmc.com/fmc-acquisition\">Stewart led the FMC Asia Pacific Health &amp; Nutrition business</a></span>, where he built their food division into a $100+ million USD business. Stewart has significant experience in major Asia Pacific economies and has guided organizations, including Research &amp;Development teams,\r\nthrough strategic planning and execution processes to deliver sustainable, profitable businesses. He\r\nis also adept at overseeing capital projects, including acquisitions and integration of acquired\r\nbusinesses, and has led manufacturing sites in China and Asia.\r\n\r\nStewart received an MBA from the University of Chicago GSB Booth. He also holds Bachelor’s and\r\nMaster’s degrees in Food Science and Engineering from the University of New South Wales.\r\nAbout West Asia Pacific\r\nIn 1983, West established operations in Singapore. In 2009, an injection molding facility opened in\r\nShanghai Qingpu Industrial Zone in China. At present, West has one digital technology center in\r\nBengaluru India, three main production bases located in Singapore, Shanghai China and Chennai\r\nIndia, and seven offices and distributor centers in Australia, China, India, Korea, and Singapore.\r\nAbout West\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/West_Pharmaceutical_Services\">West Pharmaceutical Services, Inc.</a></span> is a leading manufacturer of packaging components and delivery\r\nsystems for injectable drugs and healthcare products. Working by the side of its customers from\r\nconcept to patient, West creates products that promote the efficiency, reliability and safety of the\r\nworld’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its\r\ncustomers from locations in North and South America, Europe, Asia and Australia. West’s 2019 net\r\nsales of $1.84 billion reflect the daily use of more than 100 million of its components and devices,\r\nwhich are designed to improve the delivery of healthcare to patients around the world. For more\r\ninformation, please visit www.westpharma.com.\r\nWest and the diamond logo and By your side for a healthier world&#x2122; are registered trademarks or\r\ntrademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.','West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region','','inherit','closed','closed','','4714-revision-v1','','','2020-04-08 07:46:44','2020-04-08 07:46:44','',4714,'https://microbiozindia.com/uncategorized/4714-revision-v1/',0,'revision','',0),(4718,2,'2020-04-08 08:03:40','2020-04-08 08:03:40','West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President &amp; General Manager for the Asia Pacific region.\n\n[caption id=\"attachment_4715\" align=\"alignright\" width=\"293\"]<img class=\"wp-image-4715 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/newpic.-293x300.png\" alt=\"\" width=\"293\" height=\"300\" /> <span style=\"text-decoration: underline;\"><em>Stewart Campbell Vice President &amp; General Manger for Asia Pacific Region</em></span>[/caption]\n\nStewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise.\n\nHe will be responsible for oversight of West’s Asia Pacific business and will lead regional teams to continue establishing the company\'s leading position. \"I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately benefit our regional customers and the patients they serve,” said Stewart. “Over the past 40 years, West has built a foundation of strong leadership, quality and scientific expertise in the Asia Pacific region. I am confident that, by continuing to work by our customers’ sides, our Asia Pacific team will drive even more momentum and add even greater value across the region.\"\n\nBefore joining West, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.fmc.com/fmc-acquisition\">Stewart led the FMC Asia Pacific Health &amp; Nutrition business</a></span>, where he built their food division into a $100+ million USD business. Stewart has significant experience in major Asia Pacific economies and has guided organizations, including Research &amp;Development teams,through strategic planning and execution processes to deliver sustainable, profitable businesses. He is also adept at overseeing capital projects, including acquisitions and integration of acquired businesses, and has led manufacturing sites in China and Asia.Stewart received an MBA from the University of Chicago GSB Booth. He also holds Bachelor’s and Master’s degrees in Food Science and Engineering from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unsw.edu.au/\">University of New South Wales.</a></span>\n\n<strong>About West Asia Pacific</strong>\nIn 1983, West established operations in Singapore. In 2009, an injection molding facility opened in Shanghai Qingpu Industrial Zone in China. At present, West has one digital technology center in Bengaluru India, three main production bases located in Singapore, Shanghai China and Chennai\nIndia, and seven offices and distributor centers in Australia, China, India, Korea, and Singapore.\nAbout West\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/West_Pharmaceutical_Services\">West Pharmaceutical Services, Inc.</a></span> is a leading manufacturer of packaging components and delivery\nsystems for injectable drugs and healthcare products. Working by the side of its customers from\nconcept to patient, West creates products that promote the efficiency, reliability and safety of the\nworld’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its\ncustomers from locations in North and South America, Europe, Asia and Australia. West’s 2019 net\nsales of $1.84 billion reflect the daily use of more than 100 million of its components and devices,\nwhich are designed to improve the delivery of healthcare to patients around the world.\n\nFor more information, please visit www.westpharma.com. West and the diamond logo and By your side for a healthier world&#x2122; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.','West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region','','inherit','closed','closed','','4714-autosave-v1','','','2020-04-08 08:03:40','2020-04-08 08:03:40','',4714,'https://microbiozindia.com/uncategorized/4714-autosave-v1/',0,'revision','',0),(4719,2,'2020-04-08 08:02:36','2020-04-08 08:02:36','West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President &amp; General Manager for the Asia Pacific region.\r\n\r\n[caption id=\"attachment_4715\" align=\"alignright\" width=\"293\"]<img class=\"wp-image-4715 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/newpic.-293x300.png\" alt=\"\" width=\"293\" height=\"300\" /> <span style=\"text-decoration: underline;\"><em>Stewart Campbell Vice President &amp; General Manger for Asia Pacific Region</em></span>[/caption]\r\n\r\nStewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise.\r\n\r\nHe will be responsible for oversight of West’s Asia Pacific business and will lead regional teams to continue establishing the company\'s leading position. \"I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately benefit our regional customers and the patients they serve,” said Stewart. “Over the past 40 years, West has built a foundation of strong leadership, quality and scientific expertise in the Asia Pacific region. I am confident that, by continuing to work by our customers’ sides, our Asia Pacific team will drive even more momentum and add even greater value across the region.\"\r\n\r\nBefore joining West, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.fmc.com/fmc-acquisition\">Stewart led the FMC Asia Pacific Health &amp; Nutrition business</a></span>, where he built their food division into a $100+ million USD business. Stewart has significant experience in major Asia Pacific economies and has guided organizations, including Research &amp;Development teams,through strategic planning and execution processes to deliver sustainable, profitable businesses. He is also adept at overseeing capital projects, including acquisitions and integration of acquired businesses, and has led manufacturing sites in China and Asia.Stewart received an MBA from the University of Chicago GSB Booth. He also holds Bachelor’s and Master’s degrees in Food Science and Engineering from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unsw.edu.au/\">University of New South Wales.</a></span>\r\n\r\n<strong>About West Asia Pacific</strong>\r\nIn 1983, West established operations in Singapore. In 2009, an injection molding facility opened in\r\nShanghai Qingpu Industrial Zone in China. At present, West has one digital technology center in\r\nBengaluru India, three main production bases located in Singapore, Shanghai China and Chennai\r\nIndia, and seven offices and distributor centers in Australia, China, India, Korea, and Singapore.\r\nAbout West\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/West_Pharmaceutical_Services\">West Pharmaceutical Services, Inc.</a></span> is a leading manufacturer of packaging components and delivery\r\nsystems for injectable drugs and healthcare products. Working by the side of its customers from\r\nconcept to patient, West creates products that promote the efficiency, reliability and safety of the\r\nworld’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its\r\ncustomers from locations in North and South America, Europe, Asia and Australia. West’s 2019 net\r\nsales of $1.84 billion reflect the daily use of more than 100 million of its components and devices,\r\nwhich are designed to improve the delivery of healthcare to patients around the world. For more\r\ninformation, please visit www.westpharma.com.\r\nWest and the diamond logo and By your side for a healthier world&#x2122; are registered trademarks or\r\ntrademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.','West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region','','inherit','closed','closed','','4714-revision-v1','','','2020-04-08 08:02:36','2020-04-08 08:02:36','',4714,'https://microbiozindia.com/uncategorized/4714-revision-v1/',0,'revision','',0),(4720,2,'2020-04-08 08:04:22','2020-04-08 08:04:22','West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President &amp; General Manager for the Asia Pacific region.\r\n\r\n[caption id=\"attachment_4715\" align=\"alignright\" width=\"293\"]<img class=\"wp-image-4715 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/newpic.-293x300.png\" alt=\"\" width=\"293\" height=\"300\" /> <span style=\"text-decoration: underline;\"><em>Stewart Campbell Vice President &amp; General Manger for Asia Pacific Region</em></span>[/caption]\r\n\r\nStewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise.\r\n\r\nHe will be responsible for oversight of West’s Asia Pacific business and will lead regional teams to continue establishing the company\'s leading position. \"I am honored to serve West in this critical growth market, as it represents significant business opportunities that will ultimately benefit our regional customers and the patients they serve,” said Stewart. “Over the past 40 years, West has built a foundation of strong leadership, quality and scientific expertise in the Asia Pacific region. I am confident that, by continuing to work by our customers’ sides, our Asia Pacific team will drive even more momentum and add even greater value across the region.\"\r\n\r\nBefore joining West, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.fmc.com/fmc-acquisition\">Stewart led the FMC Asia Pacific Health &amp; Nutrition business</a></span>, where he built their food division into a $100+ million USD business. Stewart has significant experience in major Asia Pacific economies and has guided organizations, including Research &amp;Development teams,through strategic planning and execution processes to deliver sustainable, profitable businesses. He is also adept at overseeing capital projects, including acquisitions and integration of acquired businesses, and has led manufacturing sites in China and Asia.Stewart received an MBA from the University of Chicago GSB Booth. He also holds Bachelor’s and Master’s degrees in Food Science and Engineering from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unsw.edu.au/\">University of New South Wales.</a></span>\r\n\r\n<strong>About West Asia Pacific</strong>\r\nIn 1983, West established operations in Singapore. In 2009, an injection molding facility opened in Shanghai Qingpu Industrial Zone in China. At present, West has one digital technology center in Bengaluru India, three main production bases located in Singapore, Shanghai China and Chennai India, and seven offices and distributor centers in Australia, China, India, Korea, and Singapore. About West\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/West_Pharmaceutical_Services\">West Pharmaceutical Services, Inc.</a></span> is a leading manufacturer of packaging components and delivery\r\nsystems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West’s 2019 net sales of $1.84 billion reflect the daily use of more than 100 million of its components and devices,which are designed to improve the delivery of healthcare to patients around the world.\r\n\r\nFor more information, please visit www.westpharma.com. West and the diamond logo and By your side for a healthier world&#x2122; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.','West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region','','inherit','closed','closed','','4714-revision-v1','','','2020-04-08 08:04:22','2020-04-08 08:04:22','',4714,'https://microbiozindia.com/uncategorized/4714-revision-v1/',0,'revision','',0),(4721,2,'2020-04-08 08:11:46','2020-04-08 08:11:46','The MagSi-NA Pathogens Kit from AMSBIO enables easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab / nasopharyngeal swab, and any other respiratory samples for pathogen detection.\r\n\r\nThe kit is particularly suitable for total nucleic acid extraction for<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vox.com/2020/3/30/21186822/immunity-to-covid-19-test-coronavirus-rt-pcr-antibody\"> SARS-CoV-2 / COVID-19 detection, currently a major bottleneck in COVID-19 testing.</a></span>\r\n\r\nDue to the kit’s simple protocol and ready-to-use-agents, it is easy to scale to small, medium, and high-throughput automation, yielding highly pure nucleic acid in small elution volumes. T<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspx\">he MagSi-NA Pathogens Kit</a> </span>utilizes magnetic beads to ensure a consistently high yield, with the proprietary MagSi-PA VII magnetic beads optimized for fast separation even from viscous sample lysates.\r\n\r\nIn less than 30 minutes, the MagSi-NA Pathogens Kit delivers consistently high yield of total nucleic acids, which can be used for qPCR-based or any other enzymatic pathogen detection method. The kit is compatible with liquid handling robots and protocols are available for popular magnetic processors enabling easy integration into a high-throughput workflow.\r\n\r\nFor further information on the MagSi-NA Pathogens Kit please visit <span style=\"color: #000000;\"><a style=\"color: #000000;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspx\"><span style=\"color: #ff6600;\">http://www.amsbio.com/magsi-na-pathogen-kit.aspx</span> or </a></span>contact AMSBIO on +44-1235-828200 /+1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology(AMSBIO) is recognized today as a leading transatlantic company contributing tothe acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation.\r\n\r\nThis expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','Total Nucleic Acid Extraction for Pathogen Detection','','publish','open','open','','total-nucleic-acid-extraction-for-pathogen-detection','','','2020-04-08 13:28:59','2020-04-08 13:28:59','',0,'https://microbiozindia.com/?p=4721',0,'post','',0),(4722,2,'2020-04-08 08:09:29','2020-04-08 08:09:29','','AMSBIONEW..','','inherit','open','closed','','amsbionew','','','2020-04-08 08:09:29','2020-04-08 08:09:29','',4721,'https://microbiozindia.com/wp-content/uploads/2020/04/AMSBIONEW...png',0,'attachment','image/png',0),(4723,2,'2020-04-08 08:11:46','2020-04-08 08:11:46','The MagSi-NA Pathogens Kit from AMSBIO enables easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab / nasopharyngeal swab, and any other respiratory samples for pathogen detection.\r\n\r\nThe kit is particularly suitable for total nucleic acid extraction for<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vox.com/2020/3/30/21186822/immunity-to-covid-19-test-coronavirus-rt-pcr-antibody\"> SARS-CoV-2 / COVID-19 detection, currently a major bottleneck in COVID-19 testing.</a></span>\r\n\r\nDue to the kit’s simple protocol and ready-to-use-agents, it is easy to scale to small, medium, and high-throughput automation, yielding highly pure nucleic acid in small elution volumes. T<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.magtivio.com/home-2/products/portfolio-3/magsi-dna-trial-kit/\">he MagSi-NA Pathogens Kit</a> </span>utilizes magnetic beads to ensure a consistently high yield, with the proprietary MagSi-PA VII magnetic beads optimized for fast separation even from viscous sample lysates.\r\n\r\nIn less than 30 minutes, the MagSi-NA Pathogens Kit delivers consistently high yield of total nucleic acids, which can be used for qPCR-based or any other enzymatic pathogen detection method. The kit is compatible with liquid handling robots and protocols are available for popular magnetic processors enabling easy integration into a high-throughput workflow.\r\n\r\nFor further information on the MagSi-NA Pathogens Kit please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspxor\">http://www.amsbio.com/magsi-na-pathogen-kit.aspxor </a></span>contact AMSBIO on +44-1235-828200 /+1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology(AMSBIO) is recognized today as a leading transatlantic company contributing tothe acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation.\r\n\r\nThis expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','Total Nucleic Acid Extraction for Pathogen Detection','','inherit','closed','closed','','4721-revision-v1','','','2020-04-08 08:11:46','2020-04-08 08:11:46','',4721,'https://microbiozindia.com/uncategorized/4721-revision-v1/',0,'revision','',0),(4724,2,'2020-04-08 09:06:25','2020-04-08 09:06:25','No immunizations exist that secure individuals against contaminations by coronaviruses, including <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2, which causes COVID-19,</a></span> or the ones that cause SARS and MERS. As COVID-19 keeps on unleashing ruin, numerous labs around the globe have built up a laser-like spotlight on understanding the infection and finding the best technique for halting it.\r\n\r\nThis week in <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/journals/1266/\">mBio</a></span>, a diary of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">American Society of Microbiology,</a></span> a group of interdisciplinary specialists portrays a promising immunization competitor against the MERS infection. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">Since the MERS (Middle East Respiratory Syndrome)</a> </span>flare-up started in 2012, in excess of 850 individuals have kicked the bucket, and studies propose the infection has a case casualty pace of over 30%.\r\n\r\n[caption id=\"attachment_4727\" align=\"aligncenter\" width=\"469\"]<img class=\"wp-image-4727 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/200407072712_1_900x600-300x169.jpg\" alt=\"\" width=\"469\" height=\"264\" /> SARS-CoV-2 illustration (stock image). Credit: © Matthias Friel / Adobe Stock[/caption]\r\n\r\nIn the new paper, the specialists propose that the methodology they took for a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS infection immunization</a></span> may likewise neutralize SARS-CoV-2. The immunization\'s conveyance technique is a RNA infection called parainfluenza infection 5 (PIV5), which is accepted to cause a condition known as pet hotel hack in hounds however seems innocuous to individuals. The scientists added an additional quality to the infection with the goal that contaminated cells would create the S, or spike, glycoprotein known to be engaged with MERS diseases.\r\n<span style=\"text-decoration: underline;\">\"We know people have been exposed to PIV5, but it seems to be an innocuous virus in humans,\" said pediatric pulmonologist and coronavirus expert Paul McCray, M.D., at the University of Iowa, in Iowa City, who co-led the new study with virologist Biao He, Ph.D., at the University of Georgia, in Athens. \"PIV5 doesn\'t seem to cause a cytopathic effect.\"</span> The MERS virus cannot replicate in mice, so to test the vaccine McCray developed a mouse model that mimics human infections. The mice had been genetically engineered to express DPP4, the protein used by the MERS virus as an entry point for human cells.\r\nLab tests demonstrated that a solitary portion of the immunization, given intranasally, adequately made contaminated cells produce the S protein, which thusly activated invulnerable reactions against the protein in the creature have.\r\n\r\nA month after the mice got the antibody, they were presented to a strain of the MERS infection, adjusted to the mice to cause a deadly disease. The MERS infection was likewise given to gatherings of mice that had gotten an alternate <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536407/\">PIV5 immunization</a></span> - one without the qualities for the S protein - or an intramuscular antibody with inactivated MERS infection.\r\n\r\nAll the mice vaccinated with the altered PIV5 infection endure MERS infection disease. Interestingly, all the mice inoculated with the PIV5 without S kicked the bucket from the contamination. The intramuscular antibody of inactivated MERS infection just shielded 25% of the mice from a deadly disease. The mice that got inactivated MERS infection appeared better than expected degrees of eosinophils, white platelets that demonstrate contamination or aggravation.\r\n\r\nThis association raises a wellbeing worry for inactivated MERS infection as a potential antibody, said He. The examination shows that an intranasal, PIV5-based antibody is compelling against MERS in mice, said He, and ought to be researched for its potential against different perilous coronaviruses, including SARS-CoV-2.\"We\'re quite interested in using viruses as gene delivery vehicles,\" said McCray, who has also investigated similar strategies as a way to treat cystic fibrosis. Now, like colleagues around the world, McCray and He have both focused their research efforts on SARS-CoV-2, taking a similar tack to working with mouse models of infection and testing vaccines.\r\n\r\nFinding an effective vaccine against the coronavirus that causes COVID-19 is a race against time, McCray said. \"One hundred percent of the population is not going to be exposed to the virus the first time around, which means there will be more people to infect when it comes again,\" he said. \"We don\'t know yet if people get lasting immunity from the SARS-CoV-2 infection, so it\'s important to think about ways to protect the population.\"\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asm.org/Press-Releases/2020/Engineered-Virus-Might-be-Able-to-Block-Coronaviru\">Materials</a> </span>provided by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asm.org/\">American Society for Microbiology</a> </span>and Content may be edited for style and length.\r\n<strong>Journal Reference:</strong>\r\n1. Kun Li, Zhuo Li, Christine Wohlford-Lenane, David K. Meyerholz, Rudragouda Channappanavar, Dong An, Stanley Perlman, Paul B. McCray, Biao He. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. mBio, 2020; 11 (2) <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://dx.doi.org/10.1128/mBio.00554-20\">DOI: 10.1128/mBio.00554-20</a></span>','Vaccines for MERS Virus may have the option to block the coronavirus infections','','publish','open','open','','vaccines-for-mers-virus-may-have-the-option-to-block-the-coronavirus-infections','','','2020-04-08 09:06:25','2020-04-08 09:06:25','',0,'https://microbiozindia.com/?p=4724',0,'post','',0),(4725,2,'2020-04-08 08:54:40','2020-04-08 08:54:40','','Coronavirus infographics elements, human are showing coronavirus symptoms and risk factors. health and medical vector illustration.','Coronavirus CoV infographics elements, human are showing coronavirus symptoms and risk factors. health and medical vector illustration.','inherit','open','closed','','coronavirus-infographics-elements-human-are-showing-coronavirus-symptoms-and-risk-factors-health-and-medical-vector-illustration','','','2020-04-08 08:54:40','2020-04-08 08:54:40','',4724,'https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-infographics-elements-human-are-vector-29425706.jpg',0,'attachment','image/jpeg',0),(4726,2,'2020-04-08 08:55:00','2020-04-08 08:55:00','','coranavirus-4929467_1920','','inherit','open','closed','','coranavirus-4929467_1920','','','2020-04-08 08:55:00','2020-04-08 08:55:00','',4724,'https://microbiozindia.com/wp-content/uploads/2020/04/coranavirus-4929467_1920.jpg',0,'attachment','image/jpeg',0),(4727,2,'2020-04-08 08:55:14','2020-04-08 08:55:14','','200407072712_1_900x600','','inherit','open','closed','','200407072712_1_900x600','','','2020-04-08 08:55:14','2020-04-08 08:55:14','',4724,'https://microbiozindia.com/wp-content/uploads/2020/04/200407072712_1_900x600.jpg',0,'attachment','image/jpeg',0),(4728,2,'2020-04-08 09:06:25','2020-04-08 09:06:25','No immunizations exist that secure individuals against contaminations by coronaviruses, including <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2, which causes COVID-19,</a></span> or the ones that cause SARS and MERS. As COVID-19 keeps on unleashing ruin, numerous labs around the globe have built up a laser-like spotlight on understanding the infection and finding the best technique for halting it.\r\n\r\nThis week in <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/journals/1266/\">mBio</a></span>, a diary of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">American Society of Microbiology,</a></span> a group of interdisciplinary specialists portrays a promising immunization competitor against the MERS infection. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">Since the MERS (Middle East Respiratory Syndrome)</a> </span>flare-up started in 2012, in excess of 850 individuals have kicked the bucket, and studies propose the infection has a case casualty pace of over 30%.\r\n\r\n[caption id=\"attachment_4727\" align=\"aligncenter\" width=\"469\"]<img class=\"wp-image-4727 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/200407072712_1_900x600-300x169.jpg\" alt=\"\" width=\"469\" height=\"264\" /> SARS-CoV-2 illustration (stock image). Credit: © Matthias Friel / Adobe Stock[/caption]\r\n\r\nIn the new paper, the specialists propose that the methodology they took for a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS infection immunization</a></span> may likewise neutralize SARS-CoV-2. The immunization\'s conveyance technique is a RNA infection called parainfluenza infection 5 (PIV5), which is accepted to cause a condition known as pet hotel hack in hounds however seems innocuous to individuals. The scientists added an additional quality to the infection with the goal that contaminated cells would create the S, or spike, glycoprotein known to be engaged with MERS diseases.\r\n<span style=\"text-decoration: underline;\">\"We know people have been exposed to PIV5, but it seems to be an innocuous virus in humans,\" said pediatric pulmonologist and coronavirus expert Paul McCray, M.D., at the University of Iowa, in Iowa City, who co-led the new study with virologist Biao He, Ph.D., at the University of Georgia, in Athens. \"PIV5 doesn\'t seem to cause a cytopathic effect.\"</span> The MERS virus cannot replicate in mice, so to test the vaccine McCray developed a mouse model that mimics human infections. The mice had been genetically engineered to express DPP4, the protein used by the MERS virus as an entry point for human cells.\r\nLab tests demonstrated that a solitary portion of the immunization, given intranasally, adequately made contaminated cells produce the S protein, which thusly activated invulnerable reactions against the protein in the creature have.\r\n\r\nA month after the mice got the antibody, they were presented to a strain of the MERS infection, adjusted to the mice to cause a deadly disease. The MERS infection was likewise given to gatherings of mice that had gotten an alternate <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536407/\">PIV5 immunization</a></span> - one without the qualities for the S protein - or an intramuscular antibody with inactivated MERS infection.\r\n\r\nAll the mice vaccinated with the altered PIV5 infection endure MERS infection disease. Interestingly, all the mice inoculated with the PIV5 without S kicked the bucket from the contamination. The intramuscular antibody of inactivated MERS infection just shielded 25% of the mice from a deadly disease. The mice that got inactivated MERS infection appeared better than expected degrees of eosinophils, white platelets that demonstrate contamination or aggravation.\r\n\r\nThis association raises a wellbeing worry for inactivated MERS infection as a potential antibody, said He. The examination shows that an intranasal, PIV5-based antibody is compelling against MERS in mice, said He, and ought to be researched for its potential against different perilous coronaviruses, including SARS-CoV-2.\"We\'re quite interested in using viruses as gene delivery vehicles,\" said McCray, who has also investigated similar strategies as a way to treat cystic fibrosis. Now, like colleagues around the world, McCray and He have both focused their research efforts on SARS-CoV-2, taking a similar tack to working with mouse models of infection and testing vaccines.\r\n\r\nFinding an effective vaccine against the coronavirus that causes COVID-19 is a race against time, McCray said. \"One hundred percent of the population is not going to be exposed to the virus the first time around, which means there will be more people to infect when it comes again,\" he said. \"We don\'t know yet if people get lasting immunity from the SARS-CoV-2 infection, so it\'s important to think about ways to protect the population.\"\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asm.org/Press-Releases/2020/Engineered-Virus-Might-be-Able-to-Block-Coronaviru\">Materials</a> </span>provided by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asm.org/\">American Society for Microbiology</a> </span>and Content may be edited for style and length.\r\n<strong>Journal Reference:</strong>\r\n1. Kun Li, Zhuo Li, Christine Wohlford-Lenane, David K. Meyerholz, Rudragouda Channappanavar, Dong An, Stanley Perlman, Paul B. McCray, Biao He. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. mBio, 2020; 11 (2) <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://dx.doi.org/10.1128/mBio.00554-20\">DOI: 10.1128/mBio.00554-20</a></span>','Vaccines for MERS Virus may have the option to block the coronavirus infections','','inherit','closed','closed','','4724-revision-v1','','','2020-04-08 09:06:25','2020-04-08 09:06:25','',4724,'https://microbiozindia.com/uncategorized/4724-revision-v1/',0,'revision','',0),(4729,2,'2020-04-08 09:54:49','2020-04-08 09:54:49','AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.med.osaka-u.ac.jp/eng/\">Graduate School of Medicine, Osaka University, Japan</a></span> using StemFit Basic03 clinical grade s<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.takarabio.com/products/stem-cell-research/media-and-supplements/stem-cell-matrices/imatrix-511\">tem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.</a></span>\r\n\r\n[caption id=\"attachment_4674\" align=\"alignright\" width=\"300\"]<img class=\"wp-image-4674 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/amsbiopr264-imageB-300x114.jpg\" alt=\"\" width=\"300\" height=\"114\" /> SEAM (Self-formed Ectodermal Autonomous Multi-zone) of ocular cells, generated from human induced pluripotent stem cells, used to generate sheets of ocular surface ectoderm for transplant (Courtesy Hayashi et al.)[/caption]\r\n\r\nIn this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were produced using and transplanted into patients with corneal epithelial stem cell deficiency. The clinical study was approved by the Japanese government and the first transplant was performed in July 2019 with four transplantations planned in total.\r\n\r\nWhen interviewed about his group’s pioneering work - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/uploads/Interview-Dr-Hayashi-Final-AMSBIO.pdf\"><span style=\"text-decoration: underline;\">Professor Hayashi commented \"In the framework of clinical study, we consulted with the PMDA on Japanese standards for biological materials and referred to their opinions.</span> </a></span>Beneficially StemFit® Basic03 and iMatrix-511 had already been approved for clinical use by our Pharmaceuticals &amp; Medical Devices Agency, so no additional data or paperwork were required. It was very helpful\". Professor Hayashi added \"Previously, we had tried other feeder culture, but the StemFit/iMatrix-511 combination showed the most stable growth. For our application we found the compatibility with corneal differentiation was very good, it is stable and has no problems. In addition, because StemFit® Basic03 has good clinical compatibility, we have been able to conducting experiments using it from the basic research stage to eliminate the effects of changing the medium\".\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://onenucleus.com/clinical-study-ipsc-derived-corneal-epithelial-cells\">Completely free of animal- and human-derived components (and also available as GMP Grade, made in USA under US cGMP) StemFit® Basic03 from AMSBIO</a> </span>is proven to provide highly stable and reproducible culture condition for Induced Pluripotent Stem and Embryonic Stem cells under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture. StemFit® Basic03 combines high colony forming efficiency with lower than standard media volume consumption to offer cost effective colony expansion when compared to leading competitors.\r\n\r\nTo read the interview with Professor Hayashi in full, and to learn more about StemFit® Basic03 stem cell culture medium please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/\">http://www.amsbio.com/</a></span>Feeder-Free-Stem-Cell-Culture.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.\r\n\r\nFor drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','World First Clinical Study of iPSC-derived Corneal Epithelial Cells','','inherit','closed','closed','','4672-revision-v1','','','2020-04-08 09:54:49','2020-04-08 09:54:49','',4672,'https://microbiozindia.com/uncategorized/4672-revision-v1/',0,'revision','',0),(4730,2,'2020-04-08 11:03:59','2020-04-08 11:03:59','AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.med.osaka-u.ac.jp/eng/\">Graduate School of Medicine, Osaka University, Japan</a></span> using StemFit Basic03 clinical grade s<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/Feeder-Free-Stem-Cell-Culture.aspx\">tem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.</a></span>\n\n[caption id=\"attachment_4674\" align=\"alignright\" width=\"300\"]<img class=\"wp-image-4674 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/amsbiopr264-imageB-300x114.jpg\" alt=\"\" width=\"300\" height=\"114\" /> SEAM (Self-formed Ectodermal Autonomous Multi-zone) of ocular cells, generated from human induced pluripotent stem cells, used to generate sheets of ocular surface ectoderm for transplant (Courtesy Hayashi et al.)[/caption]\n\nIn this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were produced using and transplanted into patients with corneal epithelial stem cell deficiency. The clinical study was approved by the Japanese government and the first transplant was performed in July 2019 with four transplantations planned in total.\n\nWhen interviewed about his group’s pioneering work - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/uploads/Interview-Dr-Hayashi-Final-AMSBIO.pdf\"><span style=\"text-decoration: underline;\">Professor Hayashi commented \"In the framework of clinical study, we consulted with the PMDA on Japanese standards for biological materials and referred to their opinions.</span> </a></span>Beneficially StemFit® Basic03 and iMatrix-511 had already been approved for clinical use by our Pharmaceuticals &amp; Medical Devices Agency, so no additional data or paperwork were required. It was very helpful\". Professor Hayashi added \"Previously, we had tried other feeder culture, but the StemFit/iMatrix-511 combination showed the most stable growth. For our application we found the compatibility with corneal differentiation was very good, it is stable and has no problems. In addition, because StemFit® Basic03 has good clinical compatibility, we have been able to conducting experiments using it from the basic research stage to eliminate the effects of changing the medium\".\n\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://onenucleus.com/clinical-study-ipsc-derived-corneal-epithelial-cells\">Completely free of animal- and human-derived components (and also available as GMP Grade, made in USA under US cGMP) StemFit® Basic03 from AMSBIO</a> </span>is proven to provide highly stable and reproducible culture condition for Induced Pluripotent Stem and Embryonic Stem cells under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture. StemFit® Basic03 combines high colony forming efficiency with lower than standard media volume consumption to offer cost effective colony expansion when compared to leading competitors.\n\nTo read the interview with Professor Hayashi in full, and to learn more about StemFit® Basic03 stem cell culture medium please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/\">http://www.amsbio.com/</a></span>Feeder-Free-Stem-Cell-Culture.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.\n\nFounded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.\n\nFor drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','World First Clinical Study of iPSC-derived Corneal Epithelial Cells','','inherit','closed','closed','','4672-autosave-v1','','','2020-04-08 11:03:59','2020-04-08 11:03:59','',4672,'https://microbiozindia.com/uncategorized/4672-autosave-v1/',0,'revision','',0),(4731,2,'2020-04-08 11:04:14','2020-04-08 11:04:14','AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.med.osaka-u.ac.jp/eng/\">Graduate School of Medicine, Osaka University, Japan</a></span> using StemFit Basic03 clinical grade s<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/Feeder-Free-Stem-Cell-Culture.aspx\">tem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.</a></span>\r\n\r\n[caption id=\"attachment_4674\" align=\"alignright\" width=\"300\"]<img class=\"wp-image-4674 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/amsbiopr264-imageB-300x114.jpg\" alt=\"\" width=\"300\" height=\"114\" /> SEAM (Self-formed Ectodermal Autonomous Multi-zone) of ocular cells, generated from human induced pluripotent stem cells, used to generate sheets of ocular surface ectoderm for transplant (Courtesy Hayashi et al.)[/caption]\r\n\r\nIn this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were produced using and transplanted into patients with corneal epithelial stem cell deficiency. The clinical study was approved by the Japanese government and the first transplant was performed in July 2019 with four transplantations planned in total.\r\n\r\nWhen interviewed about his group’s pioneering work - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/uploads/Interview-Dr-Hayashi-Final-AMSBIO.pdf\"><span style=\"text-decoration: underline;\">Professor Hayashi commented \"In the framework of clinical study, we consulted with the PMDA on Japanese standards for biological materials and referred to their opinions.</span> </a></span>Beneficially StemFit® Basic03 and iMatrix-511 had already been approved for clinical use by our Pharmaceuticals &amp; Medical Devices Agency, so no additional data or paperwork were required. It was very helpful\". Professor Hayashi added \"Previously, we had tried other feeder culture, but the StemFit/iMatrix-511 combination showed the most stable growth. For our application we found the compatibility with corneal differentiation was very good, it is stable and has no problems. In addition, because StemFit® Basic03 has good clinical compatibility, we have been able to conducting experiments using it from the basic research stage to eliminate the effects of changing the medium\".\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/Feeder-Free-Stem-Cell-Culture.aspx\">Completely free of animal- and human-derived components (and also available as GMP Grade, made in USA under US cGMP) StemFit® Basic03 from AMSBIO</a> </span>is proven to provide highly stable and reproducible culture condition for Induced Pluripotent Stem and Embryonic Stem cells under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture. StemFit® Basic03 combines high colony forming efficiency with lower than standard media volume consumption to offer cost effective colony expansion when compared to leading competitors.\r\n\r\nTo read the interview with Professor Hayashi in full, and to learn more about StemFit® Basic03 stem cell culture medium please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/\">http://www.amsbio.com/</a></span>Feeder-Free-Stem-Cell-Culture.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.\r\n\r\nFor drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','World First Clinical Study of iPSC-derived Corneal Epithelial Cells','','inherit','closed','closed','','4672-revision-v1','','','2020-04-08 11:04:14','2020-04-08 11:04:14','',4672,'https://microbiozindia.com/uncategorized/4672-revision-v1/',0,'revision','',0),(4732,2,'2020-04-08 11:05:36','2020-04-08 11:05:36','The MagSi-NA Pathogens Kit from AMSBIO enables easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab / nasopharyngeal swab, and any other respiratory samples for pathogen detection.\r\n\r\nThe kit is particularly suitable for total nucleic acid extraction for<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vox.com/2020/3/30/21186822/immunity-to-covid-19-test-coronavirus-rt-pcr-antibody\"> SARS-CoV-2 / COVID-19 detection, currently a major bottleneck in COVID-19 testing.</a></span>\r\n\r\nDue to the kit’s simple protocol and ready-to-use-agents, it is easy to scale to small, medium, and high-throughput automation, yielding highly pure nucleic acid in small elution volumes. T<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspx\">he MagSi-NA Pathogens Kit</a> </span>utilizes magnetic beads to ensure a consistently high yield, with the proprietary MagSi-PA VII magnetic beads optimized for fast separation even from viscous sample lysates.\r\n\r\nIn less than 30 minutes, the MagSi-NA Pathogens Kit delivers consistently high yield of total nucleic acids, which can be used for qPCR-based or any other enzymatic pathogen detection method. The kit is compatible with liquid handling robots and protocols are available for popular magnetic processors enabling easy integration into a high-throughput workflow.\r\n\r\nFor further information on the MagSi-NA Pathogens Kit please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspxor\">http://www.amsbio.com/magsi-na-pathogen-kit.aspxor </a></span>contact AMSBIO on +44-1235-828200 /+1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology(AMSBIO) is recognized today as a leading transatlantic company contributing tothe acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation.\r\n\r\nThis expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','Total Nucleic Acid Extraction for Pathogen Detection','','inherit','closed','closed','','4721-revision-v1','','','2020-04-08 11:05:36','2020-04-08 11:05:36','',4721,'https://microbiozindia.com/uncategorized/4721-revision-v1/',0,'revision','',0),(4733,2,'2020-04-08 13:03:17','2020-04-08 13:03:17','The MagSi-NA Pathogens Kit from AMSBIO enables easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab / nasopharyngeal swab, and any other respiratory samples for pathogen detection.\r\n\r\nThe kit is particularly suitable for total nucleic acid extraction for<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vox.com/2020/3/30/21186822/immunity-to-covid-19-test-coronavirus-rt-pcr-antibody\"> SARS-CoV-2 / COVID-19 detection, currently a major bottleneck in COVID-19 testing.</a></span>\r\n\r\nDue to the kit’s simple protocol and ready-to-use-agents, it is easy to scale to small, medium, and high-throughput automation, yielding highly pure nucleic acid in small elution volumes. T<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspx\">he MagSi-NA Pathogens Kit</a> </span>utilizes magnetic beads to ensure a consistently high yield, with the proprietary MagSi-PA VII magnetic beads optimized for fast separation even from viscous sample lysates.\r\n\r\nIn less than 30 minutes, the MagSi-NA Pathogens Kit delivers consistently high yield of total nucleic acids, which can be used for qPCR-based or any other enzymatic pathogen detection method. The kit is compatible with liquid handling robots and protocols are available for popular magnetic processors enabling easy integration into a high-throughput workflow.\r\n\r\nFor further information on the MagSi-NA Pathogens Kit please visit <span style=\"color: #000000;\"><a style=\"color: #000000;\" href=\"http://www.amsbio.com/magsi-na-pathogen-kit.aspx\"><span style=\"color: #ff6600;\">http://www.amsbio.com/magsi-na-pathogen-kit.aspx</span> or </a></span>contact AMSBIO on +44-1235-828200 /+1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology(AMSBIO) is recognized today as a leading transatlantic company contributing tothe acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation.\r\n\r\nThis expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','Total Nucleic Acid Extraction for Pathogen Detection','','inherit','closed','closed','','4721-revision-v1','','','2020-04-08 13:03:17','2020-04-08 13:03:17','',4721,'https://microbiozindia.com/uncategorized/4721-revision-v1/',0,'revision','',0),(4734,2,'2020-04-08 14:51:07','0000-00-00 00:00:00','April 7 of each year marks the celebration of World Health Day. The objective of this day is to create awareness among people to achieve good health and secure their wellbeing. With the rapidly evolving times, it becomes essential to be prepared mentally, physically and financially for all kinds of uncertainties which may surface in the future. At unsettling times like the coronavirus outbreak, most people continue to bear their medical expenses out of their pocket and at times even end up mortgaging their assets due to a shortage of funds. No one should have to choose between good health and other necessities of life, and that’s why securing one’s health becomes imperative.\nPlanning finances on time and investing in a health insurance plan can be the first step towards ensuring a secured future. Taking suitable cover is another important factor with the increasing cost of hospitalisation, especially the exorbitant ICU charges at the time of a critical illness. Health Insurance plays a significant role in such times and allows one to get better treatments at the hospital.\nAccording to Ms. Anjali Malhotra, Chief Customer, Marketing, Digital &amp; IT Officer, Aviva India, some of the key benefits of health insurance plans are:\n• Coverage against medical expenses\nHealth insurance acts as a shield to protect your savings in case of unfortunate events like unexpected hospitalization and high medical costs. It ensures you get cover for daycare procedures, illness-related treatment costs, ambulance charges pre- and post-hospitalisation expense. Also, a comprehensive critical health illness insurance policy ensures that you can achieve quality medical treatment anywhere, at any point in time. It is never too late to make the move to invest in insurance plans for financial security.\n• Tax Benefits\nThe premium paid on a health insurance policy is eligible for deduction under Section 80D of the Income Tax Act. The amount of deduction available is up to Rs 15,000 for individuals or Rs 20,000 for senior citizens (aged above 65 years). Additionally, an amount of Rs 20,000 is also available for exemption towards premium paid for dependent parents. A taxpayer may therefore, maximise tax benefit under section 80D of the Income Tax Act by investing in health insurance.\n• Makes you prepared for uncertainties in life\nMedical emergencies can arise anytime, just like the current unexpected Coronavirus outbreak. Also, due to changing lifestyles and increasing stress levels, people are now more prone to a lot of critical illnesses. People can get stressed and anxious due to various surprises that life can spring up. That’s why, health insurance is essential to help manage stress due to insufficient funds for medical treatment at such times. Investing in health insurance at the right time gives a sense of security and prepares you for a better tomorrow.\n• Cashless claim benefit\nHealth insurance offers cashless claim facility in an unforeseen medical emergency as well as a planned hospitalization. Therefore, one can have a hassle-free medical treatment at hospitals empaneled by the insurance provider, without making out of pocket payments to the hospital. The insurance company settles claims directly with the hospital.\n• Effective financial planning\n\nSetting life goals is the key contributor that drives you to achieve them. People usually strive for financial protection for the family, loved ones and aim to invest adequately for future needs. Buying and investing in good health insurance or critical illness insurance plan is one of the first steps towards effective financial planning. Being financially prepared and secured allows you to manage your savings and investments for the future. Additionally, the taxes you save can be further invested elsewhere, such as, for child’s education or extra-curricular classes, or small investment for business or saving for child’s marriage.\n\nIt is alarming that the majority of the Indian population does not have adequate Health Insurance policy. The primary factor is the lack of awareness about the importance of health insurance and financial planning. One must understand that you can enjoy the benefits of health insurance by getting a suitable insurance with appropriate cover. This also helps you and your family creates an adequate cushion any financial exigencies arising out of health issues. So, this World Health Day, pledge to add health insurance to your financial portfolio to protect yourselves and your family against uncertainties of life.','Stay healthy and secured for any uncertainties in life this world health day','','draft','open','open','','','','','2020-04-08 14:51:07','2020-04-08 14:51:07','',0,'https://microbiozindia.com/?p=4734',0,'post','',0),(4735,2,'2020-04-08 14:50:13','2020-04-08 14:50:13','','PM-Humor-Happy-Healthy-min-1080x675','','inherit','open','closed','','pm-humor-happy-healthy-min-1080x675','','','2020-04-08 14:50:13','2020-04-08 14:50:13','',4734,'https://microbiozindia.com/wp-content/uploads/2020/04/PM-Humor-Happy-Healthy-min-1080x675-1.jpg',0,'attachment','image/jpeg',0),(4737,2,'2020-04-08 18:02:26','2020-04-08 18:02:26','Chemotherapeutic medications, otherwise called antineoplastic operators, that are recommended to treat a range of cancer types, enter the oceanic condition through human discharge and wastewater treatment facilities. An audit distributed in Environmental Toxicology and Chemistry shows that not very many investigations have portrayed the impacts of antineoplastic specialists that are discharged into sea-going conditions.\r\n\r\nThe authors noticed that with many antineoplastic specialists in late-stage clinical improvement, it is basic to comprehend the poisonous quality of these mixes in sea-going conditions so as to educate future guidelines.\r\n\r\n\"The worldwide populace is maturing, and malignancy battling pharmaceuticals are being distinguished in water frameworks. We should be proactive as an academic network and distinguish potential holes in our insight with respect to the outcomes of against neoplastic presentation in oceanic life forms,\" said relating author Christopher J. Martyniuk, of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vetmed.ufl.edu/\">University of Florida at the College of Veterinary Medicine.</a></span>\r\n\r\n<strong>Story Source:</strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://newsroom.wiley.com/press-release/environmental-toxicology-and-chemistry/what-are-environmental-impacts-cancer-drugs\">Materials</a> </span>provided by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.wiley.com/en-in\">Wiley</a></span> and Content may be edited for style and length.\r\n\r\n<strong>Journal Reference:</strong>\r\n1. Alexis M. Wormington, Maite De María, Hajime G. Kurita, Joseph H. Bisesi, Nancy D. Denslow, Christopher J. Martyniuk. Antineoplastic Agents: Environmental Prevalence and Adverse Outcomes in Aquatic Organisms. Environmental Toxicology and Chemistry, 2020; D<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://dx.doi.org/10.1002/etc.4687\">OI: 10.1002/etc.4687</a></span>','What are the ecological effects of cancer drugs?','','publish','open','open','','what-are-the-ecological-effects-of-cancer-drugs','','','2020-04-08 18:02:26','2020-04-08 18:02:26','',0,'https://microbiozindia.com/?p=4737',0,'post','',0),(4738,2,'2020-04-08 17:57:32','2020-04-08 17:57:32','','cancer-treatments_large','','inherit','open','closed','','cancer-treatments_large','','','2020-04-08 17:57:32','2020-04-08 17:57:32','',4737,'https://microbiozindia.com/wp-content/uploads/2020/04/cancer-treatments_large.jpg',0,'attachment','image/jpeg',0),(4739,2,'2020-04-08 18:02:26','2020-04-08 18:02:26','Chemotherapeutic medications, otherwise called antineoplastic operators, that are recommended to treat a range of cancer types, enter the oceanic condition through human discharge and wastewater treatment facilities. An audit distributed in Environmental Toxicology and Chemistry shows that not very many investigations have portrayed the impacts of antineoplastic specialists that are discharged into sea-going conditions.\r\n\r\nThe authors noticed that with many antineoplastic specialists in late-stage clinical improvement, it is basic to comprehend the poisonous quality of these mixes in sea-going conditions so as to educate future guidelines.\r\n\r\n\"The worldwide populace is maturing, and malignancy battling pharmaceuticals are being distinguished in water frameworks. We should be proactive as an academic network and distinguish potential holes in our insight with respect to the outcomes of against neoplastic presentation in oceanic life forms,\" said relating author Christopher J. Martyniuk, of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vetmed.ufl.edu/\">University of Florida at the College of Veterinary Medicine.</a></span>\r\n\r\n<strong>Story Source:</strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://newsroom.wiley.com/press-release/environmental-toxicology-and-chemistry/what-are-environmental-impacts-cancer-drugs\">Materials</a> </span>provided by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.wiley.com/en-in\">Wiley</a></span> and Content may be edited for style and length.\r\n\r\n<strong>Journal Reference:</strong>\r\n1. Alexis M. Wormington, Maite De María, Hajime G. Kurita, Joseph H. Bisesi, Nancy D. Denslow, Christopher J. Martyniuk. Antineoplastic Agents: Environmental Prevalence and Adverse Outcomes in Aquatic Organisms. Environmental Toxicology and Chemistry, 2020; D<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://dx.doi.org/10.1002/etc.4687\">OI: 10.1002/etc.4687</a></span>','What are the ecological effects of cancer drugs?','','inherit','closed','closed','','4737-revision-v1','','','2020-04-08 18:02:26','2020-04-08 18:02:26','',4737,'https://microbiozindia.com/uncategorized/4737-revision-v1/',0,'revision','',0),(4740,2,'2020-04-09 06:57:24','2020-04-09 06:57:24','Mumbai, India; April 9, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as \"Cipla\") today announced that it has received final approval for its<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\"> Abbreviated New Drug Application (ANDA)</a></span> for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA).\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cipla.com/\">Cipla’s</a></span> Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, is the first AB-rated generic therapeutic equivalent version of Merck Sharp &amp; Dohme Corp’s Proventil® HFA Inhalation Aerosol. It is used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.\r\n\r\nAccording to IQVIA (IMS Health): Proventil® HFA Inhalation Aerosol and its authorized generic equivalent had US sales of approximately $153M for the 12-month period ending February 2020. The entire Albuterol Sulfate HFA Inhalation Aerosol market had US sales of approximately $2.8 Billion for the 12-month period ending February 2020.\r\n\r\n<span style=\"text-decoration: underline;\">Umang Vohra (MD and Global CEO, Cipla Limited) said, “We are pleased to receive the final approval for generic Albuterol MDI from the USFDA. This further strengthens our presence in the US market. Albuterol is the first generic metered dose inhaler of Proventil® HFA Inhalation Aerosol ever approved by FDA in the US and Cipla’s first device-based inhalation product in the market. This development reiterates our commitment of strengthening our respiratory franchise and will further solidify our position as lung leader globally. We will continue to build on our portfolio of drug-device combinations in the respiratory space to serve the unmet needs of our patients across markets.”</span>\r\n\r\nWe are planning shipments in a staggered manner. We are also ensuring that we do our bit by donating the product in this time of need.','Cipla receives final approval for generic version of inhalation drug','','publish','open','open','','cipla-receives-final-approval-for-generic-version-of-inhalation-drug','','','2020-04-09 06:57:24','2020-04-09 06:57:24','',0,'https://microbiozindia.com/?p=4740',0,'post','',0),(4741,2,'2020-04-09 06:54:29','2020-04-09 06:54:29','','Cipla1280-770x433','','inherit','open','closed','','cipla1280-770x433','','','2020-04-09 06:54:29','2020-04-09 06:54:29','',4740,'https://microbiozindia.com/wp-content/uploads/2020/04/Cipla1280-770x433-1.jpg',0,'attachment','image/jpeg',0),(4742,2,'2020-04-09 06:57:24','2020-04-09 06:57:24','Mumbai, India; April 9, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as \"Cipla\") today announced that it has received final approval for its<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\"> Abbreviated New Drug Application (ANDA)</a></span> for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA).\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cipla.com/\">Cipla’s</a></span> Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, is the first AB-rated generic therapeutic equivalent version of Merck Sharp &amp; Dohme Corp’s Proventil® HFA Inhalation Aerosol. It is used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.\r\n\r\nAccording to IQVIA (IMS Health): Proventil® HFA Inhalation Aerosol and its authorized generic equivalent had US sales of approximately $153M for the 12-month period ending February 2020. The entire Albuterol Sulfate HFA Inhalation Aerosol market had US sales of approximately $2.8 Billion for the 12-month period ending February 2020.\r\n\r\n<span style=\"text-decoration: underline;\">Umang Vohra (MD and Global CEO, Cipla Limited) said, “We are pleased to receive the final approval for generic Albuterol MDI from the USFDA. This further strengthens our presence in the US market. Albuterol is the first generic metered dose inhaler of Proventil® HFA Inhalation Aerosol ever approved by FDA in the US and Cipla’s first device-based inhalation product in the market. This development reiterates our commitment of strengthening our respiratory franchise and will further solidify our position as lung leader globally. We will continue to build on our portfolio of drug-device combinations in the respiratory space to serve the unmet needs of our patients across markets.”</span>\r\n\r\nWe are planning shipments in a staggered manner. We are also ensuring that we do our bit by donating the product in this time of need.','Cipla receives final approval for generic version of inhalation drug','','inherit','closed','closed','','4740-revision-v1','','','2020-04-09 06:57:24','2020-04-09 06:57:24','',4740,'https://microbiozindia.com/uncategorized/4740-revision-v1/',0,'revision','',0),(4743,2,'2020-04-09 10:40:31','2020-04-09 10:40:31','The organization has gotten last endorsement from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">US Food and Drug Administration (USFDA)</a></span> to showcase its item which is a conventional form of Gleevec tablets, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://zyduscadila.com/\">Zydus Cadila</a></span> said in an announcement.\r\n\r\nThe Ahmedabad-based firm has gotten endorsement to advertise the medication in qualities of 100 mg and 400 mg, it included.\r\n\r\n\"This medicine is utilized to treat particular sorts of leukemia (blood malignant growth), bone marrow issue, skin disease and tumors of the stomach and stomach related framework,\" the medication producer said.\r\n\r\nThe medication will be made at the gathering\'s definition fabricating office at the SEZ, in Ahmedabad.\r\n\r\nThe organization said it currently has 285 endorsements and has so far recorded more than 386 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">abbriviated new medication application (ANDAs)</a></span> since the beginning of the documenting procedure in 2003-04.','Zydus Cadila gets USFDA gesture to showcase generic cancer drug','','publish','open','open','','zydus-cadila-gets-usfda-gesture-to-showcase-generic-cancer-medicate','','','2020-04-09 11:11:21','2020-04-09 11:11:21','',0,'https://microbiozindia.com/?p=4743',0,'post','',0),(4744,2,'2020-04-09 10:37:58','2020-04-09 10:37:58','','001ZYDUS','','inherit','open','closed','','001zydus','','','2020-04-09 10:37:58','2020-04-09 10:37:58','',4743,'https://microbiozindia.com/wp-content/uploads/2020/04/001ZYDUS.jpg',0,'attachment','image/jpeg',0),(4745,2,'2020-04-09 10:40:31','2020-04-09 10:40:31','The organization has gotten last endorsement from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">US Food and Drug Administration (USFDA)</a></span> to showcase its item which is a conventional form of Gleevec tablets, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://zyduscadila.com/\">Zydus Cadila</a></span> said in an announcement.\r\n\r\nThe Ahmedabad-based firm has gotten endorsement to advertise the medication in qualities of 100 mg and 400 mg, it included.\r\n\r\n\"This medicine is utilized to treat particular sorts of leukemia (blood malignant growth), bone marrow issue, skin disease and tumors of the stomach and stomach related framework,\" the medication producer said.\r\n\r\nThe medication will be made at the gathering\'s definition fabricating office at the SEZ, in Ahmedabad.\r\n\r\nThe organization said it currently has 285 endorsements and has so far recorded more than 386 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">abbriviated new medication application (ANDAs)</a></span> since the beginning of the documenting procedure in 2003-04.','Zydus Cadila gets USFDA gesture to showcase generic cancer medicate','','inherit','closed','closed','','4743-revision-v1','','','2020-04-09 10:40:31','2020-04-09 10:40:31','',4743,'https://microbiozindia.com/uncategorized/4743-revision-v1/',0,'revision','',0),(4746,2,'2020-04-09 11:05:45','2020-04-09 11:05:45','Granules India Ltd on Thursday said its remote auxiliary has gotten endorsement from the US wellbeing controller for Butalbital, Acetaminophen and Caffeine Capsules used to treat pressure cerebral pains.\r\n\r\nIn an administrative documenting the organization said \"<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">US Food and Drug Administration (US FDA) has endorsed the Abbreviated New Drug Application (ANDA)</a> </span>recorded by Granules Pharmaceuticals, Inc (GPI), a completely possessed remote backup of Granules India Ltd for Butalbital, Acetaminophen and Caffeine\r\n\r\nCases USP, 50 mg/300 mg/40 mg.\"\r\n\r\nIt is bioequivalent to the reference recorded medication item, Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg, of Nexgen Pharma, Inc.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules are utilized to treat pressure migraines.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg had US deals of roughly 42 million dollar MAT for the latest a year finishing off with February, 2020 as per IQVIA Health.\r\n\r\nGranules currently has an aggregate of 25 ANDA endorsements from USFDA.','Granules India gets USFDA endorsement for Butalbital, Acetaminophen, Caffeine capsules','','publish','open','open','','granules-india-gets-usfda-endorsement-for-butalbital-acetaminophen-caffeine-cases','','','2020-04-09 11:09:09','2020-04-09 11:09:09','',0,'https://microbiozindia.com/?p=4746',0,'post','',0),(4747,2,'2020-04-09 10:43:04','2020-04-09 10:43:04','','002GRANUPES','','inherit','open','closed','','002granupes','','','2020-04-09 10:43:04','2020-04-09 10:43:04','',4746,'https://microbiozindia.com/wp-content/uploads/2020/04/002GRANUPES.jpg',0,'attachment','image/jpeg',0),(4748,2,'2020-04-09 11:05:45','2020-04-09 11:05:45','Granules India Ltd on Thursday said its remote auxiliary has gotten endorsement from the US wellbeing controller for Butalbital, Acetaminophen and Caffeine Capsules used to treat pressure cerebral pains.\r\n\r\nIn an administrative documenting the organization said \"<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">US Food and Drug Administration (US FDA) has endorsed the Abbreviated New Drug Application (ANDA)</a> </span>recorded by Granules Pharmaceuticals, Inc (GPI), a completely possessed remote backup of Granules India Ltd for Butalbital, Acetaminophen and Caffeine\r\n\r\nCases USP, 50 mg/300 mg/40 mg.\"\r\n\r\nIt is bioequivalent to the reference recorded medication item, Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg, of Nexgen Pharma, Inc.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules are utilized to treat pressure migraines.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg had US deals of roughly 42 million dollar MAT for the latest a year finishing off with February, 2020 as per IQVIA Health.\r\n\r\nGranules currently has an aggregate of 25 ANDA endorsements from USFDA.','Granules India gets USFDA endorsement for Butalbital, Acetaminophen, Caffeine cases','','inherit','closed','closed','','4746-revision-v1','','','2020-04-09 11:05:45','2020-04-09 11:05:45','',4746,'https://microbiozindia.com/uncategorized/4746-revision-v1/',0,'revision','',0),(4749,2,'2020-04-09 11:09:09','2020-04-09 11:09:09','Granules India Ltd on Thursday said its remote auxiliary has gotten endorsement from the US wellbeing controller for Butalbital, Acetaminophen and Caffeine Capsules used to treat pressure cerebral pains.\r\n\r\nIn an administrative documenting the organization said \"<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">US Food and Drug Administration (US FDA) has endorsed the Abbreviated New Drug Application (ANDA)</a> </span>recorded by Granules Pharmaceuticals, Inc (GPI), a completely possessed remote backup of Granules India Ltd for Butalbital, Acetaminophen and Caffeine\r\n\r\nCases USP, 50 mg/300 mg/40 mg.\"\r\n\r\nIt is bioequivalent to the reference recorded medication item, Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg, of Nexgen Pharma, Inc.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules are utilized to treat pressure migraines.\r\n\r\nButalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg had US deals of roughly 42 million dollar MAT for the latest a year finishing off with February, 2020 as per IQVIA Health.\r\n\r\nGranules currently has an aggregate of 25 ANDA endorsements from USFDA.','Granules India gets USFDA endorsement for Butalbital, Acetaminophen, Caffeine capsules','','inherit','closed','closed','','4746-revision-v1','','','2020-04-09 11:09:09','2020-04-09 11:09:09','',4746,'https://microbiozindia.com/uncategorized/4746-revision-v1/',0,'revision','',0),(4750,2,'2020-04-09 11:11:21','2020-04-09 11:11:21','The organization has gotten last endorsement from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">US Food and Drug Administration (USFDA)</a></span> to showcase its item which is a conventional form of Gleevec tablets, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://zyduscadila.com/\">Zydus Cadila</a></span> said in an announcement.\r\n\r\nThe Ahmedabad-based firm has gotten endorsement to advertise the medication in qualities of 100 mg and 400 mg, it included.\r\n\r\n\"This medicine is utilized to treat particular sorts of leukemia (blood malignant growth), bone marrow issue, skin disease and tumors of the stomach and stomach related framework,\" the medication producer said.\r\n\r\nThe medication will be made at the gathering\'s definition fabricating office at the SEZ, in Ahmedabad.\r\n\r\nThe organization said it currently has 285 endorsements and has so far recorded more than 386 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda\">abbriviated new medication application (ANDAs)</a></span> since the beginning of the documenting procedure in 2003-04.','Zydus Cadila gets USFDA gesture to showcase generic cancer drug','','inherit','closed','closed','','4743-revision-v1','','','2020-04-09 11:11:21','2020-04-09 11:11:21','',4743,'https://microbiozindia.com/uncategorized/4743-revision-v1/',0,'revision','',0),(4751,2,'2020-04-09 12:24:01','2020-04-09 12:24:01','An ongoing report recommends that a specific protein, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/GPR56\">GPR56,</a></span> is engaged with the science of depression and the impact of antidepressants. The scientists accept that this protein could offer a novel objective for new energizer drugs.\r\n\r\nMisery is a typical mental issue and one of the main sources of incapacity around the world. Antidepressants are the principal line treatment for moderate to serious significant burdensome scenes. In spite of their adequacy, just 40% of patients react to the main energizer they attempt.\r\n\r\nThe investigation, distributed in the diary Nature interchanges, emphatically proposes that GPR56 could offer a novel objective for new stimulant medications.\r\n\r\nRight now, by Professor Gustavo Turecki of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mcgill.ca/psychiatry/about/affiliated-hospitals/dmhui\">McGill University and the Douglas Mental Health University Institute,</a></span> a global consortium of specialists and clinicians explored changes in the movement of qualities in the blood in more than 400 patients who were being treated with antidepressants.\r\n\r\nThe outcomes indicated unmistakably that there were huge changes in the degrees of GPR56 in patients who reacted well to antidepressants, however not in non-responders, or patients getting fake treatment. This revelation is especially intriguing, as GPR56 may speak to a simple to-gauge biomarker for reaction to antidepressants.\r\n\r\nThe analysts affirmed that GPR56, which can be identified through a basic blood test, was related with natural changes in the focal sensory system by doing tries different things with mice, and by considering human cerebrum tissue acquired from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://douglasbrainbank.ca/\">Douglas Bell-Canada Brain Bank</a></span>. They found that GPR56 was changed in despondency and that it was altered, both in the blood and the mind, when antidepressants were managed. These progressions were especially obvious in the prefrontal cortex, a significant zone of the mind for the guideline of feelings and insight.\r\n\r\n<span style=\"text-decoration: underline;\">\"Identifying new therapeutic strategies is a major challenge, and GPR56 is an excellent target for the development of new treatments of depression,\" said Gustavo Turecki. \"We are hopeful that this will provide an avenue to alleviate the suffering of patients who face this important, and often chronic, mental illness which is also strongly associated with the risk of addiction and an increased risk of suicide.</span>','Promising advancement in depression examine','','publish','open','open','','promising-advancement-in-depression-examine','','','2020-04-09 12:24:01','2020-04-09 12:24:01','',0,'https://microbiozindia.com/?p=4751',0,'post','',0),(4752,2,'2020-04-09 12:18:55','2020-04-09 12:18:55','','Print','Print','inherit','open','closed','','print','','','2020-04-09 12:18:55','2020-04-09 12:18:55','',4751,'https://microbiozindia.com/wp-content/uploads/2020/04/7491-Facts__Stats_Depression-1296x728-Header.jpg',0,'attachment','image/jpeg',0),(4753,2,'2020-04-09 12:24:01','2020-04-09 12:24:01','An ongoing report recommends that a specific protein, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/GPR56\">GPR56,</a></span> is engaged with the science of depression and the impact of antidepressants. The scientists accept that this protein could offer a novel objective for new energizer drugs.\r\n\r\nMisery is a typical mental issue and one of the main sources of incapacity around the world. Antidepressants are the principal line treatment for moderate to serious significant burdensome scenes. In spite of their adequacy, just 40% of patients react to the main energizer they attempt.\r\n\r\nThe investigation, distributed in the diary Nature interchanges, emphatically proposes that GPR56 could offer a novel objective for new stimulant medications.\r\n\r\nRight now, by Professor Gustavo Turecki of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mcgill.ca/psychiatry/about/affiliated-hospitals/dmhui\">McGill University and the Douglas Mental Health University Institute,</a></span> a global consortium of specialists and clinicians explored changes in the movement of qualities in the blood in more than 400 patients who were being treated with antidepressants.\r\n\r\nThe outcomes indicated unmistakably that there were huge changes in the degrees of GPR56 in patients who reacted well to antidepressants, however not in non-responders, or patients getting fake treatment. This revelation is especially intriguing, as GPR56 may speak to a simple to-gauge biomarker for reaction to antidepressants.\r\n\r\nThe analysts affirmed that GPR56, which can be identified through a basic blood test, was related with natural changes in the focal sensory system by doing tries different things with mice, and by considering human cerebrum tissue acquired from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://douglasbrainbank.ca/\">Douglas Bell-Canada Brain Bank</a></span>. They found that GPR56 was changed in despondency and that it was altered, both in the blood and the mind, when antidepressants were managed. These progressions were especially obvious in the prefrontal cortex, a significant zone of the mind for the guideline of feelings and insight.\r\n\r\n<span style=\"text-decoration: underline;\">\"Identifying new therapeutic strategies is a major challenge, and GPR56 is an excellent target for the development of new treatments of depression,\" said Gustavo Turecki. \"We are hopeful that this will provide an avenue to alleviate the suffering of patients who face this important, and often chronic, mental illness which is also strongly associated with the risk of addiction and an increased risk of suicide.</span>','Promising advancement in depression examine','','inherit','closed','closed','','4751-revision-v1','','','2020-04-09 12:24:01','2020-04-09 12:24:01','',4751,'https://microbiozindia.com/uncategorized/4751-revision-v1/',0,'revision','',0),(4754,2,'2020-04-10 08:33:45','2020-04-10 08:33:45','Minerals have a positive effect on our body. Calcium keeps our bones strong, iron delivers oxygen to your blood cells and zinc helps your <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system\">immune system</a></span> function properly. Another mineral that protects your body is Fluoride. Found in soil and rocks, fluoride is often added to toothpaste to improve its benefit to the health of your teeth. In recent decades, fluoride in toothpaste has played a big role in reducing cavities and improving people\'s overall health around the world.\r\n\r\nFluoride helps your tooth enamel in two ways: When a person\'s teeth are still beginning to emerge, this ingredient develops the enamel so that it becomes as hard as it needs to be to resist cavities and decay. After the teeth have appeared in the mouth, fluoride in toothpaste, mouthwash and even tap water helps the enamel remain strong so that it can resist the acid produced by oral bacteria when you eat sugary foods. Fluoride also has a remineralizing effect on the teeth, by which it helps rebuild worn-down or weakened enamel before it disappears.\r\n\r\nThere is no scientifically valid evidence to show that fluoride causes cancer, kidney disease, or other disorders.Usually for people is to take fluoride supplements or have a dentist or dental hygienist apply a fluoride varnish during a routine appointment. Suggests the ADA, is that putting fluoride in toothpaste has led to a major decrease in the number of cavities Americans have had since 1960.\r\n\r\nA majority of toothpastes on the market contain about 0.15% fluoride ion, which comes out to 1500 ppm (parts per million.) In 1.5 ml of toothpaste (the large stripe pictured above) you would find 2.25 mg of fluoride. In a pea sized amount of toothpaste, you would only find 0.3 mg of fluoride.\r\n\r\nOne of the customer contacted <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/\">HANNA</a></span> to determine Fluoride in ppm level. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HANNA’s HI5522 pH/ORP/ISE bench-top instrument</a></span> features up to five point calibration, five fixed standard solutions available (0.1, 1, 10, 100, 1000 choice of concentration).The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> can use ISE electrodes in the ppm scale (pH channel input) and provides a choice of measurement units (ppb, ppm, molarity, weight/volume %).Overall, the customer was pleased with the meter and the ready to use reagents and now looks to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check.html\">Hanna Instruments</a></span> as a reliable and credible source for their other testing needs.\r\n\r\nThe meter <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> here is an advanced research grade benchtop pH/ORP/ISE and EC/TDS/Salinity/Resistivity meter that is completely customizable with a large color LCD, capacitive touch keys, and USB port for computer connectivity. It have two-channel meter that allows for simultaneous measure of pH, ORP, or ISE on one channel and EC, TDS, Salinity, or Resistivity on the other. The two measurement channels of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a> </span>are galvanically isolated to eliminate noise and instability.\r\n\r\n<img class=\"alignnone size-medium wp-image-4756\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/HANNA..-300x272.png\" alt=\"\" width=\"300\" height=\"272\" />\r\n\r\nChannel one has a BNC connection for use with the expansive line of pH, ORP, and ISE electrodes that Hanna Instruments offers. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> can measure EC over a wide range from 0.000 μS/cm to 1000.0 mS/cm*. The meter can be set to auto-ranging in which the meter chooses the appropriate conductivity range from seven ranges or fixed range in which the meter will only display reading in μS/cm or mS/cm. All readings are automatically compensated for temperature variations with a built in temperature sensor.\r\n\r\n<span style=\"text-decoration: underline;\">The temperature correction coefficient is adjustable from 0.00 to 10.00 %/°C.</span>\r\n<span style=\"text-decoration: underline;\">Incremental methods like The known addition, known subtraction, analyte addition, and analyte subtraction incremental methods are pre-programmed into the <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a>.</span> This meter also offers Three selectable logging modes are availableon the <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span>: automatic, manual, and AutoHold logging. Automatic and manuallogs up to 100 lots with 50,000 records max/lot, with up to 100,000 total data points.</span>','Role of Fluoride content in your toothpaste','','publish','open','open','','role-of-fluoride-content-in-your-toothpaste','','','2020-04-13 07:25:18','2020-04-13 07:25:18','',0,'https://microbiozindia.com/?p=4754',0,'post','',0),(4755,2,'2020-04-10 08:19:47','2020-04-10 08:19:47','','HANNA','','inherit','open','closed','','hanna','','','2020-04-10 08:19:47','2020-04-10 08:19:47','',4754,'https://microbiozindia.com/wp-content/uploads/2020/04/HANNA.png',0,'attachment','image/png',0),(4756,2,'2020-04-10 08:29:08','2020-04-10 08:29:08','','HANNA..','','inherit','open','closed','','hanna-2','','','2020-04-10 08:29:08','2020-04-10 08:29:08','',4754,'https://microbiozindia.com/wp-content/uploads/2020/04/HANNA...png',0,'attachment','image/png',0),(4757,2,'2020-04-10 08:33:45','2020-04-10 08:33:45','Minerals have a positive effect on our body. Calcium keeps our bones strong, iron delivers oxygen to your blood cells and zinc helps your <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system\">immune system</a></span> function properly. Another mineral that protects your body is Fluoride. Found in soil and rocks, fluoride is often added to toothpaste to improve its benefit to the health of your teeth. In recent decades, fluoride in toothpaste has played a big role in reducing cavities and improving people\'s overall health around the world.\r\n\r\nFluoride helps your tooth enamel in two ways: When a person\'s teeth are still beginning to emerge, this ingredient develops the enamel so that it becomes as hard as it needs to be to resist cavities and decay. After the teeth have appeared in the mouth, fluoride in toothpaste, mouthwash and even tap water helps the enamel remain strong so that it can resist the acid produced by oral bacteria when you eat sugary foods. Fluoride also has a remineralizing effect on the teeth, by which it helps rebuild worn-down or weakened enamel before it disappears.\r\n\r\nThere is no scientifically valid evidence to show that fluoride causes cancer, kidney disease, or other disorders.Usually for people is to take fluoride supplements or have a dentist or dental hygienist apply a fluoride varnish during a routine appointment. Suggests the ADA, is that putting fluoride in toothpaste has led to a major decrease in the number of cavities Americans have had since 1960.\r\n\r\nA majority of toothpastes on the market contain about 0.15% fluoride ion, which comes out to 1500 ppm (parts per million.) In 1.5 ml of toothpaste (the large stripe pictured above) you would find 2.25 mg of fluoride. In a pea sized amount of toothpaste, you would only find 0.3 mg of fluoride.\r\n\r\nOne of the customer contacted <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/\">HANNA</a></span> to determine Fluoride in ppm level. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check.html\">HANNA’s HI5522 pH/ORP/ISE bench-top instrument</a></span> features up to five point calibration, five fixed standard solutions available (0.1, 1, 10, 100, 1000 choice of concentration).The HI5522 can use ISE electrodes in the ppm scale (pH channel input) and provides a choice of measurement units (ppb, ppm, molarity, weight/volume %).Overall, the customer was pleased with the meter and the ready to use reagents and now looks to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check.html\">Hanna Instruments</a></span> as a reliable and credible source for their other testing needs.\r\n\r\nThe meter HI5522 here is an advanced research grade benchtop pH/ORP/ISE and EC/TDS/Salinity/Resistivity meter that is completely customizable with a large color LCD, capacitive touch keys, and USB port for computer connectivity. It have two-channel meter that allows for simultaneous measure of pH, ORP, or ISE on one channel and EC, TDS, Salinity, or Resistivity on the other. The two measurement channels of the HI5522 are galvanically isolated to eliminate noise and instability.\r\n\r\n<img class=\"alignnone size-medium wp-image-4756\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/HANNA..-300x272.png\" alt=\"\" width=\"300\" height=\"272\" />\r\n\r\nChannel one has a BNC connection for use with the expansive line of pH, ORP, and ISE electrodes that Hanna Instruments offers. HI5522 can measure EC over a wide range from 0.000 μS/cm to 1000.0 mS/cm*. The meter can be set to auto-ranging in which the meter chooses the appropriate conductivity range from seven ranges or fixed range in which the meter will only display reading in μS/cm or mS/cm. All readings are automatically compensated for temperature variations with a built in temperature sensor.\r\n\r\n<span style=\"text-decoration: underline;\">The temperature correction coefficient is adjustable from 0.00 to 10.00 %/°C.</span>\r\n<span style=\"text-decoration: underline;\">Incremental methods like The known addition, known subtraction, analyte addition, and analyte subtraction incremental methods are pre-programmed into the HI5522. This meter also offers Three selectable logging modes are availableon the HI5522: automatic, manual, and AutoHold logging. Automatic and manuallogs up to 100 lots with 50,000 records max/lot, with up to 100,000 total data points.</span>','Role of Fluoride content in your toothpaste','','inherit','closed','closed','','4754-revision-v1','','','2020-04-10 08:33:45','2020-04-10 08:33:45','',4754,'https://microbiozindia.com/uncategorized/4754-revision-v1/',0,'revision','',0),(4758,2,'2020-04-10 10:13:18','2020-04-10 10:13:18','Researchers at University of Limerick have made a testing solutions for Covid-19 in the midst of overall deficiencies of the vital materials.\r\n\r\n<span style=\"text-decoration: underline;\">In light of the worldwide lack of reagents and extraction packs for <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://en.wikipedia.org/wiki/COVID-19_testing\">Covid-19 testing</a></span>, researchers at UL\'s Bernal Institute, in addition to the branches of compound and natural sciences at UL, united with other research places and establishments to source materials and set up a testing arrangement, which has missed the mark concerning supply.</span>\r\n\r\nThe Lysis Buffer arrangement, which is basic for DNA extraction, was approved at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hse.ie/eng/services/list/3/acutehospitals/hospitals/ulh/hospitals/uhl/\">University Hospital Limerick</a></span>, where it is presently being utilized.\r\n\r\nDr Edel Durack, instrument researcher at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Bernal Bio Laboratories and a group of professionals from the School of Natural Sciences at UL</a></span>, arranged the arrangement, which is required to produce results from persistent swabs.\r\n\r\nThe arrangement would now be able to be utilized for Covid-19 testing across Ireland. Pharmaceutical organizations can now likewise quickly produce bunches of this answer for help fulfill the need for testing patients.\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Dr Durack explained: “This was validated by University Hospital Limerick</a></span> against one of the commercially prepared products and we got the go ahead that it had passed validation, so we went back into the lab to prepare another volume. The pharma companies are looking after the upscaling of it, so they will be sourcing larger quantities of the reagents needed.\r\n\r\n<em>“We can only do a small scale here in the research labs, but we are waiting on another shipment and we will be back in the lab. We will make another small volume but it is definitely being used in the hospital and it is a stop gap, because there is definitely a week to week scramble for reagents,”</em> she added.\r\nThe creation of the Lysis Buffer is a piece of more extensive endeavors by UL, which has set up a Covid Action gathering to arrange the numerous exercises in progress and developing across grounds because of the pandemic.\r\n\r\nThe gathering is under the supervision of UL VP examine, Professor Norelee Kennedy.\r\n\r\nAt a national level, UL staff are exhorting and illuminating the legislature through the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hpsc.ie/a-z/vaccinepreventable/tuberculosistb/tbdataandreports/AER_TB_2018data_v1.0.pdf\">National Epidemiological Group, DPER,</a></span> the National Advisory Group and the Department of A Taoiseach Research Group, on how best to deal with the rising effects from Covid-19.\r\n\r\nNearby exercises incorporate staff taking a shot at the bleeding edge, different offices offering PPE to forefront laborers, other staff contributing to national master gatherings, 3d printing of other PPE for the HSE and furthermore supporting the HSE to build up a field clinic on the grounds of the University. “To help with the testing we are making Lysis Buffer in our labs. A team from across UL combined in a collaborative way to make this happen rapidly. Everyone is keen to help in any way that they can,” explained UL VPR Professor Norelee Kennedy.\r\n\r\n“UL has an extensive group of volunteers contributing to all aspects of the Covid-19 crisis. Other initiatives are also under development, where collaborative programmes with colleagues from other HEIs and industry will be pivotal to making a difference in this challenging time,” she added.','Researchers get ready basic Covid-19 testing solutions','','publish','open','open','','researchers-get-ready-basic-covid-19-testing-solutions','','','2020-04-10 10:17:46','2020-04-10 10:17:46','',0,'https://microbiozindia.com/?p=4758',0,'post','',0),(4759,2,'2020-04-10 10:07:07','2020-04-10 10:07:07','','covid19-graphic-1600x900-updated-3-17-20','','inherit','open','closed','','covid19-graphic-1600x900-updated-3-17-20','','','2020-04-10 10:07:07','2020-04-10 10:07:07','',4758,'https://microbiozindia.com/wp-content/uploads/2020/04/covid19-graphic-1600x900-updated-3-17-20.jpg',0,'attachment','image/jpeg',0),(4760,2,'2020-04-10 10:13:18','2020-04-10 10:13:18','Researchers at University of Limerick have made a testing answer for Covid-19 in the midst of overall deficiencies of the vital materials.\r\n\r\n<span style=\"text-decoration: underline;\">In light of the worldwide lack of reagents and extraction packs for <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://en.wikipedia.org/wiki/COVID-19_testing\">Covid-19 testing</a></span>, researchers at UL\'s Bernal Institute, in addition to the branches of compound and natural sciences at UL, united with other research places and establishments to source materials and set up a testing arrangement, which has missed the mark concerning supply.</span>\r\n\r\nThe Lysis Buffer arrangement, which is basic for DNA extraction, was approved at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hse.ie/eng/services/list/3/acutehospitals/hospitals/ulh/hospitals/uhl/\">University Hospital Limerick</a></span>, where it is presently being utilized.\r\n\r\nDr Edel Durack, instrument researcher at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Bernal Bio Laboratories and a group of professionals from the School of Natural Sciences at UL</a></span>, arranged the arrangement, which is required to produce results from persistent swabs.\r\n\r\nThe arrangement would now be able to be utilized for Covid-19 testing across Ireland. Pharmaceutical organizations can now likewise quickly produce bunches of this answer for help fulfill the need for testing patients.\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Dr Durack explained: “This was validated by University Hospital Limerick</a></span> against one of the commercially prepared products and we got the go ahead that it had passed validation, so we went back into the lab to prepare another volume. The pharma companies are looking after the upscaling of it, so they will be sourcing larger quantities of the reagents needed.\r\n\r\n<em>“We can only do a small scale here in the research labs, but we are waiting on another shipment and we will be back in the lab. We will make another small volume but it is definitely being used in the hospital and it is a stop gap, because there is definitely a week to week scramble for reagents,”</em> she added.\r\nThe creation of the Lysis Buffer is a piece of more extensive endeavors by UL, which has set up a Covid Action gathering to arrange the numerous exercises in progress and developing across grounds because of the pandemic.\r\n\r\nThe gathering is under the supervision of UL VP examine, Professor Norelee Kennedy.\r\n\r\nAt a national level, UL staff are exhorting and illuminating the legislature through the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hpsc.ie/a-z/vaccinepreventable/tuberculosistb/tbdataandreports/AER_TB_2018data_v1.0.pdf\">National Epidemiological Group, DPER,</a></span> the National Advisory Group and the Department of A Taoiseach Research Group, on how best to deal with the rising effects from Covid-19.\r\n\r\nNearby exercises incorporate staff taking a shot at the bleeding edge, different offices offering PPE to forefront laborers, other staff contributing to national master gatherings, 3d printing of other PPE for the HSE and furthermore supporting the HSE to build up a field clinic on the grounds of the University. “To help with the testing we are making Lysis Buffer in our labs. A team from across UL combined in a collaborative way to make this happen rapidly. Everyone is keen to help in any way that they can,” explained UL VPR Professor Norelee Kennedy.\r\n\r\n“UL has an extensive group of volunteers contributing to all aspects of the Covid-19 crisis. Other initiatives are also under development, where collaborative programmes with colleagues from other HEIs and industry will be pivotal to making a difference in this challenging time,” she added.','Researchers get ready basic Covid-19 testing solutions','','inherit','closed','closed','','4758-revision-v1','','','2020-04-10 10:13:18','2020-04-10 10:13:18','',4758,'https://microbiozindia.com/uncategorized/4758-revision-v1/',0,'revision','',0),(4761,2,'2020-04-10 10:17:46','2020-04-10 10:17:46','Researchers at University of Limerick have made a testing solutions for Covid-19 in the midst of overall deficiencies of the vital materials.\r\n\r\n<span style=\"text-decoration: underline;\">In light of the worldwide lack of reagents and extraction packs for <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://en.wikipedia.org/wiki/COVID-19_testing\">Covid-19 testing</a></span>, researchers at UL\'s Bernal Institute, in addition to the branches of compound and natural sciences at UL, united with other research places and establishments to source materials and set up a testing arrangement, which has missed the mark concerning supply.</span>\r\n\r\nThe Lysis Buffer arrangement, which is basic for DNA extraction, was approved at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hse.ie/eng/services/list/3/acutehospitals/hospitals/ulh/hospitals/uhl/\">University Hospital Limerick</a></span>, where it is presently being utilized.\r\n\r\nDr Edel Durack, instrument researcher at <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Bernal Bio Laboratories and a group of professionals from the School of Natural Sciences at UL</a></span>, arranged the arrangement, which is required to produce results from persistent swabs.\r\n\r\nThe arrangement would now be able to be utilized for Covid-19 testing across Ireland. Pharmaceutical organizations can now likewise quickly produce bunches of this answer for help fulfill the need for testing patients.\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ul.ie/news-centre/news/scientists-university-limerick-prepare-essential-covid-19-testing-solution\">Dr Durack explained: “This was validated by University Hospital Limerick</a></span> against one of the commercially prepared products and we got the go ahead that it had passed validation, so we went back into the lab to prepare another volume. The pharma companies are looking after the upscaling of it, so they will be sourcing larger quantities of the reagents needed.\r\n\r\n<em>“We can only do a small scale here in the research labs, but we are waiting on another shipment and we will be back in the lab. We will make another small volume but it is definitely being used in the hospital and it is a stop gap, because there is definitely a week to week scramble for reagents,”</em> she added.\r\nThe creation of the Lysis Buffer is a piece of more extensive endeavors by UL, which has set up a Covid Action gathering to arrange the numerous exercises in progress and developing across grounds because of the pandemic.\r\n\r\nThe gathering is under the supervision of UL VP examine, Professor Norelee Kennedy.\r\n\r\nAt a national level, UL staff are exhorting and illuminating the legislature through the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hpsc.ie/a-z/vaccinepreventable/tuberculosistb/tbdataandreports/AER_TB_2018data_v1.0.pdf\">National Epidemiological Group, DPER,</a></span> the National Advisory Group and the Department of A Taoiseach Research Group, on how best to deal with the rising effects from Covid-19.\r\n\r\nNearby exercises incorporate staff taking a shot at the bleeding edge, different offices offering PPE to forefront laborers, other staff contributing to national master gatherings, 3d printing of other PPE for the HSE and furthermore supporting the HSE to build up a field clinic on the grounds of the University. “To help with the testing we are making Lysis Buffer in our labs. A team from across UL combined in a collaborative way to make this happen rapidly. Everyone is keen to help in any way that they can,” explained UL VPR Professor Norelee Kennedy.\r\n\r\n“UL has an extensive group of volunteers contributing to all aspects of the Covid-19 crisis. Other initiatives are also under development, where collaborative programmes with colleagues from other HEIs and industry will be pivotal to making a difference in this challenging time,” she added.','Researchers get ready basic Covid-19 testing solutions','','inherit','closed','closed','','4758-revision-v1','','','2020-04-10 10:17:46','2020-04-10 10:17:46','',4758,'https://microbiozindia.com/uncategorized/4758-revision-v1/',0,'revision','',0),(4762,2,'2020-04-10 12:04:18','2020-04-10 12:04:18','On edge times — like a pandemic — can prompt unfortunate yet self-alleviating propensities. Yet, some pressure lessening practices are disturbing to clinical specialists at this moment — in particular vaping and smoking of tobacco or cannabis.\r\n\r\nSince the coronavirus assaults the lungs, this is actually the occasion, they state, when individuals ought to be decreasing — or even better, halting — their utilization of such items, not heightening them.\r\n\r\n“Quitting during this pandemic could not only save your life, but by preventing the need for your treatment in a hospital, you might also save someone else’s life,” said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.massgeneral.org/medicine/trtc/faculty-and-staff/jonathan-winickoff\">Dr Jonathan Winickoff, Director of Pediatric Research at the Tobacco Research and Treatment Centre at Massachusetts General Hospital.</a></span>\r\n\r\nOn April 9, Winickoff joined the Massachusetts lawyer general, Maura Healey, to give a warning alarming the general population and especially youngsters that smoking and vaping can likewise worsen the dangers of spreading COVID-19.\r\n\r\n“You bring this device or cigarette to your mouth to inhale and you do so repeatedly,” explained Winickoff, who is also a professor at Harvard Medical School. “You touch the cartridge. You put it next to your face. You are spreading whatever is in your hand into your body. At the same time, many of my patients who smoke or vape have increased coughing or expectorating. And that’s a recipe for increased spread.”\r\n\r\nStudies as of now adequately show that cigarette smoking debilitates the safe framework and bargains lung work. Investigation into the wellbeing impacts of vaping is constrained in light of the fact that the gadgets are moderately new, however considers recommend that e-cigarettes may cause aggravation in the aviation routes and lungs.\r\n\r\nSmokers and vapers might be increasingly powerless to coronavirus contamination, the Massachusetts warning accentuates, and once tainted, such patients may likewise make some harder memories opposing an assault of COVID-19.\r\n\r\nAn ongoing report in the New England Journal of Medicine found that Chinese coronavirus patients who smoked were more than twice as likely as the individuals who didn\'t to have serious contaminations from COVID-19.\r\n\r\nWinickoff said that reasonability regarding pot items was additionally prudent.\r\n\r\n\"Breathing in combusted or vaped cannabis items can harm lung cells, may increment viral replication, and affects the capacity to fend off disease,\" he said. \"Clean air is the thing that the lungs ought to breathe in, particularly during a worldwide pandemic.\"\r\n\r\nc.2020 The New York Times Company','Smokers and vapers might be at more serious hazard for COVID-19','','publish','open','open','','smokers-and-vapers-might-be-at-more-serious-hazard-for-covid-19','','','2020-04-10 12:04:18','2020-04-10 12:04:18','',0,'https://microbiozindia.com/?p=4762',0,'post','',0),(4763,2,'2020-04-10 12:03:06','2020-04-10 12:03:06','','smokers','','inherit','open','closed','','smokers','','','2020-04-10 12:03:06','2020-04-10 12:03:06','',4762,'https://microbiozindia.com/wp-content/uploads/2020/04/smokers.jpg',0,'attachment','image/jpeg',0),(4764,2,'2020-04-10 12:04:18','2020-04-10 12:04:18','On edge times — like a pandemic — can prompt unfortunate yet self-alleviating propensities. Yet, some pressure lessening practices are disturbing to clinical specialists at this moment — in particular vaping and smoking of tobacco or cannabis.\r\n\r\nSince the coronavirus assaults the lungs, this is actually the occasion, they state, when individuals ought to be decreasing — or even better, halting — their utilization of such items, not heightening them.\r\n\r\n“Quitting during this pandemic could not only save your life, but by preventing the need for your treatment in a hospital, you might also save someone else’s life,” said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.massgeneral.org/medicine/trtc/faculty-and-staff/jonathan-winickoff\">Dr Jonathan Winickoff, Director of Pediatric Research at the Tobacco Research and Treatment Centre at Massachusetts General Hospital.</a></span>\r\n\r\nOn April 9, Winickoff joined the Massachusetts lawyer general, Maura Healey, to give a warning alarming the general population and especially youngsters that smoking and vaping can likewise worsen the dangers of spreading COVID-19.\r\n\r\n“You bring this device or cigarette to your mouth to inhale and you do so repeatedly,” explained Winickoff, who is also a professor at Harvard Medical School. “You touch the cartridge. You put it next to your face. You are spreading whatever is in your hand into your body. At the same time, many of my patients who smoke or vape have increased coughing or expectorating. And that’s a recipe for increased spread.”\r\n\r\nStudies as of now adequately show that cigarette smoking debilitates the safe framework and bargains lung work. Investigation into the wellbeing impacts of vaping is constrained in light of the fact that the gadgets are moderately new, however considers recommend that e-cigarettes may cause aggravation in the aviation routes and lungs.\r\n\r\nSmokers and vapers might be increasingly powerless to coronavirus contamination, the Massachusetts warning accentuates, and once tainted, such patients may likewise make some harder memories opposing an assault of COVID-19.\r\n\r\nAn ongoing report in the New England Journal of Medicine found that Chinese coronavirus patients who smoked were more than twice as likely as the individuals who didn\'t to have serious contaminations from COVID-19.\r\n\r\nWinickoff said that reasonability regarding pot items was additionally prudent.\r\n\r\n\"Breathing in combusted or vaped cannabis items can harm lung cells, may increment viral replication, and affects the capacity to fend off disease,\" he said. \"Clean air is the thing that the lungs ought to breathe in, particularly during a worldwide pandemic.\"\r\n\r\nc.2020 The New York Times Company','Smokers and vapers might be at more serious hazard for COVID-19','','inherit','closed','closed','','4762-revision-v1','','','2020-04-10 12:04:18','2020-04-10 12:04:18','',4762,'https://microbiozindia.com/uncategorized/4762-revision-v1/',0,'revision','',0),(4765,2,'2020-04-10 12:04:54','0000-00-00 00:00:00','','Immunotherapy treatment after chemotherapy altogether eases back metastatic bladder malignancy','','draft','open','open','','','','','2020-04-10 12:04:54','2020-04-10 12:04:54','',0,'https://microbiozindia.com/?p=4765',0,'post','',0),(4766,2,'2020-04-10 12:07:42','2020-04-10 12:07:42','Washington D.C.: The consequences of a clinical preliminary show utilizing immunotherapy following chemotherapy treatment in patients with metastatic bladder malignancy altogether eased back the movement of disease.\r\n\r\nThe clinical preliminary drove by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.eurekalert.org/pub_releases/2020-04/tmsh-ita040720.php\">Mount Sinai scientists distributed in the Journal of Clinical Oncology.</a></span>\r\n\r\nThe investigation is the first to demonstrate that this way to deal with treatment, called switch upkeep immunotherapy, essentially eases back the exacerbating of a sort of bladder malignant growth called urothelial disease. The randomized Phase 2 preliminary tried this treatment in 108 patients.\r\n\r\nThe preliminary tried immunotherapy known as pembrolizumab after patients were treated with platinum-based chemotherapy in one gathering of patients and utilized a fake treatment after a similar kind of chemotherapy in a subsequent gathering. The time until malignancy advanced was around 60 percent longer for the pembrolizumab bunch contrasted and the benchmark group.\r\n\r\n\"This preliminary, alongside another ongoing examination testing a comparable methodology, support the utilization of switch upkeep treatment, which will probably turn into a standard of care for metastatic urothelial malignant growth, an illness described by a scarcity of advances in decades,\" said lead creator <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mountsinai.org/profiles/matthew-galsky\">Matthew Galsky, MD, Co-Director of the Center of Excellence for Bladder Cancer at Mount Sinai.</a> </span>','Immunotherapy treatment after chemotherapy altogether eases back metastatic bladder malignancy: Study','','publish','open','open','','immunotherapy-treatment-after-chemotherapy-altogether-eases-back-metastatic-bladder-malignancy-study','','','2020-04-10 12:07:42','2020-04-10 12:07:42','',0,'https://microbiozindia.com/?p=4766',0,'post','',0),(4767,2,'2020-04-10 12:06:24','2020-04-10 12:06:24','','cancer_patient_1','','inherit','open','closed','','cancer_patient_1','','','2020-04-10 12:06:24','2020-04-10 12:06:24','',4766,'https://microbiozindia.com/wp-content/uploads/2020/04/cancer_patient_1.jpg',0,'attachment','image/jpeg',0),(4768,2,'2020-04-10 12:07:42','2020-04-10 12:07:42','Washington D.C.: The consequences of a clinical preliminary show utilizing immunotherapy following chemotherapy treatment in patients with metastatic bladder malignancy altogether eased back the movement of disease.\r\n\r\nThe clinical preliminary drove by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.eurekalert.org/pub_releases/2020-04/tmsh-ita040720.php\">Mount Sinai scientists distributed in the Journal of Clinical Oncology.</a></span>\r\n\r\nThe investigation is the first to demonstrate that this way to deal with treatment, called switch upkeep immunotherapy, essentially eases back the exacerbating of a sort of bladder malignant growth called urothelial disease. The randomized Phase 2 preliminary tried this treatment in 108 patients.\r\n\r\nThe preliminary tried immunotherapy known as pembrolizumab after patients were treated with platinum-based chemotherapy in one gathering of patients and utilized a fake treatment after a similar kind of chemotherapy in a subsequent gathering. The time until malignancy advanced was around 60 percent longer for the pembrolizumab bunch contrasted and the benchmark group.\r\n\r\n\"This preliminary, alongside another ongoing examination testing a comparable methodology, support the utilization of switch upkeep treatment, which will probably turn into a standard of care for metastatic urothelial malignant growth, an illness described by a scarcity of advances in decades,\" said lead creator <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mountsinai.org/profiles/matthew-galsky\">Matthew Galsky, MD, Co-Director of the Center of Excellence for Bladder Cancer at Mount Sinai.</a> </span>','Immunotherapy treatment after chemotherapy altogether eases back metastatic bladder malignancy: Study','','inherit','closed','closed','','4766-revision-v1','','','2020-04-10 12:07:42','2020-04-10 12:07:42','',4766,'https://microbiozindia.com/uncategorized/4766-revision-v1/',0,'revision','',0),(4769,2,'2020-04-10 12:11:54','2020-04-10 12:11:54','New Delhi: As a feature of its endeavors to increase the testing limit, the Indian Council of Medical Research (ICMR) has endorsed the utilization of demonstrative machines utilized for testing drug-safe tuberculosis for leading coronavirus tests. The ICMR has approved <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://icmr.nic.in/sites/default/files/upload_documents/Guidance_on_expansion_of_testing_platforms_v1.pdf\">\'TruenatTM beta CoV test on TruelabTM workstation\'</a> </span>and has suggested it as a screening test, the summit wellbeing research body said on Friday.\r\n\r\nGiving a direction on the utilization of Truenat beta CoV, the ICMR said throat/nasal swabs will be gathered in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ihr/publications/Annex8.pdf?ua=1\">viral transport medium (VTM)</a></span> with infection lysis cradle gave along the unit.\r\n\r\n\"Prior examinations have indicated that infection lysis cushion kills Nipah and H1N1 infections. The aftereffects of soundness of viral RNA after balance of SARS-CoV-2 by infection lysis cushion are anticipated from ICMR-NIV, Pune.\r\n\r\n\"Till such time, Truenat beta CoV test should just be performed with all biosafety insurances in BSL-2 or BSL-3 arrangements at labs,\" it said.\r\n\r\nThe amended rules will be given once the outcomes from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.icmr.nic.in/institutes/icmr-niv-pune\">ICMR-NIV, Pune</a></span> are accessible, it said.\r\n\r\nThe loss of life because of the novel coronavirus rose to 199 and the quantity of cases moved to 6,412 in the nation on Friday, as per the Union Health Ministry. In any case, a count of figures revealed by different states as on Thursday appeared at any rate 6640 cases and 227 passings.\r\n\r\nThere has been a slack in the Union Health Ministry figures, contrasted with the quantity of cases reported by various states, which authorities ascribe to procedural deferrals in appointing the cases to singular states.','The ICMR has approved \'TruenatTM beta CoV test on TruelabTM workstation\' as a screening test for COVID-19','','publish','open','open','','the-icmr-has-approved-truenattm-beta-cov-test-on-truelabtm-workstation-as-a-screening-test-for-covid-19','','','2020-04-10 12:11:54','2020-04-10 12:11:54','',0,'https://microbiozindia.com/?p=4769',0,'post','',0),(4770,2,'2020-04-10 12:11:44','2020-04-10 12:11:44','','Indonesia airport in Aceh screens travelers following Coronaviru','A Health medical team officer detect body temperature or \"thermoscan\" at the domestic arrival terminal of Sultan Iskandar Muda International Airport in Aceh Besar, Aceh Province, on January 27, 2020. Supervision and anticipation of the spread of corona viruses that plague from Wuhan China, Airport authorities regulate thermoscan for passengers and tourists who arrive in Aceh through international and domestic arrivals at Sultan Iskandar Muda International Airport. Based on Chinese government data, the death toll from the corona virus outbreak reached 80 people with more than 2,300 infected. (Photo by Oviyandi Emnur/INA Photo Agency/Sipa USA)(Sipa via AP Images)','inherit','open','closed','','indonesia-airport-in-aceh-screens-travelers-following-coronaviru','','','2020-04-10 12:11:44','2020-04-10 12:11:44','',4769,'https://microbiozindia.com/wp-content/uploads/2020/04/AP_20027491503653-1280x720-1.jpg',0,'attachment','image/jpeg',0),(4771,2,'2020-04-10 12:11:54','2020-04-10 12:11:54','New Delhi: As a feature of its endeavors to increase the testing limit, the Indian Council of Medical Research (ICMR) has endorsed the utilization of demonstrative machines utilized for testing drug-safe tuberculosis for leading coronavirus tests. The ICMR has approved <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://icmr.nic.in/sites/default/files/upload_documents/Guidance_on_expansion_of_testing_platforms_v1.pdf\">\'TruenatTM beta CoV test on TruelabTM workstation\'</a> </span>and has suggested it as a screening test, the summit wellbeing research body said on Friday.\r\n\r\nGiving a direction on the utilization of Truenat beta CoV, the ICMR said throat/nasal swabs will be gathered in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ihr/publications/Annex8.pdf?ua=1\">viral transport medium (VTM)</a></span> with infection lysis cradle gave along the unit.\r\n\r\n\"Prior examinations have indicated that infection lysis cushion kills Nipah and H1N1 infections. The aftereffects of soundness of viral RNA after balance of SARS-CoV-2 by infection lysis cushion are anticipated from ICMR-NIV, Pune.\r\n\r\n\"Till such time, Truenat beta CoV test should just be performed with all biosafety insurances in BSL-2 or BSL-3 arrangements at labs,\" it said.\r\n\r\nThe amended rules will be given once the outcomes from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.icmr.nic.in/institutes/icmr-niv-pune\">ICMR-NIV, Pune</a></span> are accessible, it said.\r\n\r\nThe loss of life because of the novel coronavirus rose to 199 and the quantity of cases moved to 6,412 in the nation on Friday, as per the Union Health Ministry. In any case, a count of figures revealed by different states as on Thursday appeared at any rate 6640 cases and 227 passings.\r\n\r\nThere has been a slack in the Union Health Ministry figures, contrasted with the quantity of cases reported by various states, which authorities ascribe to procedural deferrals in appointing the cases to singular states.','The ICMR has approved \'TruenatTM beta CoV test on TruelabTM workstation\' as a screening test for COVID-19','','inherit','closed','closed','','4769-revision-v1','','','2020-04-10 12:11:54','2020-04-10 12:11:54','',4769,'https://microbiozindia.com/uncategorized/4769-revision-v1/',0,'revision','',0),(4772,2,'2020-04-11 08:22:45','2020-04-11 08:22:45','Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got leeway from sedate control specialists to make Hydroxychloroquine, which is being viewed as powerful in treating Covid-19 patients.\r\n\r\nThe organization got the permit days after the association government stepped up to the plate for enormous scope production of the medication taking into account the furious pandemic.\r\n\r\n<span style=\"color: #ff6600;\">As indicated by the organization executive P.M. Chandraiya, BCPL has the ability to produce 10 lakh hydroxychloroquine tablets every day.</span>\r\n\r\nEstablished in 1901, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://bengalchemicals.co.in/\">BCPL</a></span> is the nation\'s first pharmaceutical organization, and once made Hydroychloroquine. In any case, it quit fabricating the item decades back.\r\n\r\nChandraiya said the expense of crude materials for making the medication has gone up multiple times in the previous scarcely any weeks.\r\n\r\n\"We have mentioned the association government to set a limit for the crude material costs,\" he said.','India\'s First Pharma Company BCPL Gets Clearance For Manufacturing Hydroxychloroquine','','publish','open','open','','indias-first-pharma-company-bcpl-gets-clearance-for-manufacturing-hydroxychloroquine','','','2020-04-11 08:27:02','2020-04-11 08:27:02','',0,'https://microbiozindia.com/?p=4772',0,'post','',0),(4773,2,'2020-04-11 08:20:42','2020-04-11 08:20:42','','dt_200330_hydroxychloroquine_pills_800x450','','inherit','open','closed','','dt_200330_hydroxychloroquine_pills_800x450','','','2020-04-11 08:20:42','2020-04-11 08:20:42','',4772,'https://microbiozindia.com/wp-content/uploads/2020/04/dt_200330_hydroxychloroquine_pills_800x450.jpg',0,'attachment','image/jpeg',0),(4774,2,'2020-04-11 08:22:45','2020-04-11 08:22:45','Central Public Sector Undertaking <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://bengalchemicals.co.in/\">Bengal Chemicals and Pharmaceuticals Limited (BCPL)</a></span> on Friday (10 April) got leeway from sedate control specialists to make Hydroxychloroquine, which is being viewed as powerful in treating Covid-19 patients.\r\n\r\nThe organization got the permit days after the association government stepped up to the plate for enormous scope production of the medication taking into account the furious pandemic.\r\n\r\n<span style=\"color: #ff6600;\">As indicated by the organization executive P.M. Chandraiya, BCPL has the ability to produce 10 lakh hydroxychloroquine tablets every day.</span>\r\n\r\nEstablished in 1901, BCPL is the nation\'s first pharmaceutical organization, and once made Hydroychloroquine. In any case, it quit fabricating the item decades back.\r\n\r\nChandraiya said the expense of crude materials for making the medication has gone up multiple times in the previous scarcely any weeks.\r\n\r\n\"We have mentioned the association government to set a limit for the crude material costs,\" he said.','India\'s First Pharma Company BCPL Gets Clearance For Manufacturing Hydroxychloroquine','','inherit','closed','closed','','4772-revision-v1','','','2020-04-11 08:22:45','2020-04-11 08:22:45','',4772,'https://microbiozindia.com/uncategorized/4772-revision-v1/',0,'revision','',0),(4775,2,'2020-04-11 08:26:39','2020-04-11 08:26:39','Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got leeway from sedate control specialists to make Hydroxychloroquine, which is being viewed as powerful in treating Covid-19 patients.\r\n\r\nThe organization got the permit days after the association government stepped up to the plate for enormous scope production of the medication taking into account the furious pandemic.\r\n\r\n<span style=\"color: #ff6600;\">As indicated by the organization executive P.M. Chandraiya, BCPL has the ability to produce 10 lakh hydroxychloroquine tablets every day.</span>\r\n\r\nEstablished in 1901, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://bengalchemicals.co.in/\">BCPL</a></span> is the nation\'s first pharmaceutical organization, and once made Hydroychloroquine. In any case, it quit fabricating the item decades back.\r\n\r\nChandraiya said the expense of crude materials for making the medication has gone up multiple times in the previous scarcely any weeks.\r\n\r\n\"We have mentioned the association government to set a limit for the crude material costs,\" he said.','India\'s First Pharma Company BCPL Gets Clearance For Manufacturing Hydroxychloroquine','','inherit','closed','closed','','4772-revision-v1','','','2020-04-11 08:26:39','2020-04-11 08:26:39','',4772,'https://microbiozindia.com/uncategorized/4772-revision-v1/',0,'revision','',0),(4776,2,'2020-04-11 08:50:48','2020-04-11 08:50:48','Pharma significant Lupin on Saturday declared commitment of Rs 21 crore for aid projects coordinated towards relieving the COVID-19 emergency. The organization\'s worldwide giving system involves three separate commitments made by its workers, the organization and the advertiser family, Lupin said in an announcement.\r\n\r\nLupin\'s workers have allowed their two days\' pay rates, together contributing a total of Rs 5.5 crore to the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.pmindia.gov.in/en/about-pm-cares-fund/\">Prime Minister\'s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund),</a></span> it said.\r\n\r\n\"The organization has coordinated an equivalent whole of Rs 5.5 crore for direct activities that the organization will execute to help overburdened national and state human services frameworks through gift of individual defensive hardware, medications and giving suppers to cutting edge laborers and the poor,\" Lupin said.\r\n\r\nMoreover, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Desh_Bandhu_Gupta\">the promoter Desh Bandhu Gupta family</a> </span>has submitted an entirety of Rs 10 crore for other direct effect activities in India and somewhere else on the planet to enhance Lupin\'s aid ventures to handle the COVID-19 emergency, it included.\r\n\r\nAs one of the main pharmaceutical organizations internationally, Lupin stays focused on guaranteeing continuous inventory of drugs across India and worldwide markets while guaranteeing security of our work force included, Lupin MD Nilesh Gupta said.\r\n\r\n\"We are appreciative for this chance to help the individuals who are at the forefront of this fight against COVID-19,\" he included.','Lupin contributes Rs 21 cr for COVID-19 aid ventures','','publish','open','open','','lupin-contributes-rs-21-cr-for-covid-19-aid-ventures','','','2020-04-11 08:50:48','2020-04-11 08:50:48','',0,'https://microbiozindia.com/?p=4776',0,'post','',0),(4777,2,'2020-04-11 08:50:48','2020-04-11 08:50:48','Pharma significant Lupin on Saturday declared commitment of Rs 21 crore for aid projects coordinated towards relieving the COVID-19 emergency. The organization\'s worldwide giving system involves three separate commitments made by its workers, the organization and the advertiser family, Lupin said in an announcement.\r\n\r\nLupin\'s workers have allowed their two days\' pay rates, together contributing a total of Rs 5.5 crore to the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.pmindia.gov.in/en/about-pm-cares-fund/\">Prime Minister\'s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund),</a></span> it said.\r\n\r\n\"The organization has coordinated an equivalent whole of Rs 5.5 crore for direct activities that the organization will execute to help overburdened national and state human services frameworks through gift of individual defensive hardware, medications and giving suppers to cutting edge laborers and the poor,\" Lupin said.\r\n\r\nMoreover, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Desh_Bandhu_Gupta\">the promoter Desh Bandhu Gupta family</a> </span>has submitted an entirety of Rs 10 crore for other direct effect activities in India and somewhere else on the planet to enhance Lupin\'s aid ventures to handle the COVID-19 emergency, it included.\r\n\r\nAs one of the main pharmaceutical organizations internationally, Lupin stays focused on guaranteeing continuous inventory of drugs across India and worldwide markets while guaranteeing security of our work force included, Lupin MD Nilesh Gupta said.\r\n\r\n\"We are appreciative for this chance to help the individuals who are at the forefront of this fight against COVID-19,\" he included.','Lupin contributes Rs 21 cr for COVID-19 aid ventures','','inherit','closed','closed','','4776-revision-v1','','','2020-04-11 08:50:48','2020-04-11 08:50:48','',4776,'https://microbiozindia.com/uncategorized/4776-revision-v1/',0,'revision','',0),(4778,2,'2020-04-11 12:17:25','2020-04-11 12:17:25','SMS Pharma said there is no material effect on its present and future incomes or edges as income contributed from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/ranitidine-oral-tablet\">Ranitidine</a> </span>item in earlier years is underneath 1% of absolute income.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/smspharmaceuticals/SP38\">SMS Pharmaceuticals</a></span> on 9 April 2020 gave refreshes against US sedate controller\'s announcement regarding Ranitidine. In September 2019, the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\"> US Food and Drug Administration (USFDA)</a></span> saw that some Ranitidine prescriptions contain a nitrosamine debasement called N-nitrosodimethylamine (NDMA) at low levels. USFDA has mentioned Ranitidine definition producers to pull back all remedy and over-the-counter (OTC) ranitidine drugs from the market quickly as a major aspect of a progressing examination of a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">contaminant NDMA in Ranitidine prescriptions.</a></span>\r\n\r\nSMS Pharma is one of the maker of Ranitidine HCI Active Pharmaceuticals Ingredient (API). The organization said it has played out the definite hazard appraisal concentrate for the development of NDMA contamination in the Ranitidine HCl sedate substance. It is seen that, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">NDM</a></span>A debasement is expanding in the capacity of the medication substance. The organization has changed the procedure of Ranitidine HCl sedate substance to control the NDMA debasement during the capacity and the adjusted procedure subtleties has been submitted to the FDA. The adjusted procedure material is increasingly steady and the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">NDMA</a> </span>polluting influence is very much controlled, the organization said.\r\n\r\nAccording to the ordinary procedure of GMP rules, the USFDA has led CGMP review in the organization\'s API fabricating office during January 2020 and along these lines it got the EIR report. The approval clumps of altered procedure have been as of now started for the necessary dependability examines and the steadiness information will be refreshed to the authority as required. The action would take around 9 to 10 months time span.\r\n\r\nSMS Pharma said that till date, it has not sold any Ranitidine API for the business conveyance in the US. Whatever the amounts sold are with the end goal of medication item improvement and the item has not gone into plugs till date in the US showcase. The portion of SMS Pharmaceuticals\' income contributed from Ranitidine item during the most recent multi year is beneath 1% of the all out incomes. Thus, there is no material effect on the organization\'s present and future incomes just as edges.\r\n\r\nThe organization\'s business supplies of the Ranitidine HCl sedate substance to its clients for US advertise is as of now postponed by 9-10 months and expected to begin by end the present schedule year. Meanwhile, the firm will use these abilities to other existing items. Henceforth, there is no effect on activities or incomes during the current budgetary year just as future years.\r\n\r\nSMS Pharmaceuticals\' united net benefit dropped 19.11% to Rs 7.62 crore on a 20.54% decrease in net deals to Rs 80.45 crore in Q3 December 2019 over Q3 December 2018.\r\n\r\nSMS Pharmaceuticals is occupied with the assembling and offer of dynamic pharmaceutical fixings (APIs) and their intermediates. The association\'s essential items/administrations incorporate pharmaceuticals. The organization\'s item run incorporates API and intermediates.\r\n\r\nPortions of SMS Pharmaceuticals declined 1.59% to Rs 34.15 on Thursday, 9 April 2020. The market was closed on Friday, 10 April 2020, for an open occasion.\r\n\r\nPowered by Capital Market - Live News','SMS Pharma reports on USFDA articulation on Ranitidine','','publish','open','open','','sms-pharma-reports-on-usfda-articulation-on-ranitidine','','','2020-04-11 12:17:25','2020-04-11 12:17:25','',0,'https://microbiozindia.com/?p=4778',0,'post','',0),(4779,2,'2020-04-11 12:13:37','2020-04-11 12:13:37','','AAE4','','inherit','open','closed','','aae4','','','2020-04-11 12:13:37','2020-04-11 12:13:37','',4778,'https://microbiozindia.com/wp-content/uploads/2020/04/AAE4.png',0,'attachment','image/png',0),(4780,2,'2020-04-11 12:17:25','2020-04-11 12:17:25','SMS Pharma said there is no material effect on its present and future incomes or edges as income contributed from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/ranitidine-oral-tablet\">Ranitidine</a> </span>item in earlier years is underneath 1% of absolute income.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/smspharmaceuticals/SP38\">SMS Pharmaceuticals</a></span> on 9 April 2020 gave refreshes against US sedate controller\'s announcement regarding Ranitidine. In September 2019, the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\"> US Food and Drug Administration (USFDA)</a></span> saw that some Ranitidine prescriptions contain a nitrosamine debasement called N-nitrosodimethylamine (NDMA) at low levels. USFDA has mentioned Ranitidine definition producers to pull back all remedy and over-the-counter (OTC) ranitidine drugs from the market quickly as a major aspect of a progressing examination of a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">contaminant NDMA in Ranitidine prescriptions.</a></span>\r\n\r\nSMS Pharma is one of the maker of Ranitidine HCI Active Pharmaceuticals Ingredient (API). The organization said it has played out the definite hazard appraisal concentrate for the development of NDMA contamination in the Ranitidine HCl sedate substance. It is seen that, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">NDM</a></span>A debasement is expanding in the capacity of the medication substance. The organization has changed the procedure of Ranitidine HCl sedate substance to control the NDMA debasement during the capacity and the adjusted procedure subtleties has been submitted to the FDA. The adjusted procedure material is increasingly steady and the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine\">NDMA</a> </span>polluting influence is very much controlled, the organization said.\r\n\r\nAccording to the ordinary procedure of GMP rules, the USFDA has led CGMP review in the organization\'s API fabricating office during January 2020 and along these lines it got the EIR report. The approval clumps of altered procedure have been as of now started for the necessary dependability examines and the steadiness information will be refreshed to the authority as required. The action would take around 9 to 10 months time span.\r\n\r\nSMS Pharma said that till date, it has not sold any Ranitidine API for the business conveyance in the US. Whatever the amounts sold are with the end goal of medication item improvement and the item has not gone into plugs till date in the US showcase. The portion of SMS Pharmaceuticals\' income contributed from Ranitidine item during the most recent multi year is beneath 1% of the all out incomes. Thus, there is no material effect on the organization\'s present and future incomes just as edges.\r\n\r\nThe organization\'s business supplies of the Ranitidine HCl sedate substance to its clients for US advertise is as of now postponed by 9-10 months and expected to begin by end the present schedule year. Meanwhile, the firm will use these abilities to other existing items. Henceforth, there is no effect on activities or incomes during the current budgetary year just as future years.\r\n\r\nSMS Pharmaceuticals\' united net benefit dropped 19.11% to Rs 7.62 crore on a 20.54% decrease in net deals to Rs 80.45 crore in Q3 December 2019 over Q3 December 2018.\r\n\r\nSMS Pharmaceuticals is occupied with the assembling and offer of dynamic pharmaceutical fixings (APIs) and their intermediates. The association\'s essential items/administrations incorporate pharmaceuticals. The organization\'s item run incorporates API and intermediates.\r\n\r\nPortions of SMS Pharmaceuticals declined 1.59% to Rs 34.15 on Thursday, 9 April 2020. The market was closed on Friday, 10 April 2020, for an open occasion.\r\n\r\nPowered by Capital Market - Live News','SMS Pharma reports on USFDA articulation on Ranitidine','','inherit','closed','closed','','4778-revision-v1','','','2020-04-11 12:17:25','2020-04-11 12:17:25','',4778,'https://microbiozindia.com/uncategorized/4778-revision-v1/',0,'revision','',0),(4782,2,'2020-04-11 14:12:12','2020-04-11 14:12:12','A coronavirus antibody could be accessible for the overall population by September, an Oxford teacher has guaranteed.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ox.ac.uk/news-and-events/find-an-expert/professor-sarah-gilbert\">Sarah Gilbert, a teacher of vaccinology at Oxford University</a></span>, is driving a group of analysts in the advancement of an immunization that would secure the world against coronavirus.\r\n\r\nIn a meeting with The Times, the teacher said that she and her group have just made a potential antibody that is because of start human preliminaries inside about fourteen days.\r\n\r\n<span style=\"text-decoration: underline;\">She told the paper she is \"80%\" sure of its prosperity, \"in light of different things that we have finished with this kind of antibody\".</span>\r\n\r\nMost industry specialists state that an immunization could take up to year and a half to be created and dispersed all inclusive.\r\n\r\nNotwithstanding, Professor Gilbert accepts that by letting volunteers from places that have not forced lockdown measures become contaminated normally at the earliest opportunity, it will quicken the clinical preliminary procedure.\r\n\r\n<span style=\"color: #000000;\">\"On the off chance that one of those (places) ends up having a high pace of infection transmission then we will get our adequacy results rapidly, so that is one system for decreasing the time,\" she said.</span>\r\n\r\n<span style=\"color: #000000;\">\"All out lockdowns do make it harder. Be that as it may, we don\'t need the crowd insusceptibility either. We need them to be vulnerable and uncovered for the preliminaries simply to test the viability.\"</span>\r\n\r\nAll together for the immunization to be dispersed in the pre-winter, Professor Gilbert says the British government should begin creation before it is demonstrated to work.\r\n\r\nShe told the paper: \"We would prefer not to get to in the not so distant future and find we have a profoundly powerful antibody and we haven\'t got any immunization to utilize.\"','Oxford Professor claims Covid-19 antibody could be prepared by winter this year','','publish','open','open','','oxford-professor-claims-covid-19-antibody-could-be-prepared-by-winter-this-year','','','2020-04-11 14:12:12','2020-04-11 14:12:12','',0,'https://microbiozindia.com/?p=4782',0,'post','',0),(4783,2,'2020-04-11 14:09:18','2020-04-11 14:09:18','','_111277139_gettyimages-1154450279','','inherit','open','closed','','_111277139_gettyimages-1154450279','','','2020-04-11 14:09:18','2020-04-11 14:09:18','',4782,'https://microbiozindia.com/wp-content/uploads/2020/04/111277139_gettyimages-1154450279.jpg',0,'attachment','image/jpeg',0),(4784,2,'2020-04-11 14:12:12','2020-04-11 14:12:12','A coronavirus antibody could be accessible for the overall population by September, an Oxford teacher has guaranteed.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ox.ac.uk/news-and-events/find-an-expert/professor-sarah-gilbert\">Sarah Gilbert, a teacher of vaccinology at Oxford University</a></span>, is driving a group of analysts in the advancement of an immunization that would secure the world against coronavirus.\r\n\r\nIn a meeting with The Times, the teacher said that she and her group have just made a potential antibody that is because of start human preliminaries inside about fourteen days.\r\n\r\n<span style=\"text-decoration: underline;\">She told the paper she is \"80%\" sure of its prosperity, \"in light of different things that we have finished with this kind of antibody\".</span>\r\n\r\nMost industry specialists state that an immunization could take up to year and a half to be created and dispersed all inclusive.\r\n\r\nNotwithstanding, Professor Gilbert accepts that by letting volunteers from places that have not forced lockdown measures become contaminated normally at the earliest opportunity, it will quicken the clinical preliminary procedure.\r\n\r\n<span style=\"color: #000000;\">\"On the off chance that one of those (places) ends up having a high pace of infection transmission then we will get our adequacy results rapidly, so that is one system for decreasing the time,\" she said.</span>\r\n\r\n<span style=\"color: #000000;\">\"All out lockdowns do make it harder. Be that as it may, we don\'t need the crowd insusceptibility either. We need them to be vulnerable and uncovered for the preliminaries simply to test the viability.\"</span>\r\n\r\nAll together for the immunization to be dispersed in the pre-winter, Professor Gilbert says the British government should begin creation before it is demonstrated to work.\r\n\r\nShe told the paper: \"We would prefer not to get to in the not so distant future and find we have a profoundly powerful antibody and we haven\'t got any immunization to utilize.\"','Oxford Professor claims Covid-19 antibody could be prepared by winter this year','','inherit','closed','closed','','4782-revision-v1','','','2020-04-11 14:12:12','2020-04-11 14:12:12','',4782,'https://microbiozindia.com/uncategorized/4782-revision-v1/',0,'revision','',0),(4785,2,'2020-04-12 08:25:18','2020-04-12 08:25:18','Researchers think one explanation behind the quick spread of the new coronavirus is that a few people who are contaminated don\'t get any side effects whatsoever. These asymptomatic bearers can accidentally spread the infection to other people.\r\n\r\nPresently, U.S. government specialists need to realize exactly what number of individuals may have had the infection while never knowing it. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.medicinenet.com/script/main/art.asp?articlekey=9786\">The National Institutes of Health (NIH)</a></span> declared Friday that it is propelling an examination to decide the degree to which the infection has spread undetected.\r\n\r\nSpecialists intend to gather blood tests from up to 10,000 individuals in the United States to search for signs that an individual has recently experienced the infection. To do that, researchers will investigate blood tests for the nearness of antibodies, or proteins that the invulnerable framework produces to battle contamination. On the off chance that an individual has been contaminated, their blood will contain antibodies explicit to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span>, the infection that causes Covid-19. An individual with these antibodies could be safe to Covid-19, at any rate for a while.\r\n\r\n[caption id=\"attachment_4787\" align=\"aligncenter\" width=\"608\"]<img class=\"wp-image-4787\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/SSR-300x143.png\" alt=\"\" width=\"608\" height=\"290\" />             <em>Take 1 minute to report your health daily, even if you\'re well.<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://covid.joinzoe.com/\">Click here</a></span></em>[/caption]\r\n\r\n\"An immunizer test is thinking once again into the insusceptible framework\'s history with a rearview reflect,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://health.usnews.com/doctors/matthew-memoli-832139\">Matthew Memoli, MD</a></span>, head agent of the investigation, in an April 10 explanation. This is an alternate sort of test than the one that is being utilized to analyze coronavirus cases, which includes a nasal swab and searches for the nearness of the infection\'s hereditary material. On the other hand, immune response tests are not yet generally accessible, however organizations are dashing to deliver them.\r\n\r\nSound volunteers beyond 18 a years old have not had an affirmed instance of Covid-19 or ebb and flow manifestations of the infection can take an interest. A few members will give a blood test at the NIH <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.washingtonpost.com/local/md-politics/tensions-flare-again-over-african-american-burial-ground-in-bethesda/2017/11/11/9ba5a4e2-c4a2-11e7-84bc-5e285c7f4512_story.html\">grounds in Bethesda, Maryland.</a></span> Others will get a pinprick blood assortment unit via the post office to take an example of their blood at home. They\'ll at that point transport the example back to agents to be broke down. The finger-prick test is protected and is like an at-home blood glucose test for diabetes.\r\n\r\nThe consequences of the examination could give bits of knowledge into which networks and populaces have been generally influenced by the new infection. \"This examination will give us a more clear image of the genuine size of the Covid-19 pandemic in the United States,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.niaid.nih.gov/about/director\">Anthony Fauci, MD, chief of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH</a></span>, in an announcement.\r\n\r\nA Q&amp;A on the NIAID site says members ought not expect a quick turnaround of their blood test results. It will take specialists weeks or long stretches of examination to affirm the test\'s exactness. From that point onward, study members can demand the consequences of their own test.','Impressive study objective to Find Undetected Covid-19 Cases','','publish','open','open','','impressive-study-objective-to-find-undetected-covid-19-cases','','','2020-04-12 08:25:18','2020-04-12 08:25:18','',0,'https://microbiozindia.com/?p=4785',0,'post','',0),(4786,2,'2020-04-12 08:17:43','2020-04-12 08:17:43','','AAA','','inherit','open','closed','','aaa-14','','','2020-04-12 08:17:43','2020-04-12 08:17:43','',4785,'https://microbiozindia.com/wp-content/uploads/2020/04/AAA.jpg',0,'attachment','image/jpeg',0),(4787,2,'2020-04-12 08:17:48','2020-04-12 08:17:48','','SSR','','inherit','open','closed','','ssr','','','2020-04-12 08:17:48','2020-04-12 08:17:48','',4785,'https://microbiozindia.com/wp-content/uploads/2020/04/SSR.png',0,'attachment','image/png',0),(4788,2,'2020-04-12 08:25:18','2020-04-12 08:25:18','Researchers think one explanation behind the quick spread of the new coronavirus is that a few people who are contaminated don\'t get any side effects whatsoever. These asymptomatic bearers can accidentally spread the infection to other people.\r\n\r\nPresently, U.S. government specialists need to realize exactly what number of individuals may have had the infection while never knowing it. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.medicinenet.com/script/main/art.asp?articlekey=9786\">The National Institutes of Health (NIH)</a></span> declared Friday that it is propelling an examination to decide the degree to which the infection has spread undetected.\r\n\r\nSpecialists intend to gather blood tests from up to 10,000 individuals in the United States to search for signs that an individual has recently experienced the infection. To do that, researchers will investigate blood tests for the nearness of antibodies, or proteins that the invulnerable framework produces to battle contamination. On the off chance that an individual has been contaminated, their blood will contain antibodies explicit to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span>, the infection that causes Covid-19. An individual with these antibodies could be safe to Covid-19, at any rate for a while.\r\n\r\n[caption id=\"attachment_4787\" align=\"aligncenter\" width=\"608\"]<img class=\"wp-image-4787\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/SSR-300x143.png\" alt=\"\" width=\"608\" height=\"290\" />             <em>Take 1 minute to report your health daily, even if you\'re well.<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://covid.joinzoe.com/\">Click here</a></span></em>[/caption]\r\n\r\n\"An immunizer test is thinking once again into the insusceptible framework\'s history with a rearview reflect,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://health.usnews.com/doctors/matthew-memoli-832139\">Matthew Memoli, MD</a></span>, head agent of the investigation, in an April 10 explanation. This is an alternate sort of test than the one that is being utilized to analyze coronavirus cases, which includes a nasal swab and searches for the nearness of the infection\'s hereditary material. On the other hand, immune response tests are not yet generally accessible, however organizations are dashing to deliver them.\r\n\r\nSound volunteers beyond 18 a years old have not had an affirmed instance of Covid-19 or ebb and flow manifestations of the infection can take an interest. A few members will give a blood test at the NIH <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.washingtonpost.com/local/md-politics/tensions-flare-again-over-african-american-burial-ground-in-bethesda/2017/11/11/9ba5a4e2-c4a2-11e7-84bc-5e285c7f4512_story.html\">grounds in Bethesda, Maryland.</a></span> Others will get a pinprick blood assortment unit via the post office to take an example of their blood at home. They\'ll at that point transport the example back to agents to be broke down. The finger-prick test is protected and is like an at-home blood glucose test for diabetes.\r\n\r\nThe consequences of the examination could give bits of knowledge into which networks and populaces have been generally influenced by the new infection. \"This examination will give us a more clear image of the genuine size of the Covid-19 pandemic in the United States,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.niaid.nih.gov/about/director\">Anthony Fauci, MD, chief of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH</a></span>, in an announcement.\r\n\r\nA Q&amp;A on the NIAID site says members ought not expect a quick turnaround of their blood test results. It will take specialists weeks or long stretches of examination to affirm the test\'s exactness. From that point onward, study members can demand the consequences of their own test.','Impressive study objective to Find Undetected Covid-19 Cases','','inherit','closed','closed','','4785-revision-v1','','','2020-04-12 08:25:18','2020-04-12 08:25:18','',4785,'https://microbiozindia.com/uncategorized/4785-revision-v1/',0,'revision','',0),(4789,2,'2020-04-12 09:07:03','2020-04-12 09:07:03','The Union science and innovation service will subsidize a Pune-based firm to build up an antibody for Covid-19 which is relied upon to enter stage 1 preliminary in 18-20 months. <span style=\"color: #ff6600;\">Seagull Biosolutions</span> is the primary organization the administration is monetarily backing for coronavirus antibody endeavors. It will likewise deliver at-home test units for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mygov.in/covid-19/\">Covid-19</a></span> that can recognize even <a href=\"https://www.verywellhealth.com/how-do-you-define-asymptomatic-2721956\"><span style=\"color: #ff6600;\">asymptomatic diseases</span>.</a>\r\n\r\nFor the two purposes, Seagull will utilize its current <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1613213\">Active Virosome Technology (AVT)</a></span> which can create novel Active Virosome specialists to actuate antibodies. The firm is creating two sorts of specialists to deliver 19 kinds of killing antibodies. While the primary operator will communicate the S protein — which intercedes connection of the infection to the host cell surface receptors — the other will communicate basic proteins of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">Covid-19.</a></span>\r\n\r\nThe organization will direct tests on wild mice to check adequacy of the two AV operators. The following round of tests would be on mice models of SARS illness and later on monkeys or another little creature. The AV-immunization specialist will at that point be set up for stage 1 clinical preliminaries.\r\n\r\nVishwas Joshi, author and MD of the firm, disclosed to TOI that their AVT stage has recently been utilized to create antibodies for ebola, zika, chikungunya and dengue.','Pune firm first in Quite some time to get govt financing for COVID-19 antibody','','publish','open','open','','pune-firm-first-in-quite-some-time-to-get-govt-financing-for-covid-19-antibody','','','2020-04-12 09:07:03','2020-04-12 09:07:03','',0,'https://microbiozindia.com/?p=4789',0,'post','',0),(4790,2,'2020-04-12 09:01:43','2020-04-12 09:01:43','','vaccine-4948463','','inherit','open','closed','','vaccine-4948463','','','2020-04-12 09:01:43','2020-04-12 09:01:43','',4789,'https://microbiozindia.com/wp-content/uploads/2020/04/vaccine-4948463.jpg',0,'attachment','image/jpeg',0),(4791,2,'2020-04-12 09:07:03','2020-04-12 09:07:03','The Union science and innovation service will subsidize a Pune-based firm to build up an antibody for Covid-19 which is relied upon to enter stage 1 preliminary in 18-20 months. <span style=\"color: #ff6600;\">Seagull Biosolutions</span> is the primary organization the administration is monetarily backing for coronavirus antibody endeavors. It will likewise deliver at-home test units for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mygov.in/covid-19/\">Covid-19</a></span> that can recognize even <a href=\"https://www.verywellhealth.com/how-do-you-define-asymptomatic-2721956\"><span style=\"color: #ff6600;\">asymptomatic diseases</span>.</a>\r\n\r\nFor the two purposes, Seagull will utilize its current <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1613213\">Active Virosome Technology (AVT)</a></span> which can create novel Active Virosome specialists to actuate antibodies. The firm is creating two sorts of specialists to deliver 19 kinds of killing antibodies. While the primary operator will communicate the S protein — which intercedes connection of the infection to the host cell surface receptors — the other will communicate basic proteins of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">Covid-19.</a></span>\r\n\r\nThe organization will direct tests on wild mice to check adequacy of the two AV operators. The following round of tests would be on mice models of SARS illness and later on monkeys or another little creature. The AV-immunization specialist will at that point be set up for stage 1 clinical preliminaries.\r\n\r\nVishwas Joshi, author and MD of the firm, disclosed to TOI that their AVT stage has recently been utilized to create antibodies for ebola, zika, chikungunya and dengue.','Pune firm first in Quite some time to get govt financing for COVID-19 antibody','','inherit','closed','closed','','4789-revision-v1','','','2020-04-12 09:07:03','2020-04-12 09:07:03','',4789,'https://microbiozindia.com/uncategorized/4789-revision-v1/',0,'revision','',0),(4792,2,'2020-04-12 13:10:11','2020-04-12 13:10:11','The COVID-19 pandemic has hit more than 22,000 human services laborers across 52 nations and districts, the World Health Organization said Saturday.\r\n\r\nAs per its every day circumstance report,<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796b143_4\"> 22,073 COVID-19 cases among human services laborers have been accounted for to the WHO as of Wednesday, April 8.</a></span>\r\n\r\nThe report said the number is likely under-spoke to as there is so far no efficient announcing of contaminations among social insurance laborers to the WHO.\r\n\r\nStarter results recommend medicinal services laborers are being contaminated both in the work environment and in the network, regularly through tainted relatives.\r\n\r\nTo secure forefront medicinal services laborers, the WHO focused on the right utilization of individual defensive hardware like veils, goggles, gloves, and outfits.\r\n\r\nTaking note of the danger of burnout among social insurance suppliers, the WHO called for regarding their privileges to nice working conditions.','More than 22,000 health service workers and doctors tainted by COVID-19: WHO','','publish','open','open','','more-than-22000-health-service-workers-doctors-tainted-by-covid-19-who','','','2020-04-12 13:16:43','2020-04-12 13:16:43','',0,'https://microbiozindia.com/?p=4792',0,'post','',0),(4793,2,'2020-04-12 13:09:10','2020-04-12 13:09:10','','virus-4942002','','inherit','open','closed','','virus-4942002','','','2020-04-12 13:09:10','2020-04-12 13:09:10','',4792,'https://microbiozindia.com/wp-content/uploads/2020/04/virus-4942002.png',0,'attachment','image/png',0),(4794,2,'2020-04-12 13:10:11','2020-04-12 13:10:11','The COVID-19 pandemic has hit more than 22,000 human services laborers across 52 nations and districts, the World Health Organization said Saturday.\r\n\r\nAs per its every day circumstance report,<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796b143_4\"> 22,073 COVID-19 cases among human services laborers have been accounted for to the WHO as of Wednesday, April 8.</a></span>\r\n\r\nThe report said the number is likely under-spoke to as there is so far no efficient announcing of contaminations among social insurance laborers to the WHO.\r\n\r\nStarter results recommend medicinal services laborers are being contaminated both in the work environment and in the network, regularly through tainted relatives.\r\n\r\nTo secure forefront medicinal services laborers, the WHO focused on the right utilization of individual defensive hardware like veils, goggles, gloves, and outfits.\r\n\r\nTaking note of the danger of burnout among social insurance suppliers, the WHO called for regarding their privileges to nice working conditions.','More than 22,000 health services workers, doctors tainted by COVID-19: WHO','','inherit','closed','closed','','4792-revision-v1','','','2020-04-12 13:10:11','2020-04-12 13:10:11','',4792,'https://microbiozindia.com/uncategorized/4792-revision-v1/',0,'revision','',0),(4795,2,'2020-04-12 13:15:17','2020-04-12 13:15:17','The COVID-19 pandemic has hit more than 22,000 human services laborers across 52 nations and districts, the World Health Organization said Saturday.\r\n\r\nAs per its every day circumstance report,<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796b143_4\"> 22,073 COVID-19 cases among human services laborers have been accounted for to the WHO as of Wednesday, April 8.</a></span>\r\n\r\nThe report said the number is likely under-spoke to as there is so far no efficient announcing of contaminations among social insurance laborers to the WHO.\r\n\r\nStarter results recommend medicinal services laborers are being contaminated both in the work environment and in the network, regularly through tainted relatives.\r\n\r\nTo secure forefront medicinal services laborers, the WHO focused on the right utilization of individual defensive hardware like veils, goggles, gloves, and outfits.\r\n\r\nTaking note of the danger of burnout among social insurance suppliers, the WHO called for regarding their privileges to nice working conditions.','More than 22,000 health service workers and doctors tainted by COVID-19: WHO','','inherit','closed','closed','','4792-revision-v1','','','2020-04-12 13:15:17','2020-04-12 13:15:17','',4792,'https://microbiozindia.com/uncategorized/4792-revision-v1/',0,'revision','',0),(4796,2,'2020-04-13 07:18:30','2020-04-13 07:18:30','In a novel report, analysts have built up a PC model to screen drugs for unintended heart reactions, particularly arrhythmia chance.\r\n\r\nThe investigation drove by C<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://health.ucdavis.edu/physiology/faculty/vorobyov.html\">olleen E. Clancy, educator of physiology and layer science, and Igor Vorobyov, partner teacher of physiology and membrane biology</a></span> was published in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ahajournals.org/journal/res\">journal Circulation Research.</a></span>\r\n\r\nClancy is a perceived innovator in utilizing elite registering to comprehend electrical changes in the heart.\r\n\r\n\"One fundamental explanation behind a medication being expelled from the market is conceivably perilous arrhythmias,\" Clancy said. \"Indeed, even medications created to treat arrhythmia have wound up really causing them.\"\r\n\r\nThe issue, as indicated by Clancy, is that there is no simple method to see how a medication associates with <span style=\"text-decoration: underline;\">hERG-encoded potassium channels fundamental to typical heart rhythm.</span>\r\n\r\n<span style=\"text-decoration: underline;\">\"So far there has been no surefire approach to figure out which medications will be helpful and which will destructive,\" Clancy said. \"What we have indicated is that we would now be able to make this assurance beginning from the synthetic structure of a medication and afterward anticipating its effect on the heart rhythm.\"</span>\r\n\r\nUtilizing a medication\'s compound recipe, the PC model uncovers how that sedate explicitly cooperates with hERG channels just as cardiovascular cells and tissue. The results would then be able to be approved with correlations with clinical information from electrocardiogram (ECG) consequences of patients.\r\n\r\nFor the examination, the specialists approved the model with ECGs of patients consuming two medications known to cooperate with hERG channels - one with a solid wellbeing profile and another known to expand arrhythmias. The outcomes demonstrated the exactness of the model.\r\n\r\nClancy imagines the model will offer a fundamental pre-advertise trial of heart medicate security. That test could eventually be utilized for other organ frameworks, for example, the liver and mind.\r\n\r\n\"Each new medication needs to experience a screening for heart poisonous quality, and this could be a significant initial step to proposing damage or security before proceeding onward to increasingly costly and broad testing,\" Clancy said.','Scientists create PC model that predicts how medications influence heart rhythm','','publish','open','open','','scientists-create-pc-model-that-predicts-how-medications-influence-heart-rhythm','','','2020-04-13 07:18:30','2020-04-13 07:18:30','',0,'https://microbiozindia.com/?p=4796',0,'post','',0),(4797,2,'2020-04-13 07:17:44','2020-04-13 07:17:44','','heartbeat-1892826_1920','','inherit','open','closed','','heartbeat-1892826_1920','','','2020-04-13 07:17:44','2020-04-13 07:17:44','',4796,'https://microbiozindia.com/wp-content/uploads/2020/04/heartbeat-1892826_1920.jpg',0,'attachment','image/jpeg',0),(4798,2,'2020-04-13 07:18:30','2020-04-13 07:18:30','In a novel report, analysts have built up a PC model to screen drugs for unintended heart reactions, particularly arrhythmia chance.\r\n\r\nThe investigation drove by C<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://health.ucdavis.edu/physiology/faculty/vorobyov.html\">olleen E. Clancy, educator of physiology and layer science, and Igor Vorobyov, partner teacher of physiology and membrane biology</a></span> was published in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ahajournals.org/journal/res\">journal Circulation Research.</a></span>\r\n\r\nClancy is a perceived innovator in utilizing elite registering to comprehend electrical changes in the heart.\r\n\r\n\"One fundamental explanation behind a medication being expelled from the market is conceivably perilous arrhythmias,\" Clancy said. \"Indeed, even medications created to treat arrhythmia have wound up really causing them.\"\r\n\r\nThe issue, as indicated by Clancy, is that there is no simple method to see how a medication associates with <span style=\"text-decoration: underline;\">hERG-encoded potassium channels fundamental to typical heart rhythm.</span>\r\n\r\n<span style=\"text-decoration: underline;\">\"So far there has been no surefire approach to figure out which medications will be helpful and which will destructive,\" Clancy said. \"What we have indicated is that we would now be able to make this assurance beginning from the synthetic structure of a medication and afterward anticipating its effect on the heart rhythm.\"</span>\r\n\r\nUtilizing a medication\'s compound recipe, the PC model uncovers how that sedate explicitly cooperates with hERG channels just as cardiovascular cells and tissue. The results would then be able to be approved with correlations with clinical information from electrocardiogram (ECG) consequences of patients.\r\n\r\nFor the examination, the specialists approved the model with ECGs of patients consuming two medications known to cooperate with hERG channels - one with a solid wellbeing profile and another known to expand arrhythmias. The outcomes demonstrated the exactness of the model.\r\n\r\nClancy imagines the model will offer a fundamental pre-advertise trial of heart medicate security. That test could eventually be utilized for other organ frameworks, for example, the liver and mind.\r\n\r\n\"Each new medication needs to experience a screening for heart poisonous quality, and this could be a significant initial step to proposing damage or security before proceeding onward to increasingly costly and broad testing,\" Clancy said.','Scientists create PC model that predicts how medications influence heart rhythm','','inherit','closed','closed','','4796-revision-v1','','','2020-04-13 07:18:30','2020-04-13 07:18:30','',4796,'https://microbiozindia.com/uncategorized/4796-revision-v1/',0,'revision','',0),(4799,2,'2020-04-13 07:22:31','2020-04-13 07:22:31','Pharma major Dr Reddy\'s Laboratories Ltd has propelled Invista. It is a detailing of Dasatinib that is bioequivalent to the pioneer brand.\r\n\r\nPatent on Dasatinib is possessed by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bms.com/\">Bristol-Myers-Squibb</a></span>. The Indian patent has lapsed on April 12, 2020.\r\n\r\nIt is demonstrated for the treatment of ceaseless quickened or myeloid or lymphoid impact stage and recently analyzed in interminable stage grown-up patients with Chronic Myeloid Leukemia (CML) in India.\r\n\r\n\"The improvement and dispatch of Invista is a critical advance forward in improving access to drugs at a reasonable cost for CML patients in India,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.reuters.com/companies/REDY.BO\">M V Ramana, Chief Executive Office</a></span>r, Branded Markets (India and Emerging Markets), Dr Reddy\'s Laboratories said in a discharge on Monday.\r\n\r\nHyderabad - based Dr Reddy\'s Invista is accessible in qualities of 50, 70 and 100 mg','Dr Reddy\'s introduces generic cancer drug Invista in india','','publish','open','open','','dr-reddys-introduces-generic-cancer-drug-invista-in-india','','','2020-04-13 07:22:31','2020-04-13 07:22:31','',0,'https://microbiozindia.com/?p=4799',0,'post','',0),(4800,2,'2020-04-13 07:20:53','2020-04-13 07:20:53','','19_08_2019_13_48_27_6847449','','inherit','open','closed','','19_08_2019_13_48_27_6847449','','','2020-04-13 07:20:53','2020-04-13 07:20:53','',4799,'https://microbiozindia.com/wp-content/uploads/2020/04/19_08_2019_13_48_27_6847449.png',0,'attachment','image/png',0),(4801,2,'2020-04-13 07:22:31','2020-04-13 07:22:31','Pharma major Dr Reddy\'s Laboratories Ltd has propelled Invista. It is a detailing of Dasatinib that is bioequivalent to the pioneer brand.\r\n\r\nPatent on Dasatinib is possessed by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bms.com/\">Bristol-Myers-Squibb</a></span>. The Indian patent has lapsed on April 12, 2020.\r\n\r\nIt is demonstrated for the treatment of ceaseless quickened or myeloid or lymphoid impact stage and recently analyzed in interminable stage grown-up patients with Chronic Myeloid Leukemia (CML) in India.\r\n\r\n\"The improvement and dispatch of Invista is a critical advance forward in improving access to drugs at a reasonable cost for CML patients in India,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.reuters.com/companies/REDY.BO\">M V Ramana, Chief Executive Office</a></span>r, Branded Markets (India and Emerging Markets), Dr Reddy\'s Laboratories said in a discharge on Monday.\r\n\r\nHyderabad - based Dr Reddy\'s Invista is accessible in qualities of 50, 70 and 100 mg','Dr Reddy\'s introduces generic cancer drug Invista in india','','inherit','closed','closed','','4799-revision-v1','','','2020-04-13 07:22:31','2020-04-13 07:22:31','',4799,'https://microbiozindia.com/uncategorized/4799-revision-v1/',0,'revision','',0),(4802,2,'2020-04-13 07:24:02','2020-04-13 07:24:02','Minerals have a positive effect on our body. Calcium keeps our bones strong, iron delivers oxygen to your blood cells and zinc helps your <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system\">immune system</a></span> function properly. Another mineral that protects your body is Fluoride. Found in soil and rocks, fluoride is often added to toothpaste to improve its benefit to the health of your teeth. In recent decades, fluoride in toothpaste has played a big role in reducing cavities and improving people\'s overall health around the world.\n\nFluoride helps your tooth enamel in two ways: When a person\'s teeth are still beginning to emerge, this ingredient develops the enamel so that it becomes as hard as it needs to be to resist cavities and decay. After the teeth have appeared in the mouth, fluoride in toothpaste, mouthwash and even tap water helps the enamel remain strong so that it can resist the acid produced by oral bacteria when you eat sugary foods. Fluoride also has a remineralizing effect on the teeth, by which it helps rebuild worn-down or weakened enamel before it disappears.\n\nThere is no scientifically valid evidence to show that fluoride causes cancer, kidney disease, or other disorders.Usually for people is to take fluoride supplements or have a dentist or dental hygienist apply a fluoride varnish during a routine appointment. Suggests the ADA, is that putting fluoride in toothpaste has led to a major decrease in the number of cavities Americans have had since 1960.\n\nA majority of toothpastes on the market contain about 0.15% fluoride ion, which comes out to 1500 ppm (parts per million.) In 1.5 ml of toothpaste (the large stripe pictured above) you would find 2.25 mg of fluoride. In a pea sized amount of toothpaste, you would only find 0.3 mg of fluoride.\n\nOne of the customer contacted <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/\">HANNA</a></span> to determine Fluoride in ppm level. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HANNA’s HI5522 pH/ORP/ISE bench-top instrument</a></span> features up to five point calibration, five fixed standard solutions available (0.1, 1, 10, 100, 1000 choice of concentration).The HI5522 can use ISE electrodes in the ppm scale (pH channel input) and provides a choice of measurement units (ppb, ppm, molarity, weight/volume %).Overall, the customer was pleased with the meter and the ready to use reagents and now looks to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check.html\">Hanna Instruments</a></span> as a reliable and credible source for their other testing needs.\n\nThe meter HI5522 here is an advanced research grade benchtop pH/ORP/ISE and EC/TDS/Salinity/Resistivity meter that is completely customizable with a large color LCD, capacitive touch keys, and USB port for computer connectivity. It have two-channel meter that allows for simultaneous measure of pH, ORP, or ISE on one channel and EC, TDS, Salinity, or Resistivity on the other. The two measurement channels of the HI5522 are galvanically isolated to eliminate noise and instability.\n\n<img class=\"alignnone size-medium wp-image-4756\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/HANNA..-300x272.png\" alt=\"\" width=\"300\" height=\"272\" />\n\nChannel one has a BNC connection for use with the expansive line of pH, ORP, and ISE electrodes that Hanna Instruments offers. HI5522 can measure EC over a wide range from 0.000 μS/cm to 1000.0 mS/cm*. The meter can be set to auto-ranging in which the meter chooses the appropriate conductivity range from seven ranges or fixed range in which the meter will only display reading in μS/cm or mS/cm. All readings are automatically compensated for temperature variations with a built in temperature sensor.\n\n<span style=\"text-decoration: underline;\">The temperature correction coefficient is adjustable from 0.00 to 10.00 %/°C.</span>\n<span style=\"text-decoration: underline;\">Incremental methods like The known addition, known subtraction, analyte addition, and analyte subtraction incremental methods are pre-programmed into the HI5522. This meter also offers Three selectable logging modes are availableon the HI5522: automatic, manual, and AutoHold logging. Automatic and manuallogs up to 100 lots with 50,000 records max/lot, with up to 100,000 total data points.</span>','Role of Fluoride content in your toothpaste','','inherit','closed','closed','','4754-autosave-v1','','','2020-04-13 07:24:02','2020-04-13 07:24:02','',4754,'https://microbiozindia.com/uncategorized/4754-autosave-v1/',0,'revision','',0),(4803,2,'2020-04-13 07:25:18','2020-04-13 07:25:18','Minerals have a positive effect on our body. Calcium keeps our bones strong, iron delivers oxygen to your blood cells and zinc helps your <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.health.harvard.edu/staying-healthy/how-to-boost-your-immune-system\">immune system</a></span> function properly. Another mineral that protects your body is Fluoride. Found in soil and rocks, fluoride is often added to toothpaste to improve its benefit to the health of your teeth. In recent decades, fluoride in toothpaste has played a big role in reducing cavities and improving people\'s overall health around the world.\r\n\r\nFluoride helps your tooth enamel in two ways: When a person\'s teeth are still beginning to emerge, this ingredient develops the enamel so that it becomes as hard as it needs to be to resist cavities and decay. After the teeth have appeared in the mouth, fluoride in toothpaste, mouthwash and even tap water helps the enamel remain strong so that it can resist the acid produced by oral bacteria when you eat sugary foods. Fluoride also has a remineralizing effect on the teeth, by which it helps rebuild worn-down or weakened enamel before it disappears.\r\n\r\nThere is no scientifically valid evidence to show that fluoride causes cancer, kidney disease, or other disorders.Usually for people is to take fluoride supplements or have a dentist or dental hygienist apply a fluoride varnish during a routine appointment. Suggests the ADA, is that putting fluoride in toothpaste has led to a major decrease in the number of cavities Americans have had since 1960.\r\n\r\nA majority of toothpastes on the market contain about 0.15% fluoride ion, which comes out to 1500 ppm (parts per million.) In 1.5 ml of toothpaste (the large stripe pictured above) you would find 2.25 mg of fluoride. In a pea sized amount of toothpaste, you would only find 0.3 mg of fluoride.\r\n\r\nOne of the customer contacted <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/\">HANNA</a></span> to determine Fluoride in ppm level. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HANNA’s HI5522 pH/ORP/ISE bench-top instrument</a></span> features up to five point calibration, five fixed standard solutions available (0.1, 1, 10, 100, 1000 choice of concentration).The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> can use ISE electrodes in the ppm scale (pH channel input) and provides a choice of measurement units (ppb, ppm, molarity, weight/volume %).Overall, the customer was pleased with the meter and the ready to use reagents and now looks to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.hannainst.com/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check.html\">Hanna Instruments</a></span> as a reliable and credible source for their other testing needs.\r\n\r\nThe meter <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> here is an advanced research grade benchtop pH/ORP/ISE and EC/TDS/Salinity/Resistivity meter that is completely customizable with a large color LCD, capacitive touch keys, and USB port for computer connectivity. It have two-channel meter that allows for simultaneous measure of pH, ORP, or ISE on one channel and EC, TDS, Salinity, or Resistivity on the other. The two measurement channels of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a> </span>are galvanically isolated to eliminate noise and instability.\r\n\r\n<img class=\"alignnone size-medium wp-image-4756\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/HANNA..-300x272.png\" alt=\"\" width=\"300\" height=\"272\" />\r\n\r\nChannel one has a BNC connection for use with the expansive line of pH, ORP, and ISE electrodes that Hanna Instruments offers. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span> can measure EC over a wide range from 0.000 μS/cm to 1000.0 mS/cm*. The meter can be set to auto-ranging in which the meter chooses the appropriate conductivity range from seven ranges or fixed range in which the meter will only display reading in μS/cm or mS/cm. All readings are automatically compensated for temperature variations with a built in temperature sensor.\r\n\r\n<span style=\"text-decoration: underline;\">The temperature correction coefficient is adjustable from 0.00 to 10.00 %/°C.</span>\r\n<span style=\"text-decoration: underline;\">Incremental methods like The known addition, known subtraction, analyte addition, and analyte subtraction incremental methods are pre-programmed into the <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a>.</span> This meter also offers Three selectable logging modes are availableon the <span style=\"color: #ff6600; text-decoration: underline;\"><a style=\"color: #ff6600; text-decoration: underline;\" href=\"https://hannainst.in/hi5522-research-grade-ph-orp-ise-and-ec-tds-salinity-resistivity-meter-with-cal-check-2866.html\">HI5522</a></span>: automatic, manual, and AutoHold logging. Automatic and manuallogs up to 100 lots with 50,000 records max/lot, with up to 100,000 total data points.</span>','Role of Fluoride content in your toothpaste','','inherit','closed','closed','','4754-revision-v1','','','2020-04-13 07:25:18','2020-04-13 07:25:18','',4754,'https://microbiozindia.com/uncategorized/4754-revision-v1/',0,'revision','',0),(4804,2,'2020-04-13 09:06:12','2020-04-13 09:06:12','There are 70 coronavirus antibodies being developed all inclusive, with three competitors previously being tried in human preliminaries, as indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/\">World Health Organization</a></span>, as drugmakers race to discover a remedy for the savage pathogen.\r\n\r\nThe uttermost along in the clinical procedure is an exploratory antibody created by Hong Kong-recorded <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Biologics Inc.</a></span> what\'s more, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://publons.com/institution/9480/\">Beijing Institute of Biotechnology</a></span>, which is in stage 2. The other two being tried in people are medicines grown independently by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.wsj.com/articles/drugmaker-moderna-delivers-first-coronavirus-vaccine-for-human-testing-11582579099\">U.S. drugmakers Moderna Inc.</a></span> what\'s more, Inovio Pharmaceuticals Inc., as indicated by a WHO record.\r\n\r\nProgress is happening at remarkable speed in creating antibodies as the irresistible pathogen looks probably not going to be gotten rid of through control gauges alone. <span style=\"text-decoration: underline;\">The medication business is wanting to pack the time it takes to get an immunization to showcase - as a rule around 10 to 15 years - to inside the following year.</span>\r\n\r\n<span style=\"text-decoration: underline;\">Drugmakers of all shapes and sizes have hopped in to attempt to build up an immunization, which would be the best method to contain the infection. Pharmaceutical mammoths like Pfizer Inc. also, Sanofi have antibody up-and-comers in the preclinical stages, as indicated by the WHO report.</span>\r\n\r\nCanSino said a month ago it got Chinese administrative endorsement to begin human preliminaries of its immunization. Cambridge, Massachusetts-based Moderna - which has never put out an item - got administrative endorsement to move rapidly to human preliminaries in March, skirting the long stretches of creature preliminaries that are the standard in creating antibodies. Inovio started its human preliminaries a week ago.','Up to 70 coronavirus antibodies in progress,three being tried on human says WHO','','publish','open','open','','up-to-70-coronavirus-antibodies-in-progressthree-being-tried-on-human-says-who','','','2020-04-13 09:06:12','2020-04-13 09:06:12','',0,'https://microbiozindia.com/?p=4804',0,'post','',0),(4805,2,'2020-04-13 09:02:53','2020-04-13 09:02:53','','nurse-4967171_1920','','inherit','open','closed','','nurse-4967171_1920','','','2020-04-13 09:02:53','2020-04-13 09:02:53','',4804,'https://microbiozindia.com/wp-content/uploads/2020/04/nurse-4967171_1920.jpg',0,'attachment','image/jpeg',0),(4806,2,'2020-04-13 09:06:12','2020-04-13 09:06:12','There are 70 coronavirus antibodies being developed all inclusive, with three competitors previously being tried in human preliminaries, as indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/\">World Health Organization</a></span>, as drugmakers race to discover a remedy for the savage pathogen.\r\n\r\nThe uttermost along in the clinical procedure is an exploratory antibody created by Hong Kong-recorded <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Biologics Inc.</a></span> what\'s more, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://publons.com/institution/9480/\">Beijing Institute of Biotechnology</a></span>, which is in stage 2. The other two being tried in people are medicines grown independently by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.wsj.com/articles/drugmaker-moderna-delivers-first-coronavirus-vaccine-for-human-testing-11582579099\">U.S. drugmakers Moderna Inc.</a></span> what\'s more, Inovio Pharmaceuticals Inc., as indicated by a WHO record.\r\n\r\nProgress is happening at remarkable speed in creating antibodies as the irresistible pathogen looks probably not going to be gotten rid of through control gauges alone. <span style=\"text-decoration: underline;\">The medication business is wanting to pack the time it takes to get an immunization to showcase - as a rule around 10 to 15 years - to inside the following year.</span>\r\n\r\n<span style=\"text-decoration: underline;\">Drugmakers of all shapes and sizes have hopped in to attempt to build up an immunization, which would be the best method to contain the infection. Pharmaceutical mammoths like Pfizer Inc. also, Sanofi have antibody up-and-comers in the preclinical stages, as indicated by the WHO report.</span>\r\n\r\nCanSino said a month ago it got Chinese administrative endorsement to begin human preliminaries of its immunization. Cambridge, Massachusetts-based Moderna - which has never put out an item - got administrative endorsement to move rapidly to human preliminaries in March, skirting the long stretches of creature preliminaries that are the standard in creating antibodies. Inovio started its human preliminaries a week ago.','Up to 70 coronavirus antibodies in progress,three being tried on human says WHO','','inherit','closed','closed','','4804-revision-v1','','','2020-04-13 09:06:12','2020-04-13 09:06:12','',4804,'https://microbiozindia.com/uncategorized/4804-revision-v1/',0,'revision','',0),(4807,2,'2020-04-13 09:24:22','0000-00-00 00:00:00','','Gilead\'s Experimental Coronavirus Drug Shows \"Cheerful\" Signs in Small Group','','draft','open','open','','','','','2020-04-13 09:24:22','2020-04-13 09:24:22','',0,'https://microbiozindia.com/?p=4807',0,'post','',0),(4808,2,'2020-04-13 12:16:45','2020-04-13 12:16:45','Drug producer Lupin on Monday said it has gotten an Establishment Inspection Report (EIR) from the US wellbeing controller for its assembling plant in Nagpur.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">US Food and Drug Administration (USFDA) issues an EIR to an organization when an assessment is sufficiently shut.</a></span>\r\n\r\nThe wellbeing controller had assessed the organization\'s Nagpur producing office between January 6 and January 10, 2020, Lupin Ltd said in an announcement.\r\n\r\n\"We are extremely glad to have gotten the EIR for our Nagpur office, our biggest and most progressive oral strong measurement office. We stay focused on upgrading consistence and quality benchmarks over the entirety of our assembling locales,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.lupin.com/our-world/management-and-board-of-directors/\">Lupin Managing Director Nilesh Gupta said.</a></span>\r\n\r\nThis story has been distributed from a wire office feed without alterations to the content. Just the feature has been changed.','Lupin gets EIR from USFDA for its Nagpur Plant','','publish','open','open','','lupin-gets-eir-from-usfda-for-its-nagpur-plant','','','2020-04-13 12:16:45','2020-04-13 12:16:45','',0,'https://microbiozindia.com/?p=4808',0,'post','',0),(4809,2,'2020-04-13 12:10:18','2020-04-13 12:10:18','','lupin','','inherit','open','closed','','lupin','','','2020-04-13 12:10:18','2020-04-13 12:10:18','',4808,'https://microbiozindia.com/wp-content/uploads/2020/04/lupin.jpg',0,'attachment','image/jpeg',0),(4810,2,'2020-04-13 12:10:32','2020-04-13 12:10:32','','125969-usfda-approved','','inherit','open','closed','','125969-usfda-approved','','','2020-04-13 12:10:32','2020-04-13 12:10:32','',4808,'https://microbiozindia.com/wp-content/uploads/2020/04/125969-usfda-approved.jpg',0,'attachment','image/jpeg',0),(4811,2,'2020-04-13 12:16:45','2020-04-13 12:16:45','Drug producer Lupin on Monday said it has gotten an Establishment Inspection Report (EIR) from the US wellbeing controller for its assembling plant in Nagpur.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">US Food and Drug Administration (USFDA) issues an EIR to an organization when an assessment is sufficiently shut.</a></span>\r\n\r\nThe wellbeing controller had assessed the organization\'s Nagpur producing office between January 6 and January 10, 2020, Lupin Ltd said in an announcement.\r\n\r\n\"We are extremely glad to have gotten the EIR for our Nagpur office, our biggest and most progressive oral strong measurement office. We stay focused on upgrading consistence and quality benchmarks over the entirety of our assembling locales,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.lupin.com/our-world/management-and-board-of-directors/\">Lupin Managing Director Nilesh Gupta said.</a></span>\r\n\r\nThis story has been distributed from a wire office feed without alterations to the content. Just the feature has been changed.','Lupin gets EIR from USFDA for its Nagpur Plant','','inherit','closed','closed','','4808-revision-v1','','','2020-04-13 12:16:45','2020-04-13 12:16:45','',4808,'https://microbiozindia.com/uncategorized/4808-revision-v1/',0,'revision','',0),(4812,2,'2020-04-13 12:19:34','2020-04-13 12:19:34','Caplin Steriles Ltd, a backup of Caplin Point Laboratories Ltd, has gotten last endorsement from the United States Food and Drug Administration (USFDA) for its Abbreviated <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203955Orig1s000ltr.pdf\">New Drug Application (ANDA) Ropivacaine Hydrochloride infusion USP.</a></span>\r\n\r\nRopivacaine Hydrochloride is a long-acting nearby sedative medication utilized for medical procedure or intense agony the board. The organization is additionally dealing with an arrangement of 35 straightforward and complex injectable and ophthalmic items, to be documented throughout the following 4 years, the organization said in an announcement.\r\n\r\n\"We\'re happy to get this endorsement, especially as this item has been much of the time on the lack list in the US as of late. We would dispatch this item in the blink of an eye, and plan to reduce a portion of the deficiencies,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.caplinpoint.net/managementteam.aspx\">C.C. Paarthipan, Chairman of Caplin Point said.</a></span>\r\n\r\nThe organization has gotten last endorsement for Ropivacaine Hydrochloride infusion USP 0.2 percent in 40 mg/20 mL (2 mg/mL), 0.5 percent in 100 mg/20 mL (5 mg/mL), 0.5 percent in 150 mg/30 mL (5 mg/mL) and 1 percent in 200 mg/20 mL (10 mg/mL) Single-portion vial introductions, a nonexclusive restorative identical adaptation of (RLD), Naropin Injection of Fresenius Kabi USA.\r\n\r\nAs per IQVIATM (IMS Health), Ropivacaine Hydrochloride infusion USP had US deals information of about $34 million for the year time frame finishing December 2019.\r\n\r\n<span style=\"text-decoration: underline;\">Caplin Steriles has created and recorded 16 ANDAs all alone and with accomplices, with eight endorsements up until this point.</span>','Caplin Steriles packs USFDA endorsement for nearby sedative medication','','publish','open','open','','caplin-steriles-packs-usfda-endorsement-for-nearby-sedative-medication','','','2020-04-13 12:19:34','2020-04-13 12:19:34','',0,'https://microbiozindia.com/?p=4812',0,'post','',0),(4813,2,'2020-04-13 12:19:34','2020-04-13 12:19:34','Caplin Steriles Ltd, a backup of Caplin Point Laboratories Ltd, has gotten last endorsement from the United States Food and Drug Administration (USFDA) for its Abbreviated <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203955Orig1s000ltr.pdf\">New Drug Application (ANDA) Ropivacaine Hydrochloride infusion USP.</a></span>\r\n\r\nRopivacaine Hydrochloride is a long-acting nearby sedative medication utilized for medical procedure or intense agony the board. The organization is additionally dealing with an arrangement of 35 straightforward and complex injectable and ophthalmic items, to be documented throughout the following 4 years, the organization said in an announcement.\r\n\r\n\"We\'re happy to get this endorsement, especially as this item has been much of the time on the lack list in the US as of late. We would dispatch this item in the blink of an eye, and plan to reduce a portion of the deficiencies,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.caplinpoint.net/managementteam.aspx\">C.C. Paarthipan, Chairman of Caplin Point said.</a></span>\r\n\r\nThe organization has gotten last endorsement for Ropivacaine Hydrochloride infusion USP 0.2 percent in 40 mg/20 mL (2 mg/mL), 0.5 percent in 100 mg/20 mL (5 mg/mL), 0.5 percent in 150 mg/30 mL (5 mg/mL) and 1 percent in 200 mg/20 mL (10 mg/mL) Single-portion vial introductions, a nonexclusive restorative identical adaptation of (RLD), Naropin Injection of Fresenius Kabi USA.\r\n\r\nAs per IQVIATM (IMS Health), Ropivacaine Hydrochloride infusion USP had US deals information of about $34 million for the year time frame finishing December 2019.\r\n\r\n<span style=\"text-decoration: underline;\">Caplin Steriles has created and recorded 16 ANDAs all alone and with accomplices, with eight endorsements up until this point.</span>','Caplin Steriles packs USFDA endorsement for nearby sedative medication','','inherit','closed','closed','','4812-revision-v1','','','2020-04-13 12:19:34','2020-04-13 12:19:34','',4812,'https://microbiozindia.com/uncategorized/4812-revision-v1/',0,'revision','',0),(4814,2,'2020-04-13 12:56:17','2020-04-13 12:56:17','Two IIT Bombay alumini startups have together built up an UVC light based sanitisation box prototype for fundamentals. This could be estimated between Rs 1,000-1,500.\r\n\r\nThe coronavirus (COVID-19) outbreak has prompted a worry about disease spread from fundamental goods like vegetables, packed food and milk, natural products, money notes. To manage this issue, two Indian Institute of Technology (IIT) Bombay alumini startups have built up a model that endeavors to destroy virus utilizing Ultraviolet C (UVC) lights.\r\n\r\nThis model has been created by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gtarangenergy.com/\">GTarang Energy Solutions</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.manastuspace.com/\">Manastu Space Technologies.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/startup/worried-about-covid-19-infection-through-surfaces-heres-a-device-that-could-kill-it-5139911.html\">In an association with Moneycontrol,</a></span> Ratnesh Mishra, prime supporter of GTarang Energy Solutions, said that the expense of the gadget could be in gteh scope of Rs 1,000-Rs 1,500.\r\n\r\n\"We are looking searching for associations in assembling and dissemination. We would likewise need to accomplish more preliminaries of the item with the neighborhood governments,\" he said.\r\n\r\nAmong the intended interest group will be family units, businesspeople and conveyance firms. Mishra included that the greatest center fragment will be family units the nation over.','Two IIT Bombay alumni startups have together built up an UVC light based sanitisation box','','publish','open','open','','two-iit-bombay-alumni-startups-have-together-built-up-an-uvc-light-based-sanitisation-box','','','2020-04-13 12:56:17','2020-04-13 12:56:17','',0,'https://microbiozindia.com/?p=4814',0,'post','',0),(4815,2,'2020-04-13 12:56:08','2020-04-13 12:56:08','','coronavirus-4945416_1920','','inherit','open','closed','','coronavirus-4945416_1920','','','2020-04-13 12:56:08','2020-04-13 12:56:08','',4814,'https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4945416_1920.jpg',0,'attachment','image/jpeg',0),(4816,2,'2020-04-13 12:56:17','2020-04-13 12:56:17','Two IIT Bombay alumini startups have together built up an UVC light based sanitisation box prototype for fundamentals. This could be estimated between Rs 1,000-1,500.\r\n\r\nThe coronavirus (COVID-19) outbreak has prompted a worry about disease spread from fundamental goods like vegetables, packed food and milk, natural products, money notes. To manage this issue, two Indian Institute of Technology (IIT) Bombay alumini startups have built up a model that endeavors to destroy virus utilizing Ultraviolet C (UVC) lights.\r\n\r\nThis model has been created by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gtarangenergy.com/\">GTarang Energy Solutions</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.manastuspace.com/\">Manastu Space Technologies.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/startup/worried-about-covid-19-infection-through-surfaces-heres-a-device-that-could-kill-it-5139911.html\">In an association with Moneycontrol,</a></span> Ratnesh Mishra, prime supporter of GTarang Energy Solutions, said that the expense of the gadget could be in gteh scope of Rs 1,000-Rs 1,500.\r\n\r\n\"We are looking searching for associations in assembling and dissemination. We would likewise need to accomplish more preliminaries of the item with the neighborhood governments,\" he said.\r\n\r\nAmong the intended interest group will be family units, businesspeople and conveyance firms. Mishra included that the greatest center fragment will be family units the nation over.','Two IIT Bombay alumni startups have together built up an UVC light based sanitisation box','','inherit','closed','closed','','4814-revision-v1','','','2020-04-13 12:56:17','2020-04-13 12:56:17','',4814,'https://microbiozindia.com/uncategorized/4814-revision-v1/',0,'revision','',0),(4817,2,'2020-04-14 07:08:59','2020-04-14 07:08:59','The Indian Council of Medical Research on Monday said antiviral medication remdesivir, which was utilized during the Ebola episode, might be profoundly powerful in halting the replication component of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2 that causes COVID-19.</a></span>\r\n\r\nThe ICMR said investigate on its viability in the treatment of COVID-19 is a piece of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/\">WHO\'s</a> </span>\"Solidarity Trial\".\r\n\r\nAs indicated by an as of late distributed investigation in the New England Journal of Medicine, two out of three basically sick coronavirus tainted patients who were on oxygen support or on ventilators gave indications of progress when they were regulated remdesivir.\r\n\r\n<span style=\"text-decoration: underline;\">Remarking on the investigation, Head of Epidemiology and Communicable infections at ICMR Raman R Gangakhedkar said that medicate which was utilized against Ebola infection, as indicated by the scientists, prevents the propagation of coronavirus which is the reason they accept that it could be powerful in COVID-19 treatment.</span>','Antiviral medication remdesivir might be powerful in halting replication of coronavirus: ICMR','','publish','open','open','','antiviral-medication-remdesivir-might-be-powerful-in-halting-replication-of-coronavirus-icmr','','','2020-04-14 07:08:59','2020-04-14 07:08:59','',0,'https://microbiozindia.com/?p=4817',0,'post','',0),(4818,2,'2020-04-14 07:08:43','2020-04-14 07:08:43','','coronavirus-4957673_640','','inherit','open','closed','','coronavirus-4957673_640','','','2020-04-14 07:08:43','2020-04-14 07:08:43','',4817,'https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4957673_640.jpg',0,'attachment','image/jpeg',0),(4819,2,'2020-04-14 07:08:59','2020-04-14 07:08:59','The Indian Council of Medical Research on Monday said antiviral medication remdesivir, which was utilized during the Ebola episode, might be profoundly powerful in halting the replication component of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2 that causes COVID-19.</a></span>\r\n\r\nThe ICMR said investigate on its viability in the treatment of COVID-19 is a piece of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/\">WHO\'s</a> </span>\"Solidarity Trial\".\r\n\r\nAs indicated by an as of late distributed investigation in the New England Journal of Medicine, two out of three basically sick coronavirus tainted patients who were on oxygen support or on ventilators gave indications of progress when they were regulated remdesivir.\r\n\r\n<span style=\"text-decoration: underline;\">Remarking on the investigation, Head of Epidemiology and Communicable infections at ICMR Raman R Gangakhedkar said that medicate which was utilized against Ebola infection, as indicated by the scientists, prevents the propagation of coronavirus which is the reason they accept that it could be powerful in COVID-19 treatment.</span>','Antiviral medication remdesivir might be powerful in halting replication of coronavirus: ICMR','','inherit','closed','closed','','4817-revision-v1','','','2020-04-14 07:08:59','2020-04-14 07:08:59','',4817,'https://microbiozindia.com/uncategorized/4817-revision-v1/',0,'revision','',0),(4820,2,'2020-04-14 08:01:31','2020-04-14 08:01:31','While trying to shield social insurance laborers and residents from coronavirus, a group of analysts at Indian Institute of Technology (IIT), Guwahati have built up a moderate antimicrobial spray based covering for PPE packs to slaughter and forestall the spread of organisms once they interact with the covered PPE surface.\r\n\r\nThey have likewise evolved 3D printed ear watch for the agreeable utilization of face covers by social insurance laborers, said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Institute_of_Technology_Guwahati\">IIT Guwahati</a></span> in an announcement.\r\n\r\nIn a public statement, IIT Guwahati said that the ideas were created by Dr Biman B. Mandal, Professor, Department of Biosciences and Bioengineering, IIT Guwahati, alongside his Ph.D. researchers, Bibhas K. Bhunia and Ashutosh Bandyopadhyay.\r\n\r\nDiscussing the work, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.iitg.ac.in/biman.mandal/ps.html\">Dr. Biman B. Mandal, Professor, Department of Biosciences and Bioengineering, IIT Guwahati, stated,</a></span> \"Compelling yet reasonable innovations are need of great importance for India. We at IIT-G under the administration of our Director, Prof. T.G. Sitharam, are resolved to add to the country\'s quick need at this hour of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> emergency.\"\r\n\r\nPPEs that are being utilized directly are intended to shield the wearer from irresistible microorganisms/watery infection beads going about as a hindrance.\r\n\r\nNonetheless, these PPE, by and large, don\'t be able to forestall the spread of organisms as the outside of the texture promptly permits adherence and collection of microorganisms with time. This prompts additionally spread of the organisms because of the careless treatment of PPE and wrong removal conventions, said IIT Guwahati.\r\n\r\nThe vital relationship of metal nanoparticle mixed drink, for example, copper, silver and other dynamic fixings, present in the shower goes about as an antimicrobial specialist.\r\n\r\n<span style=\"text-decoration: underline;\">This guarantees constrained infiltration and aggregation of microbial contaminants on PPE. In this manner, the covering can possibly lessen the danger of auxiliary contamination by restricting the transmission of the microorganisms.</span>','IIT Guwahati analysts create reasonable antiviral spray based covering for PPE','','publish','open','open','','iit-guwahati-analysts-create-reasonable-antiviral-spray-based-covering-for-ppe','','','2020-04-14 08:01:31','2020-04-14 08:01:31','',0,'https://microbiozindia.com/?p=4820',0,'post','',0),(4821,2,'2020-04-14 08:01:13','2020-04-14 08:01:13','','corona-5017617_640','','inherit','open','closed','','corona-5017617_640','','','2020-04-14 08:01:13','2020-04-14 08:01:13','',4820,'https://microbiozindia.com/wp-content/uploads/2020/04/corona-5017617_640.jpg',0,'attachment','image/jpeg',0),(4822,2,'2020-04-14 08:01:31','2020-04-14 08:01:31','While trying to shield social insurance laborers and residents from coronavirus, a group of analysts at Indian Institute of Technology (IIT), Guwahati have built up a moderate antimicrobial spray based covering for PPE packs to slaughter and forestall the spread of organisms once they interact with the covered PPE surface.\r\n\r\nThey have likewise evolved 3D printed ear watch for the agreeable utilization of face covers by social insurance laborers, said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Institute_of_Technology_Guwahati\">IIT Guwahati</a></span> in an announcement.\r\n\r\nIn a public statement, IIT Guwahati said that the ideas were created by Dr Biman B. Mandal, Professor, Department of Biosciences and Bioengineering, IIT Guwahati, alongside his Ph.D. researchers, Bibhas K. Bhunia and Ashutosh Bandyopadhyay.\r\n\r\nDiscussing the work, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.iitg.ac.in/biman.mandal/ps.html\">Dr. Biman B. Mandal, Professor, Department of Biosciences and Bioengineering, IIT Guwahati, stated,</a></span> \"Compelling yet reasonable innovations are need of great importance for India. We at IIT-G under the administration of our Director, Prof. T.G. Sitharam, are resolved to add to the country\'s quick need at this hour of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> emergency.\"\r\n\r\nPPEs that are being utilized directly are intended to shield the wearer from irresistible microorganisms/watery infection beads going about as a hindrance.\r\n\r\nNonetheless, these PPE, by and large, don\'t be able to forestall the spread of organisms as the outside of the texture promptly permits adherence and collection of microorganisms with time. This prompts additionally spread of the organisms because of the careless treatment of PPE and wrong removal conventions, said IIT Guwahati.\r\n\r\nThe vital relationship of metal nanoparticle mixed drink, for example, copper, silver and other dynamic fixings, present in the shower goes about as an antimicrobial specialist.\r\n\r\n<span style=\"text-decoration: underline;\">This guarantees constrained infiltration and aggregation of microbial contaminants on PPE. In this manner, the covering can possibly lessen the danger of auxiliary contamination by restricting the transmission of the microorganisms.</span>','IIT Guwahati analysts create reasonable antiviral spray based covering for PPE','','inherit','closed','closed','','4820-revision-v1','','','2020-04-14 08:01:31','2020-04-14 08:01:31','',4820,'https://microbiozindia.com/uncategorized/4820-revision-v1/',0,'revision','',0),(4823,2,'2020-04-14 08:29:23','2020-04-14 08:29:23','Robots will serve nourishment and offer medication to COVID-19 patients in two emergency clinics in Jharkhand\'s West Singhbhum locale from Tuesday, in a stage to shield specialists and wellbeing laborers from getting tainted with coronavirus.\r\n\r\nCreated by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://chaibasa.nic.in/about-district/whos-who/\">District Deputy Development Commissioner (DDC) Aditya Ranjan</a></span>, the remote-controlled COBOT-Robotics will give nourishment and medication to patients without human mediation, an official discharge said.\r\n\r\nThe 20 and 30-bed \'cutting edge segregation wards\' will be introduced at the ANM Skill Center, Chaibasa Sadar Hospital and COVID-19 Railway Hospital, Chakradharpur individually on Tuesday, it said.\r\n\r\n\"Each bed has been planned like a room where medication and nourishment will be given to patients through COBOT-Robotics.\r\n\r\nThis is the first-of-its sort activity in the nation,\" the discharge stated, citing the DDC.\r\n\r\nA group of specialists, under the supervision of the DDC, planned and customized COBOT-Robotics in a carport in Ranjan\'s living arrangement, the discharge said.\r\n\r\nThe DDC had before planned a stall to ensure wellbeing laborers gathering tests of people suspected to be contaminated with coronavirus, it included.','Robots to serve nourishment, medication to COVID-19 patients in Jharkhand','','publish','open','open','','robots-to-serve-nourishment-medication-to-covid-19-patients-in-jharkhand','','','2020-04-14 08:29:23','2020-04-14 08:29:23','',0,'https://microbiozindia.com/?p=4823',0,'post','',0),(4824,2,'2020-04-14 08:27:45','2020-04-14 08:27:45','','humanoid-1477614_640','','inherit','open','closed','','humanoid-1477614_640','','','2020-04-14 08:27:45','2020-04-14 08:27:45','',4823,'https://microbiozindia.com/wp-content/uploads/2020/04/humanoid-1477614_640.jpg',0,'attachment','image/jpeg',0),(4825,2,'2020-04-14 08:29:23','2020-04-14 08:29:23','Robots will serve nourishment and offer medication to COVID-19 patients in two emergency clinics in Jharkhand\'s West Singhbhum locale from Tuesday, in a stage to shield specialists and wellbeing laborers from getting tainted with coronavirus.\r\n\r\nCreated by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://chaibasa.nic.in/about-district/whos-who/\">District Deputy Development Commissioner (DDC) Aditya Ranjan</a></span>, the remote-controlled COBOT-Robotics will give nourishment and medication to patients without human mediation, an official discharge said.\r\n\r\nThe 20 and 30-bed \'cutting edge segregation wards\' will be introduced at the ANM Skill Center, Chaibasa Sadar Hospital and COVID-19 Railway Hospital, Chakradharpur individually on Tuesday, it said.\r\n\r\n\"Each bed has been planned like a room where medication and nourishment will be given to patients through COBOT-Robotics.\r\n\r\nThis is the first-of-its sort activity in the nation,\" the discharge stated, citing the DDC.\r\n\r\nA group of specialists, under the supervision of the DDC, planned and customized COBOT-Robotics in a carport in Ranjan\'s living arrangement, the discharge said.\r\n\r\nThe DDC had before planned a stall to ensure wellbeing laborers gathering tests of people suspected to be contaminated with coronavirus, it included.','Robots to serve nourishment, medication to COVID-19 patients in Jharkhand','','inherit','closed','closed','','4823-revision-v1','','','2020-04-14 08:29:23','2020-04-14 08:29:23','',4823,'https://microbiozindia.com/uncategorized/4823-revision-v1/',0,'revision','',0),(4826,2,'2020-04-14 10:34:58','2020-04-14 10:34:58','China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.xinhuanet.com/english/\">Xinhua</a></span> provided details regarding Tuesday.\r\n\r\nThe antibodies are being created by a Beijing-based unit of Nasdaq-recorded <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.sinovac.com/\">Sinovac Biotec</a></span>h, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.sinopharm.com/1156.html\">China National Pharmaceutical Group.</a></span>\r\n\r\nIn March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China\'s Academy of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Academy_of_Military_Medical_Sciences\">Military Medical Sciences</a></span> and HK-recorded biotech firm <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Bio</a></span>, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nih.gov/\">U.S. National Institutes of Health.</a></span>','China endorses two trial coronavirus antibodies to enter clinical preliminaries','','publish','open','open','','china-endorses-two-trial-coronavirus-antibodies-to-enter-clinical-preliminaries','','','2020-04-14 10:34:58','2020-04-14 10:34:58','',0,'https://microbiozindia.com/?p=4826',0,'post','',0),(4827,2,'2020-04-14 10:34:45','2020-04-14 10:34:45','','syringe-3902915_640','','inherit','open','closed','','syringe-3902915_640','','','2020-04-14 10:34:45','2020-04-14 10:34:45','',4826,'https://microbiozindia.com/wp-content/uploads/2020/04/syringe-3902915_640.jpg',0,'attachment','image/jpeg',0),(4828,2,'2020-04-14 10:34:58','2020-04-14 10:34:58','China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.xinhuanet.com/english/\">Xinhua</a></span> provided details regarding Tuesday.\r\n\r\nThe antibodies are being created by a Beijing-based unit of Nasdaq-recorded <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.sinovac.com/\">Sinovac Biotec</a></span>h, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.sinopharm.com/1156.html\">China National Pharmaceutical Group.</a></span>\r\n\r\nIn March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China\'s Academy of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Academy_of_Military_Medical_Sciences\">Military Medical Sciences</a></span> and HK-recorded biotech firm <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Bio</a></span>, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nih.gov/\">U.S. National Institutes of Health.</a></span>','China endorses two trial coronavirus antibodies to enter clinical preliminaries','','inherit','closed','closed','','4826-revision-v1','','','2020-04-14 10:34:58','2020-04-14 10:34:58','',4826,'https://microbiozindia.com/uncategorized/4826-revision-v1/',0,'revision','',0),(4829,2,'2020-04-14 12:39:56','2020-04-14 12:39:56','Prime minister Narendra Modi in his speech to the country on Tuesday morning asked to download the \'Aarogya Setu App\'.\r\n\r\nThus, we should comprehend what this application is about. This application is intended to help control the spread of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/health-topics/coronavirus\">coronavirus</a></span> and make its data open to the ordinary citizens. This unique application additionally helps in discovering crown constructive individuals present close by.\r\n\r\nSubsequent to downloading, this application inquires as to whether you have hack, fever or inconvenience breathing and so on. On the off chance that you don\'t have any such issue, you will be in the Green Zone.\r\n\r\nThis application advises client to keep the cell phone\'s Bluetooth and area gadgets on. At whatever point the client visits a packed spot, this application continues sending messages from close by cell phones through the Bluetooth. At the point when the client remains close to somebody who is additionally an ordinary it shows green zone. However, on the off chance that that individual gets crown positive following 10 days, this application will alarm you right away.\r\n\r\nIn such a circumstance, the user can get oneself checked too. This application likewise tells about hotspots, with the goal that the client can change the course.\r\n\r\nThis application has propelled by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://mhrd.gov.in/\">Ministry of Human Resource Development</a></span> is related with Digital India for the wellbeing and prosperity of each Indian.\r\n\r\nA senior service official stated, \"This best in class application will make figurings based on associations with others, Bluetooth innovation, calculation and computerized reasoning.\"\r\n\r\nSince its dispatch, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mygov.in/aarogya-setu-app/\">Aarogya Setu</a></span> application has been downloaded by more than one crore individuals on both Android and iPhone cell phones.\r\n\r\nAccessible in 11 dialects, the application is intended for use on an all-India premise. Its plan is to such an extent that it can likewise take immense remaining burden.\r\n\r\n<strong>How to download Aarogya Setu?</strong>\r\n\r\nThe application can be downloaded on Apple\'s App Store or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://play.google.com/store/apps/details?id=nic.goi.aarogyasetu&amp;hl=en_IN\">Google\'s Play Store</a></span> for iPhone and Android cell phone clients, separately. Aarogya Setu can be found with a basic hunt on every stage\'s application store.','You should know what is Aarogya Setu application, how it helps battle coronavirus','','publish','open','open','','you-should-know-what-is-aarogya-setu-application-how-it-helps-battle-coronavirus','','','2020-04-14 12:39:56','2020-04-14 12:39:56','',0,'https://microbiozindia.com/?p=4829',0,'post','',0),(4830,2,'2020-04-14 12:39:47','2020-04-14 12:39:47','','aarogya-setu-app','','inherit','open','closed','','aarogya-setu-app','','','2020-04-14 12:39:47','2020-04-14 12:39:47','',4829,'https://microbiozindia.com/wp-content/uploads/2020/04/aarogya-setu-app.jpg',0,'attachment','image/jpeg',0),(4831,2,'2020-04-14 12:39:56','2020-04-14 12:39:56','Prime minister Narendra Modi in his speech to the country on Tuesday morning asked to download the \'Aarogya Setu App\'.\r\n\r\nThus, we should comprehend what this application is about. This application is intended to help control the spread of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/health-topics/coronavirus\">coronavirus</a></span> and make its data open to the ordinary citizens. This unique application additionally helps in discovering crown constructive individuals present close by.\r\n\r\nSubsequent to downloading, this application inquires as to whether you have hack, fever or inconvenience breathing and so on. On the off chance that you don\'t have any such issue, you will be in the Green Zone.\r\n\r\nThis application advises client to keep the cell phone\'s Bluetooth and area gadgets on. At whatever point the client visits a packed spot, this application continues sending messages from close by cell phones through the Bluetooth. At the point when the client remains close to somebody who is additionally an ordinary it shows green zone. However, on the off chance that that individual gets crown positive following 10 days, this application will alarm you right away.\r\n\r\nIn such a circumstance, the user can get oneself checked too. This application likewise tells about hotspots, with the goal that the client can change the course.\r\n\r\nThis application has propelled by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://mhrd.gov.in/\">Ministry of Human Resource Development</a></span> is related with Digital India for the wellbeing and prosperity of each Indian.\r\n\r\nA senior service official stated, \"This best in class application will make figurings based on associations with others, Bluetooth innovation, calculation and computerized reasoning.\"\r\n\r\nSince its dispatch, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mygov.in/aarogya-setu-app/\">Aarogya Setu</a></span> application has been downloaded by more than one crore individuals on both Android and iPhone cell phones.\r\n\r\nAccessible in 11 dialects, the application is intended for use on an all-India premise. Its plan is to such an extent that it can likewise take immense remaining burden.\r\n\r\n<strong>How to download Aarogya Setu?</strong>\r\n\r\nThe application can be downloaded on Apple\'s App Store or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://play.google.com/store/apps/details?id=nic.goi.aarogyasetu&amp;hl=en_IN\">Google\'s Play Store</a></span> for iPhone and Android cell phone clients, separately. Aarogya Setu can be found with a basic hunt on every stage\'s application store.','You should know what is Aarogya Setu application, how it helps battle coronavirus','','inherit','closed','closed','','4829-revision-v1','','','2020-04-14 12:39:56','2020-04-14 12:39:56','',4829,'https://microbiozindia.com/uncategorized/4829-revision-v1/',0,'revision','',0),(4833,2,'2020-04-14 16:10:35','2020-04-14 16:10:35','In an uncommon coordinated effort, French biopharmaceutical company<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.sanofi.com/\"> Sanofi</a> a</span>nd its British opponent <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gsk.com/en-gb/home/\">GlaxoSmithKline plc (GSK)</a></span> have banded together to build up an immunization against covid-19, which if fruitful, will be popularized in the second 50% of one year from now, the French firm said in a discharge.\r\n\r\n\"This cooperation unites two of the world\'s biggest immunizations organizations. By consolidating our logical skill, advancements and abilities, we accept that we can help quicken the worldwide exertion to build up an antibody to shield whatever number individuals as would be prudent from Covid-19,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gsk.com/en-gb/media/press-releases/emma-walmsley-to-succeed-andrew-witty-as-chief-executive-officer-of-glaxosmithkline/\">GSK CEO Emma Walmsley said according to the discharge.</a></span>\r\n\r\nUnder the organization, Sanofi will contribute its S-protein COVID-19 antigen, which has created an accurate hereditary match to proteins found on the outside of the infection, and the DNA succession encoding this antigen is the premise of Sanofi\'s authorized recombinant flu item in the US.\r\n\r\nGSK, then again, will give its demonstrated pandemic adjuvant innovation, which is an immunological specialist that is added to an immunization to help its invulnerable reaction to create more antibodies and longer-enduring resistance.\r\n\r\nThe two firms have set up a joint team, co-led by Sanofi\'s worldwide head of immunizations David Loew and GSK\'s leader of antibodies business Roger Connor. The taskforce will assemble assets to quicken the advancement.\r\n\r\n\"As the world faces this phenomenal worldwide wellbeing emergency, plainly nobody organization can go only it. That is the reason Sanofi is proceeding to supplement its mastery and assets with our companions, for example, GSK, with the objective to make and supply adequate amounts of immunizations that will help stop this infection,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://fortune.com/2019/12/09/on-leading-sanofi-paul-hudson-outlook/\">Sanofi CEO Paul Hudson said.</a></span>\r\n\r\nThe two organizations intend to begin the primary period of clinical preliminaries in the second 50% of this current year and expect to finish improvement and make the antibody accessible continuously 50% of 2021, Sanofi said in its discharge.\r\n\r\nAs of now, there are 70 immunizations being developed all around, with antibodies of three firms- - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Biological Inc</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.inovio.com/\">Inovio Pharmaceuticals</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.modernatx.com/\">Moderna</a></span>—previously experiencing human preliminaries. Of these three, preliminaries of China-based CanSino\'s antibody is the farthest, in stage 2.','GSK and Sanofi accomplice to create antibody against covid-19','','publish','open','open','','gsk-and-sanofi-accomplice-to-create-antibody-against-covid-19','','','2020-04-14 16:10:35','2020-04-14 16:10:35','',0,'https://microbiozindia.com/?p=4833',0,'post','',0),(4834,2,'2020-04-14 16:06:16','2020-04-14 16:06:16','','1501578989451173(1)','A logo sign outside a facility occupied by GlaxoSmithKline, in Rockville, Maryland on April 4, 2015. Photo credit: Kristoffer Tripplaar/ Sipa USA *** Please Use Credit from Credit Field ***','inherit','open','closed','','15015789894511731','','','2020-04-14 16:06:16','2020-04-14 16:06:16','',4833,'https://microbiozindia.com/wp-content/uploads/2020/04/15015789894511731.jpg',0,'attachment','image/jpeg',0),(4835,2,'2020-04-14 16:10:35','2020-04-14 16:10:35','In an uncommon coordinated effort, French biopharmaceutical company<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.sanofi.com/\"> Sanofi</a> a</span>nd its British opponent <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gsk.com/en-gb/home/\">GlaxoSmithKline plc (GSK)</a></span> have banded together to build up an immunization against covid-19, which if fruitful, will be popularized in the second 50% of one year from now, the French firm said in a discharge.\r\n\r\n\"This cooperation unites two of the world\'s biggest immunizations organizations. By consolidating our logical skill, advancements and abilities, we accept that we can help quicken the worldwide exertion to build up an antibody to shield whatever number individuals as would be prudent from Covid-19,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gsk.com/en-gb/media/press-releases/emma-walmsley-to-succeed-andrew-witty-as-chief-executive-officer-of-glaxosmithkline/\">GSK CEO Emma Walmsley said according to the discharge.</a></span>\r\n\r\nUnder the organization, Sanofi will contribute its S-protein COVID-19 antigen, which has created an accurate hereditary match to proteins found on the outside of the infection, and the DNA succession encoding this antigen is the premise of Sanofi\'s authorized recombinant flu item in the US.\r\n\r\nGSK, then again, will give its demonstrated pandemic adjuvant innovation, which is an immunological specialist that is added to an immunization to help its invulnerable reaction to create more antibodies and longer-enduring resistance.\r\n\r\nThe two firms have set up a joint team, co-led by Sanofi\'s worldwide head of immunizations David Loew and GSK\'s leader of antibodies business Roger Connor. The taskforce will assemble assets to quicken the advancement.\r\n\r\n\"As the world faces this phenomenal worldwide wellbeing emergency, plainly nobody organization can go only it. That is the reason Sanofi is proceeding to supplement its mastery and assets with our companions, for example, GSK, with the objective to make and supply adequate amounts of immunizations that will help stop this infection,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://fortune.com/2019/12/09/on-leading-sanofi-paul-hudson-outlook/\">Sanofi CEO Paul Hudson said.</a></span>\r\n\r\nThe two organizations intend to begin the primary period of clinical preliminaries in the second 50% of this current year and expect to finish improvement and make the antibody accessible continuously 50% of 2021, Sanofi said in its discharge.\r\n\r\nAs of now, there are 70 immunizations being developed all around, with antibodies of three firms- - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.cansinotech.com/\">CanSino Biological Inc</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.inovio.com/\">Inovio Pharmaceuticals</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.modernatx.com/\">Moderna</a></span>—previously experiencing human preliminaries. Of these three, preliminaries of China-based CanSino\'s antibody is the farthest, in stage 2.','GSK and Sanofi accomplice to create antibody against covid-19','','inherit','closed','closed','','4833-revision-v1','','','2020-04-14 16:10:35','2020-04-14 16:10:35','',4833,'https://microbiozindia.com/uncategorized/4833-revision-v1/',0,'revision','',0),(4836,2,'2020-04-15 08:17:07','2020-04-15 08:17:07','Vault Health, a startup spend significant time in human services for men, has gone concentration to help satisfy interest for hard to get COVID-19 tests in 48 states by working with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rucdr.org/\">RUCDR Infinite Biologics</a></span> to give a first-of-its-sort FDA EUA-endorsed spit test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19.</a></span>\r\n\r\n\"This is not our core business, but we built our healthcare platform to do good and we can\'t think of anything more important than helping people get the answer they need now. We know availability of COVID-19 testing has been inconsistent across the US.\r\n\r\n<span style=\"text-decoration: underline;\">This is frustrating for those that have symptoms and anyone who is looking for an answer and peace of mind about their health in these uncertain times. We are encouraged that the FDA issued an Emergency Use Authorization to RUCDR Infinite Biologics for this saliva test so we can immediately help people,\" said Jason Feldman, CEO, Vault Health.</span>\r\n\r\nThe physician-ordered, provider-supervised and physician-reported saliva collection test for COVID-19, which has the same effectiveness as the swab test, is performed under the supervision of a Vault healthcare provider through a video telehealth visit eliminating the risk of person-to-person exposure to the virus.\r\n\r\nThis test is precise in detecting the SARS-CoV-2 virus, which causes COVID-19, and the expression of three genes that are only found in the virus using a technique called qPCR. Vault Health will also be following state and federal reporting guidelines to provide requisite patient infection data to help the work of health authorities as they continue to respond to this unprecedented pandemic.\r\n\r\n\"We implemented and are supporting this test for three reasons. Beyond the rapid and accurate testing of COVID-19, this test has other crucial benefits: it expands the availability of testing across the US, decreases the risk of medical professionals who are currently directly exposed to the virus when performing a nasal swab collection, and preserves precious personal protective equipment (PPE) which is in limited supply. We are excited that Vault Health is moving so fast to deliver this solution,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rucdr.org/directors\">Dr. Andrew Brooks, COO and Director of Technology Development, RUCDR Infinite Biologics.</a></span>\r\n\r\n<strong><span style=\"text-decoration: underline;\">Vault Health streamlined the process for prescribing, supervising and reporting results for the test:</span></strong>\r\n1.Complete an online form with personal information and questions about COVID-19 symptoms, (must be at least 18 years old)\r\n2.Receive test kit via UPS overnight shipping\r\n3.Open box and follow instructions for a Zoom video conference with Vault medical practitioner\r\n4.When instructed by the medical practitioner on the Zoom conference, show the empty collection tube, then when instructed, fill with saliva, cap tube releasing the preservation agent\r\n5.Ship back to lab in the pre-addressed UPS overnight pouch provided\r\n6.Upon receipt at RUCDR\'s New Jersey facility, the sample will be processed and lab results will be available within 48-72 hours\r\n\r\nBeginning today, Vault will make available thousands of tests a week and will continue to scale up test availability as lab capacity of RUCDR Infinite Biologics quickly expands.\r\nUS residents that are 18 years or older can visit www.vaulthealth.com and order a lab test for $150, which covers cost for telemedicine, operations, overnight shipping, test kit and lab processing, with no profit to Vault Health.\r\n\r\n<strong>About Vault</strong>\r\nVault is a performance healthcare service designed to help men take control of their health through specialized in-home treatments for a better body, better sex and better brain. Through extensive education, professional medical evaluation, and personalized treatment, Vault overcomes shortcomings in existing men\'s healthcare offerings to help more men achieve optimal overall health. To learn more about Vault and schedule an assessment, visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vaulthealth.com/\">www.vaulthealth.com</a></span>.','Vault Health Launches Saliva-based FDA EUA Approved Test for COVID-19','','publish','open','open','','vault-health-launches-saliva-based-fda-eua-approved-test-for-covid-19','','','2020-04-15 08:17:07','2020-04-15 08:17:07','',0,'https://microbiozindia.com/?p=4836',0,'post','',0),(4837,2,'2020-04-15 08:10:44','2020-04-15 08:10:44','','face-mask-4986596_640','','inherit','open','closed','','face-mask-4986596_640','','','2020-04-15 08:10:44','2020-04-15 08:10:44','',4836,'https://microbiozindia.com/wp-content/uploads/2020/04/face-mask-4986596_640.jpg',0,'attachment','image/jpeg',0),(4838,2,'2020-04-15 08:17:07','2020-04-15 08:17:07','Vault Health, a startup spend significant time in human services for men, has gone concentration to help satisfy interest for hard to get COVID-19 tests in 48 states by working with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rucdr.org/\">RUCDR Infinite Biologics</a></span> to give a first-of-its-sort FDA EUA-endorsed spit test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19.</a></span>\r\n\r\n\"This is not our core business, but we built our healthcare platform to do good and we can\'t think of anything more important than helping people get the answer they need now. We know availability of COVID-19 testing has been inconsistent across the US.\r\n\r\n<span style=\"text-decoration: underline;\">This is frustrating for those that have symptoms and anyone who is looking for an answer and peace of mind about their health in these uncertain times. We are encouraged that the FDA issued an Emergency Use Authorization to RUCDR Infinite Biologics for this saliva test so we can immediately help people,\" said Jason Feldman, CEO, Vault Health.</span>\r\n\r\nThe physician-ordered, provider-supervised and physician-reported saliva collection test for COVID-19, which has the same effectiveness as the swab test, is performed under the supervision of a Vault healthcare provider through a video telehealth visit eliminating the risk of person-to-person exposure to the virus.\r\n\r\nThis test is precise in detecting the SARS-CoV-2 virus, which causes COVID-19, and the expression of three genes that are only found in the virus using a technique called qPCR. Vault Health will also be following state and federal reporting guidelines to provide requisite patient infection data to help the work of health authorities as they continue to respond to this unprecedented pandemic.\r\n\r\n\"We implemented and are supporting this test for three reasons. Beyond the rapid and accurate testing of COVID-19, this test has other crucial benefits: it expands the availability of testing across the US, decreases the risk of medical professionals who are currently directly exposed to the virus when performing a nasal swab collection, and preserves precious personal protective equipment (PPE) which is in limited supply. We are excited that Vault Health is moving so fast to deliver this solution,\" said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rucdr.org/directors\">Dr. Andrew Brooks, COO and Director of Technology Development, RUCDR Infinite Biologics.</a></span>\r\n\r\n<strong><span style=\"text-decoration: underline;\">Vault Health streamlined the process for prescribing, supervising and reporting results for the test:</span></strong>\r\n1.Complete an online form with personal information and questions about COVID-19 symptoms, (must be at least 18 years old)\r\n2.Receive test kit via UPS overnight shipping\r\n3.Open box and follow instructions for a Zoom video conference with Vault medical practitioner\r\n4.When instructed by the medical practitioner on the Zoom conference, show the empty collection tube, then when instructed, fill with saliva, cap tube releasing the preservation agent\r\n5.Ship back to lab in the pre-addressed UPS overnight pouch provided\r\n6.Upon receipt at RUCDR\'s New Jersey facility, the sample will be processed and lab results will be available within 48-72 hours\r\n\r\nBeginning today, Vault will make available thousands of tests a week and will continue to scale up test availability as lab capacity of RUCDR Infinite Biologics quickly expands.\r\nUS residents that are 18 years or older can visit www.vaulthealth.com and order a lab test for $150, which covers cost for telemedicine, operations, overnight shipping, test kit and lab processing, with no profit to Vault Health.\r\n\r\n<strong>About Vault</strong>\r\nVault is a performance healthcare service designed to help men take control of their health through specialized in-home treatments for a better body, better sex and better brain. Through extensive education, professional medical evaluation, and personalized treatment, Vault overcomes shortcomings in existing men\'s healthcare offerings to help more men achieve optimal overall health. To learn more about Vault and schedule an assessment, visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vaulthealth.com/\">www.vaulthealth.com</a></span>.','Vault Health Launches Saliva-based FDA EUA Approved Test for COVID-19','','inherit','closed','closed','','4836-revision-v1','','','2020-04-15 08:17:07','2020-04-15 08:17:07','',4836,'https://microbiozindia.com/uncategorized/4836-revision-v1/',0,'revision','',0),(4839,2,'2020-04-15 08:48:32','2020-04-15 08:48:32','A breathing aid that can help keep Covid-19 patients out of intensive care, has been developed in just 5 days by mechanical engineers at University College London and clinicians at University College London Hospital working in conjunction with Mercedes-AMG High Performance Powertrains.\r\n\r\nThe breathing aid, known as a Continuous Positive Airway Pressure (CPAP), has been used extensively in hospitals in China and Italy to help Covid-19 patients with serious lung infections to breathe more easily, when oxygen alone is insufficient. An important component in the device is a machined Vyon® F Silencer developed and delivered in just five days by UK life sciences manufacturer - Porvair Sciences Ltd.\r\n\r\nKevin Doolan, General Manager of Porvair Sciences said \"We are very proud to be part of this collaborative effort to deliver large numbers of CPAP devices. By focusing our manufacturing resource, we were able, within days, to deliver the Vyon high-density polyethylene component that functions as a silencer for the CPAP device. The tortuous path of our Vyon® porous plastic materials ensure the air flow has to escape to the atmosphere by expanding through the porous structure, thus reducing the noise level. As a result, both care staff and patients operating in the healthcare environment where CPAP devices are used will be subject to considerably less noise.\"\r\n\r\nTo discuss how a bespoke ultra-pure Vyon® component can help improve your healthcare products performance and competitiveness, please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.\r\n\r\nPorvair Sciences are global leaders and original manufacturers and developers of cutting-edge porous plastics technologies. With patents dating back to the 1950’s, our porous plastics continue to evolve, adapt and respond to changes in technologies, markets and customer needs. Empowered by 50 years of industrial experience, we strive to continue delivering world class, high performing products while providing superior customer service, every step of the way. Our diverse team of scientists, engineers and creative thinkers are committed to providing expert solutions that brings value and integrity to our customers.\r\n\r\nFor further information please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vyonporousplastics.com/medical-and-healthcare/\">https://www.vyonporousplastics.com/medical-and-healthcare/</a></span>','Collaborative Effort Delivers Life-Saving Breathing Aid','','publish','open','open','','collaborative-effort-delivers-life-saving-breathing-aid','','','2020-04-15 08:48:32','2020-04-15 08:48:32','',0,'https://microbiozindia.com/?p=4839',0,'post','',0),(4840,2,'2020-04-15 08:48:03','2020-04-15 08:48:03','','3zvKd','','inherit','open','closed','','3zvkd','','','2020-04-15 08:48:03','2020-04-15 08:48:03','',4839,'https://microbiozindia.com/wp-content/uploads/2020/04/3zvKd.png',0,'attachment','image/png',0),(4841,2,'2020-04-15 08:48:32','2020-04-15 08:48:32','A breathing aid that can help keep Covid-19 patients out of intensive care, has been developed in just 5 days by mechanical engineers at University College London and clinicians at University College London Hospital working in conjunction with Mercedes-AMG High Performance Powertrains.\r\n\r\nThe breathing aid, known as a Continuous Positive Airway Pressure (CPAP), has been used extensively in hospitals in China and Italy to help Covid-19 patients with serious lung infections to breathe more easily, when oxygen alone is insufficient. An important component in the device is a machined Vyon® F Silencer developed and delivered in just five days by UK life sciences manufacturer - Porvair Sciences Ltd.\r\n\r\nKevin Doolan, General Manager of Porvair Sciences said \"We are very proud to be part of this collaborative effort to deliver large numbers of CPAP devices. By focusing our manufacturing resource, we were able, within days, to deliver the Vyon high-density polyethylene component that functions as a silencer for the CPAP device. The tortuous path of our Vyon® porous plastic materials ensure the air flow has to escape to the atmosphere by expanding through the porous structure, thus reducing the noise level. As a result, both care staff and patients operating in the healthcare environment where CPAP devices are used will be subject to considerably less noise.\"\r\n\r\nTo discuss how a bespoke ultra-pure Vyon® component can help improve your healthcare products performance and competitiveness, please contact Porvair Sciences Ltd on +44-1978-661144 or enquiries@porvairsciences.com.\r\n\r\nPorvair Sciences are global leaders and original manufacturers and developers of cutting-edge porous plastics technologies. With patents dating back to the 1950’s, our porous plastics continue to evolve, adapt and respond to changes in technologies, markets and customer needs. Empowered by 50 years of industrial experience, we strive to continue delivering world class, high performing products while providing superior customer service, every step of the way. Our diverse team of scientists, engineers and creative thinkers are committed to providing expert solutions that brings value and integrity to our customers.\r\n\r\nFor further information please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.vyonporousplastics.com/medical-and-healthcare/\">https://www.vyonporousplastics.com/medical-and-healthcare/</a></span>','Collaborative Effort Delivers Life-Saving Breathing Aid','','inherit','closed','closed','','4839-revision-v1','','','2020-04-15 08:48:32','2020-04-15 08:48:32','',4839,'https://microbiozindia.com/uncategorized/4839-revision-v1/',0,'revision','',0),(4842,2,'2020-04-15 10:29:06','2020-04-15 10:29:06','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n[caption id=\"attachment_4847\" align=\"alignright\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','publish','open','open','','can-stem-cells-aid-covid-19-cure','','','2020-04-15 10:43:47','2020-04-15 10:43:47','',0,'https://microbiozindia.com/?p=4842',0,'post','',0),(4843,2,'2020-04-15 10:24:38','2020-04-15 10:24:38','','stem-5004507_640','','inherit','open','closed','','stem-5004507_640','','','2020-04-15 10:24:38','2020-04-15 10:24:38','',4842,'https://microbiozindia.com/wp-content/uploads/2020/04/stem-5004507_640.jpg',0,'attachment','image/jpeg',0),(4844,2,'2020-04-15 10:29:06','2020-04-15 10:29:06','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:29:06','2020-04-15 10:29:06','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4845,2,'2020-04-15 10:32:03','2020-04-15 10:32:03','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:32:03','2020-04-15 10:32:03','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4846,2,'2020-04-15 10:32:24','2020-04-15 10:32:24','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:32:24','2020-04-15 10:32:24','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4847,2,'2020-04-15 10:39:09','2020-04-15 10:39:09','','MRVIPUL.','','inherit','open','closed','','mrvipul','','','2020-04-15 10:39:09','2020-04-15 10:39:09','',4842,'https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL..png',0,'attachment','image/png',0),(4848,2,'2020-04-15 10:42:47','2020-04-15 10:42:47','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\n\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\n\n[caption id=\"attachment_4847\" align=\"alignleft\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" data-wp-editing=\"1\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\n\n<strong>How coronavirus affects the body?</strong>\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\n\n<strong>Is it similar to flu?</strong>\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\n\n<strong>How can stem cells help?</strong>\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\n\n<strong>The role of stem cells can be pointed out as:</strong>\n1.Reduce inflammatory effects.\n2.Enhance immune regulatory functions.\n3.Regeneration and healing of damaged tissues.\n4.Differentiate into different cell-types.\n\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\n\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-autosave-v1','','','2020-04-15 10:42:47','2020-04-15 10:42:47','',4842,'https://microbiozindia.com/uncategorized/4842-autosave-v1/',0,'revision','',0),(4849,2,'2020-04-15 10:40:21','2020-04-15 10:40:21','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n[caption id=\"attachment_4847\" align=\"alignright\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:40:21','2020-04-15 10:40:21','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4850,2,'2020-04-15 10:41:40','2020-04-15 10:41:40','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n[caption id=\"attachment_4847\" align=\"alignleft\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:41:40','2020-04-15 10:41:40','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4851,2,'2020-04-15 10:43:28','2020-04-15 10:43:28','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n[caption id=\"attachment_4847\" align=\"alignnone\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:43:28','2020-04-15 10:43:28','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4852,2,'2020-04-15 10:43:47','2020-04-15 10:43:47','What is the most trending mortality-friendly virus? The unanimous answer to this question is COVID-19. With over 42000 global deaths, its high time to contain and eradicate this epidemic. Coronavirus or <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span> spreads by fluid droplets from the mouth and nose and can be picked up by a second person upon coming in contact with the infected liquid droplets.\r\n\r\nThis contact can be upon shaking hands or touching a surface where the liquid droplets are present as a result of sneezing or coughing. Recently, reports from Kunming district, China, have highlighted the successful effects of stem cells in the recovery of coronavirus infected patients and therefore it is important to understand how stem cells can be a strong force against coronavirus infection. Are these just medical miracles or is there a logical standpoint?\r\n\r\n[caption id=\"attachment_4847\" align=\"alignright\" width=\"162\"]<img class=\"wp-image-4847\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/MRVIPUL.-262x300.png\" alt=\"\" width=\"162\" height=\"185\" /> <em><span style=\"font-size: 8pt;\">Mr. Vipul Jain(CEO,Advancells)</span></em>[/caption]\r\n\r\n<strong>How coronavirus affects the body?</strong>\r\nWhen coronavirus enters body, it targets lungs and respiratory cells. The next step starts with damaging these respiratory cells which make up the first line of immune protection for our body. As a result, the filter system switches off and debris starts filling up in the lungs, leading to a shortage of breath and cough. Once these mild symptoms kick in, the body gears up to protect itself by activating the immune system by developing a fever, coughing, and a running nose. Thus, to understand it briefly, coronavirus infection affects the immune system with time and may also harm body cells in the process in case of overriding the safety limit. With the immune system being affected, other infections and diseases can easily catch up and lead to the deterioration of one’s health condition.\r\n\r\n<strong>Is it similar to flu?</strong>\r\nCoronavirus is not structurally similar to the flu virus. In fact, coronavirus COVID-19 is even different from other coronavirus strains like <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/ith/diseases/sars/en/\">SARS-CoV</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)\">MERS-CoV</a></span>. But if we have to look at the similarities, symptoms are the most important domain. Symptoms like cough, fever, breath shortage, lung inflammation, etc. are the symptoms of flu as well as coronavirus disease. Therefore, although designing of COVID-19 targeted drugs will take different biomolecules into consideration, the mechanism and effects of body healing will be similar, i.e. reversing the immune-compromised health condition.\r\n\r\n<strong>How can stem cells help?</strong>\r\nClinical trials have already emerged on the potential use of stem cells in the treatment of COVD-19 infected patients. Moreover, successful cases have also been reported in some districts of China for the recovery of coronavirus patients upon administration of stem cells. The scientific community has dived deep into utilizing stem cells for treatment of COVD-19. But why? How can stem cells help?\r\nStem cells can differentiate into a variety of cell lineages and are thus regarded as a fundamental alternative to conventional treatment, in the form of regenerative therapies.\r\n\r\n<strong>The role of stem cells can be pointed out as:</strong>\r\n1.Reduce inflammatory effects.\r\n2.Enhance immune regulatory functions.\r\n3.Regeneration and healing of damaged tissues.\r\n4.Differentiate into different cell-types.\r\n\r\nPrior research studies have shown anti-inflammatory effects of stem cells and their ability to reduce virus-induced lung injury. These effects can be very well hypothesized in cases of COVID-19. Stem cells can reduce the lung and respiratory tract damage caused by COVD-19 infections by fast rejuvenation and tissue repair effects, and can also strengthen the immune system as a protective shield against any secondary infection during the period of COVID-19 incubation inside one’s body.\r\n\r\nMoreover, along with the fast-paced vaccine development research against COVID-19, stem cells are a force to reckon with. Owing to the immune-regulatory and immune-modulatory role of stem cells, people can be administered stem cells before being given COVID-19 vaccines, so that the body can fight back other infections and be less susceptible to the infection symptoms. This strategy will help the body cope up and be prepared to fight any recurrence of COVD-19.','Can stem cells aid COVID-19 cure?','','inherit','closed','closed','','4842-revision-v1','','','2020-04-15 10:43:47','2020-04-15 10:43:47','',4842,'https://microbiozindia.com/uncategorized/4842-revision-v1/',0,'revision','',0),(4853,2,'2020-04-15 12:00:34','2020-04-15 12:00:34','HALIX B.V. has joined a consortium of accomplices under the direction of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ox.ac.uk/\">University of Oxford</a></span>, to give GMP fabricating administrations supporting the huge scope creation of a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/COVID-19_vaccine\">COVID-19 immunization (ChAdOx1 nCoV-19)</a></span>, being created by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ndm.ox.ac.uk/the-jenner-institute\">University\'s Jenner Institute</a></span>. This GMP producing scale-up is occurring nearby early stage clinical preliminaries. The preliminaries are significant in testing whether the immunization is demonstrated to be successful.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.prosci-inc.com/covid-19/\">nCoV-19 antibody</a></span> depends on the Jenner Institute\'s adenovirus immunization vector (ChAdOx1) innovation, which was picked as the most reasonable contender for a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2 (COVID-19)</a> </span>immunization as it can produce a solid single portion invulnerable reaction, and isn\'t an imitating infection, so it can\'t cause contamination in the inoculated person.\r\n\r\nUnder the coordinated effort, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a></span> will use its fresh out of the box new cutting edge GMP offices with limit up to 1,000 L SUB scale, applying its viral vector bioprocessing ability, to move a modern scale sedate substance process from Pall in the UK, supporting the production of ChAdOx1 nCoV-19 clinical preliminary material. In light of this exchange, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a> </span>what\'s more, the consortium will be in a situation to make at a bigger scope. This is a key advance in diminishing the time it would typically take to make the immunization accessible for sending and could assist with ending the further spread of this pandemic.\r\n\r\nThe enormous scope producing venture is a community oriented exertion, drove by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jenner.ac.uk/dr-sandy-douglas\">Dr Sandy Douglas at the Jenner Institute.</a> </span>The ChAdOx1 coronavirus immunization coalition encases viral vector producing and administrative consistence specialists from the University of Oxford\'s Jenner Institute and Clinical Biomanufacturing Facility, the Vaccine Manufacturing and Innovation Center (VMIC), Pall Biotech and Cobra Biologics.\r\n\r\nAlex Huybens, Chief Operations Officer of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX,</a></span> states: \"We are focused on filling in as one group over the business bringing our aggregate ability, track record and assembling capacities, to help the Jenner Institute\'s fast clinical advancement of this nCoV-19 immunization possibility to battle this developing emergency as fast as could reasonably be expected.\"\r\n\r\n<a href=\"https://www.halix.nl/\">HALIX</a> has a built up specialized and quality reputation for the turn of events and GMP assembling of viral vectors utilized against irresistible ailments, for example, HIV, ZIKA, chikungunya and this season\'s flu virus. Our pristine 6,700 m2 BSL2 GMP office, situated in Leiden (the Netherlands), gives both clinical and business scale fabricating capacities in completely autonomous, independent Grade B and C cleanrooms for infection items.\r\n\r\nThe clinical preliminary program, drove by Professor Sarah Gilbert at the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group, will enlist up to 510 volunteers, who will get either the ChAdOx1 nCoV-19 immunization or a control infusion for correlation. Since March 23, 2020, The University of Oxford is enlisting people in the UK to partake in trialing the immunization. For additional data on the immunization, visit: <span style=\"color: #ff6600;\">https://covid19vaccinetrial.web.ox.ac.uk/.</span>','HALIX Enters partners with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine','','publish','open','open','','halix-enters-partners-with-the-university-of-oxford-for-gmp-manufacturing-of-a-covid-19-vaccine','','','2020-04-15 12:01:43','2020-04-15 12:01:43','',0,'https://microbiozindia.com/?p=4853',0,'post','',0),(4854,2,'2020-04-15 11:55:18','2020-04-15 11:55:18','','AAH','','inherit','open','closed','','aah','','','2020-04-15 11:55:18','2020-04-15 11:55:18','',4853,'https://microbiozindia.com/wp-content/uploads/2020/04/AAH.jpg',0,'attachment','image/jpeg',0),(4855,2,'2020-04-15 12:00:34','2020-04-15 12:00:34','HALIX B.V. has joined a consortium of accomplices under the direction of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ox.ac.uk/\">University of Oxford</a></span>, to give GMP fabricating administrations supporting the huge scope creation of a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/COVID-19_vaccine\">COVID-19 immunization (ChAdOx1 nCoV-19)</a></span>, being created by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ndm.ox.ac.uk/the-jenner-institute\">University\'s Jenner Institute</a></span>. This GMP producing scale-up is occurring nearby early stage clinical preliminaries. The preliminaries are significant in testing whether the immunization is demonstrated to be successful.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.prosci-inc.com/covid-19/\">nCoV-19 antibody</a></span> depends on the Jenner Institute\'s adenovirus immunization vector (ChAdOx1) innovation, which was picked as the most reasonable contender for a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2 (COVID-19)</a> </span>immunization as it can produce a solid single portion invulnerable reaction, and isn\'t an imitating infection, so it can\'t cause contamination in the inoculated person.\r\n\r\nUnder the coordinated effort, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a></span> will use its fresh out of the box new cutting edge GMP offices with limit up to 1,000 L SUB scale, applying its viral vector bioprocessing ability, to move a modern scale sedate substance process from Pall in the UK, supporting the production of ChAdOx1 nCoV-19 clinical preliminary material. In light of this exchange, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a> </span>what\'s more, the consortium will be in a situation to make at a bigger scope. This is a key advance in diminishing the time it would typically take to make the immunization accessible for sending and could assist with ending the further spread of this pandemic.\r\n\r\nThe enormous scope producing venture is a community oriented exertion, drove by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jenner.ac.uk/dr-sandy-douglas\">Dr Sandy Douglas at the Jenner Institute.</a> </span>The ChAdOx1 coronavirus immunization coalition encases viral vector producing and administrative consistence specialists from the University of Oxford\'s Jenner Institute and Clinical Biomanufacturing Facility, the Vaccine Manufacturing and Innovation Center (VMIC), Pall Biotech and Cobra Biologics.\r\n\r\nAlex Huybens, Chief Operations Officer of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX,</a></span> states: \"We are focused on filling in as one group over the business bringing our aggregate ability, track record and assembling capacities, to help the Jenner Institute\'s fast clinical advancement of this nCoV-19 immunization possibility to battle this developing emergency as fast as could reasonably be expected.\"\r\n\r\n<a href=\"https://www.halix.nl/\">HALIX</a> has a built up specialized and quality reputation for the turn of events and GMP assembling of viral vectors utilized against irresistible ailments, for example, HIV, ZIKA, chikungunya and this season\'s flu virus. Our pristine 6,700 m2 BSL2 GMP office, situated in Leiden (the Netherlands), gives both clinical and business scale fabricating capacities in completely autonomous, independent Grade B and C cleanrooms for infection items.\r\n\r\nThe clinical preliminary program, drove by Professor Sarah Gilbert at the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group, will enlist up to 510 volunteers, who will get either the ChAdOx1 nCoV-19 immunization or a control infusion for correlation. Since March 23, 2020, The University of Oxford is enlisting people in the UK to partake in trialing the immunization. For additional data on the immunization, visit: https://covid19vaccinetrial.web.ox.ac.uk/.','HALIX Enters partners with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine','','inherit','closed','closed','','4853-revision-v1','','','2020-04-15 12:00:34','2020-04-15 12:00:34','',4853,'https://microbiozindia.com/uncategorized/4853-revision-v1/',0,'revision','',0),(4856,2,'2020-04-15 12:01:43','2020-04-15 12:01:43','HALIX B.V. has joined a consortium of accomplices under the direction of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ox.ac.uk/\">University of Oxford</a></span>, to give GMP fabricating administrations supporting the huge scope creation of a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/COVID-19_vaccine\">COVID-19 immunization (ChAdOx1 nCoV-19)</a></span>, being created by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ndm.ox.ac.uk/the-jenner-institute\">University\'s Jenner Institute</a></span>. This GMP producing scale-up is occurring nearby early stage clinical preliminaries. The preliminaries are significant in testing whether the immunization is demonstrated to be successful.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.prosci-inc.com/covid-19/\">nCoV-19 antibody</a></span> depends on the Jenner Institute\'s adenovirus immunization vector (ChAdOx1) innovation, which was picked as the most reasonable contender for a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2 (COVID-19)</a> </span>immunization as it can produce a solid single portion invulnerable reaction, and isn\'t an imitating infection, so it can\'t cause contamination in the inoculated person.\r\n\r\nUnder the coordinated effort, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a></span> will use its fresh out of the box new cutting edge GMP offices with limit up to 1,000 L SUB scale, applying its viral vector bioprocessing ability, to move a modern scale sedate substance process from Pall in the UK, supporting the production of ChAdOx1 nCoV-19 clinical preliminary material. In light of this exchange, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX B.V.</a> </span>what\'s more, the consortium will be in a situation to make at a bigger scope. This is a key advance in diminishing the time it would typically take to make the immunization accessible for sending and could assist with ending the further spread of this pandemic.\r\n\r\nThe enormous scope producing venture is a community oriented exertion, drove by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jenner.ac.uk/dr-sandy-douglas\">Dr Sandy Douglas at the Jenner Institute.</a> </span>The ChAdOx1 coronavirus immunization coalition encases viral vector producing and administrative consistence specialists from the University of Oxford\'s Jenner Institute and Clinical Biomanufacturing Facility, the Vaccine Manufacturing and Innovation Center (VMIC), Pall Biotech and Cobra Biologics.\r\n\r\nAlex Huybens, Chief Operations Officer of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.halix.nl/\">HALIX,</a></span> states: \"We are focused on filling in as one group over the business bringing our aggregate ability, track record and assembling capacities, to help the Jenner Institute\'s fast clinical advancement of this nCoV-19 immunization possibility to battle this developing emergency as fast as could reasonably be expected.\"\r\n\r\n<a href=\"https://www.halix.nl/\">HALIX</a> has a built up specialized and quality reputation for the turn of events and GMP assembling of viral vectors utilized against irresistible ailments, for example, HIV, ZIKA, chikungunya and this season\'s flu virus. Our pristine 6,700 m2 BSL2 GMP office, situated in Leiden (the Netherlands), gives both clinical and business scale fabricating capacities in completely autonomous, independent Grade B and C cleanrooms for infection items.\r\n\r\nThe clinical preliminary program, drove by Professor Sarah Gilbert at the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group, will enlist up to 510 volunteers, who will get either the ChAdOx1 nCoV-19 immunization or a control infusion for correlation. Since March 23, 2020, The University of Oxford is enlisting people in the UK to partake in trialing the immunization. For additional data on the immunization, visit: <span style=\"color: #ff6600;\">https://covid19vaccinetrial.web.ox.ac.uk/.</span>','HALIX Enters partners with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine','','inherit','closed','closed','','4853-revision-v1','','','2020-04-15 12:01:43','2020-04-15 12:01:43','',4853,'https://microbiozindia.com/uncategorized/4853-revision-v1/',0,'revision','',0),(4857,2,'2020-04-15 12:22:31','2020-04-15 12:22:31','The identification of conceivably pathogenic coronavirus in Indian bats anxieties the requirement for upgrading screening for novel infections in them, as per an examination by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/workforcealliance/members_partners/member_list/icmr/en/\">Indian Council of Medical Research (ICMR).</a></span>\r\nThis study was a step towards understanding the coronavirus circulation in Indian bats. \"One Health approach with collaborative activities by the animal health and human health sectors in these surveillance activities shall be of use to public health,\" the study published in the <a href=\"http://www.ijmr.org.in/\">Indian Journal of Medical Research said.</a>\r\n\"This would help in the development of diagnostic assays for novel viruses with outbreak potential and be useful in disease interventions. Proactive surveillance remains crucial for identifying the emerging novel viruses with epidemic potential and measures for risk mitigation,\" said the study authored by Pragya D Yadav as the first author.\r\n\r\nA study by the Indian Council of Medical Research (ICMR) has found the presence of a bat coronavirus in bat species from Kerala, Himachal Pradesh, Puducherry and Tamil Nadu.\r\nThere have been studies and theories that the coronavirus pandemic which spread from Wuhan in China had originated from bats.\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://weather.com/en-IN/india/news/news/2020-04-15-icmr-study-finds-two-kinds-coronaviruses-indian-bat-species\">The ICMR study for the first time has found the presence of a different kind of coronavirus, bat coronavirus (BtCoV) in two bat species from these four states.</a></span>\r\n\r\nAccording to the study published in the Indian Journal of Medical Research, there is no evidence to suggest that the bat coronaviruses can cause disease in humans.\r\n\r\nBats from the Rousettus and Pteropus species from the four states were found positive. These bat coronaviruses are not related to the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30235-8/fulltext\"> SARS-CoV2</a></span> which is causing the Covid 19 pandemic.\r\nThe Pteropus bat species were earlier found positive for Nipah virus in 2018 and 2019 in Kerala.\r\n\"Bats are considered to be the natural reservoir for many viruses, of which some are potential human pathogens. In India, an association of Pteropus medius bats with the Nipah virus was reported in the past. It is suspected that the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also has its association with bats,\" the objective of the study titled \'<span style=\"text-decoration: underline;\">Detection of coronaviruses in Pteropus and Rousettus species of bats from different states of India\' said.<img class=\"aligncenter wp-image-4859 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/NEWCORONA-300x300.jpg\" alt=\"\" width=\"342\" height=\"342\" /></span>\r\n\r\nIn conclusion, the study showed detection of pathogenic CoVs in two species of Indian bats. Continuous active surveillance is required to identify the emerging novel viruses with epidemic potential.\r\n\"There is a need of proactive surveillance of zoonotic infections in bats. Detection and identifications of such aetiological agents will provide leads for the development of diagnostic along with preparedness and readiness to deal with such emergent viruses thereby quickly containing them,\" the study said.\r\n\r\n<span style=\"text-decoration: underline;\">The recognition and distinguishing proof of such infections from bats likewise prescribes cross-sectional counter acting agent overviews (human and residential creatures) in areas where the infections have been identified. Essentially, if epidemiological circumstance requests, proof based reconnaissance ought to likewise be directed. There is a need of creating solid components for working mutually with different partners, for example, natural life, poultry, creature cultivation and human wellbeing divisions.</span>\r\n\r\nIn the current situation of changing demography and natural controls, it is trying to have keeps an eye on the experiences of bats with different creatures and people. Consequently, dynamic and consistent reconnaissance stays vital for flare-up alarms for bat-related viral operators with scourge potential, which would be useful in opportune intercessions, the investigation said.\r\n\r\nIn spite of the fact that CoVs in the subfamily Coronavirinae don\'t for the most part produce clinical manifestations in their regular hosts (bats), unplanned transmission of these infections to people and different creatures may bring about respiratory, enteric, hepatic or neurologic maladies of variable seriousness. It is as yet not comprehended with regards to why just certain CoVs can contaminate individuals, the examination said.','Coronavirus found in two Indian bat strains uncovers ICMR study','','publish','open','open','','coronavirus-found-in-two-indian-bat-strains-uncovers-icmr-study','','','2020-04-15 12:22:31','2020-04-15 12:22:31','',0,'https://microbiozindia.com/?p=4857',0,'post','',0),(4858,2,'2020-04-15 12:15:39','2020-04-15 12:15:39','','flying-foxes-2237209_640','','inherit','open','closed','','flying-foxes-2237209_640','','','2020-04-15 12:15:39','2020-04-15 12:15:39','',4857,'https://microbiozindia.com/wp-content/uploads/2020/04/flying-foxes-2237209_640.jpg',0,'attachment','image/jpeg',0),(4859,2,'2020-04-15 12:22:11','2020-04-15 12:22:11','','NEWCORONA','','inherit','open','closed','','newcorona','','','2020-04-15 12:22:11','2020-04-15 12:22:11','',4857,'https://microbiozindia.com/wp-content/uploads/2020/04/NEWCORONA.jpg',0,'attachment','image/jpeg',0),(4860,2,'2020-04-15 12:22:31','2020-04-15 12:22:31','The identification of conceivably pathogenic coronavirus in Indian bats anxieties the requirement for upgrading screening for novel infections in them, as per an examination by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/workforcealliance/members_partners/member_list/icmr/en/\">Indian Council of Medical Research (ICMR).</a></span>\r\nThis study was a step towards understanding the coronavirus circulation in Indian bats. \"One Health approach with collaborative activities by the animal health and human health sectors in these surveillance activities shall be of use to public health,\" the study published in the <a href=\"http://www.ijmr.org.in/\">Indian Journal of Medical Research said.</a>\r\n\"This would help in the development of diagnostic assays for novel viruses with outbreak potential and be useful in disease interventions. Proactive surveillance remains crucial for identifying the emerging novel viruses with epidemic potential and measures for risk mitigation,\" said the study authored by Pragya D Yadav as the first author.\r\n\r\nA study by the Indian Council of Medical Research (ICMR) has found the presence of a bat coronavirus in bat species from Kerala, Himachal Pradesh, Puducherry and Tamil Nadu.\r\nThere have been studies and theories that the coronavirus pandemic which spread from Wuhan in China had originated from bats.\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://weather.com/en-IN/india/news/news/2020-04-15-icmr-study-finds-two-kinds-coronaviruses-indian-bat-species\">The ICMR study for the first time has found the presence of a different kind of coronavirus, bat coronavirus (BtCoV) in two bat species from these four states.</a></span>\r\n\r\nAccording to the study published in the Indian Journal of Medical Research, there is no evidence to suggest that the bat coronaviruses can cause disease in humans.\r\n\r\nBats from the Rousettus and Pteropus species from the four states were found positive. These bat coronaviruses are not related to the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30235-8/fulltext\"> SARS-CoV2</a></span> which is causing the Covid 19 pandemic.\r\nThe Pteropus bat species were earlier found positive for Nipah virus in 2018 and 2019 in Kerala.\r\n\"Bats are considered to be the natural reservoir for many viruses, of which some are potential human pathogens. In India, an association of Pteropus medius bats with the Nipah virus was reported in the past. It is suspected that the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also has its association with bats,\" the objective of the study titled \'<span style=\"text-decoration: underline;\">Detection of coronaviruses in Pteropus and Rousettus species of bats from different states of India\' said.<img class=\"aligncenter wp-image-4859 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/NEWCORONA-300x300.jpg\" alt=\"\" width=\"342\" height=\"342\" /></span>\r\n\r\nIn conclusion, the study showed detection of pathogenic CoVs in two species of Indian bats. Continuous active surveillance is required to identify the emerging novel viruses with epidemic potential.\r\n\"There is a need of proactive surveillance of zoonotic infections in bats. Detection and identifications of such aetiological agents will provide leads for the development of diagnostic along with preparedness and readiness to deal with such emergent viruses thereby quickly containing them,\" the study said.\r\n\r\n<span style=\"text-decoration: underline;\">The recognition and distinguishing proof of such infections from bats likewise prescribes cross-sectional counter acting agent overviews (human and residential creatures) in areas where the infections have been identified. Essentially, if epidemiological circumstance requests, proof based reconnaissance ought to likewise be directed. There is a need of creating solid components for working mutually with different partners, for example, natural life, poultry, creature cultivation and human wellbeing divisions.</span>\r\n\r\nIn the current situation of changing demography and natural controls, it is trying to have keeps an eye on the experiences of bats with different creatures and people. Consequently, dynamic and consistent reconnaissance stays vital for flare-up alarms for bat-related viral operators with scourge potential, which would be useful in opportune intercessions, the investigation said.\r\n\r\nIn spite of the fact that CoVs in the subfamily Coronavirinae don\'t for the most part produce clinical manifestations in their regular hosts (bats), unplanned transmission of these infections to people and different creatures may bring about respiratory, enteric, hepatic or neurologic maladies of variable seriousness. It is as yet not comprehended with regards to why just certain CoVs can contaminate individuals, the examination said.','Coronavirus found in two Indian bat strains uncovers ICMR study','','inherit','closed','closed','','4857-revision-v1','','','2020-04-15 12:22:31','2020-04-15 12:22:31','',4857,'https://microbiozindia.com/uncategorized/4857-revision-v1/',0,'revision','',0),(4861,2,'2020-04-15 13:21:21','2020-04-15 13:21:21','Nuremberg, April 15th 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the leading providers of innovative technologies and solutions for health and hygiene, has proven in a screening test in cooperation with a renowned and certified test laboratory in Germany, that MicroSilver BG&#x2122; and various products that contain MicroSilver BG&#x2122; are effective against enveloped viruses.\r\n\r\nThe family of enveloped viruses includes for example the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.msdmanuals.com/professional/infectious-diseases/respiratory-viruses/coronaviruses-and-acute-respiratory-syndromes-covid-19,-mers,-and-sars\">current corona virus (SARS-Cov2), SARS (SARS-Cov), MERS (MERS-CoV) and influenza A.</a></span> Hand sanitizers, hand gels, surface and textile sprays as well as shampoos were successfully tested. In addition, the tests demonstrated synergetic effects between MicroSilver BG&#x2122; and alcohol as well as with surfactants and soaps. All the products tested have been available on the market for some time.\r\n\r\nMicroSilver BG&#x2122; is used in many healthcare and hygiene related products on the market including: skincare, wound care, medical devices (e.g. catheters, dental fillers); products for surfaces for consumer and industrial goods including: hospital chairs, sanitary equipment, door handles and frames, pipes, architectural wall paints, and coatings for equipment and airplanes. MicroSilver BG&#x2122; has been used for many years for its effective broad-spectrum antimicrobial properties and now the latest testing confirms that MicroSilver also has anti-viral effects.\r\n\r\nMicroSilver BG&#x2122; is manufactured in Bio-Gate’s AG own facilities in Germany. MicroSilver BG&#x2122; is a pure silver powder additive with highly porous and micro-sized particles of silver. The large micro-particles remain on the surface of the skin / mucosa tissue. MicroSilver BG&#x2122; is a natural product certified according to COSMOS/Ecocert and the Natural Product Association (NPA)\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://markets.businessinsider.com/stocks/bio-gate/company-profile\">Marc Lloret-Grau, CEO of Bio-Gate AG:</a></span> \"The Covid-19 pandemic and its rapid spread has shown how important the use of antiviral and antibacterial products has become in daily life. Doctors and virologists point out that, especially after the upcoming relaxation of corona measures, hygiene must be paid more attention to in order to keep new infections as low as possible. Bio-Gate has a variety of products to support the necessary hygienic requirements. The product range extends from antiviral and antibacterial solutions for the end user, through medical devices such as catheters, to supplements to the hygiene strategy in hygiene-sensitive areas such as hospitals and healthcare facilities. By proving the antiviral efficacy, we further round off our product portfolio with MicroSilver BG&#x2122;\".\r\n\r\n<span style=\"text-decoration: underline;\">For further information, please contact:</span>\r\n\r\nBio-Gate AG\r\nNeumeyerstr. 28-34\r\n90411 Nuremberg\r\nGermany\r\nwww.bio-gate.de','Screening test proves effectiveness of various MicroSilver BG&#x2122; products against viruses','','publish','open','open','','screening-test-proves-effectiveness-of-various-microsilver-bg-products-against-viruses','','','2020-04-15 13:23:01','2020-04-15 13:23:01','',0,'https://microbiozindia.com/?p=4861',0,'post','',0),(4862,2,'2020-04-15 13:19:53','2020-04-15 13:19:53','','SSBIO','','inherit','open','closed','','ssbio','','','2020-04-15 13:19:53','2020-04-15 13:19:53','',4861,'https://microbiozindia.com/wp-content/uploads/2020/04/SSBIO.png',0,'attachment','image/png',0),(4863,2,'2020-04-15 13:21:21','2020-04-15 13:21:21','Nuremberg, April 15th 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the leading providers of innovative technologies and solutions for health and hygiene, has proven in a screening test in cooperation with a renowned and certified test laboratory in Germany, that MicroSilver BG&#x2122; and various products that contain MicroSilver BG&#x2122; are effective against enveloped viruses.\r\n\r\nThe family of enveloped viruses includes for example the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.msdmanuals.com/professional/infectious-diseases/respiratory-viruses/coronaviruses-and-acute-respiratory-syndromes-covid-19,-mers,-and-sars\">current corona virus (SARS-Cov2), SARS (SARS-Cov), MERS (MERS-CoV) and influenza A.</a></span> Hand sanitizers, hand gels, surface and textile sprays as well as shampoos were successfully tested. In addition, the tests demonstrated synergetic effects between MicroSilver BG&#x2122; and alcohol as well as with surfactants and soaps. All the products tested have been available on the market for some time.\r\n\r\nMicroSilver BG&#x2122; is used in many healthcare and hygiene related products on the market including: skincare, wound care, medical devices (e.g. catheters, dental fillers); products for surfaces for consumer and industrial goods including: hospital chairs, sanitary equipment, door handles and frames, pipes, architectural wall paints, and coatings for equipment and airplanes. MicroSilver BG&#x2122; has been used for many years for its effective broad-spectrum antimicrobial properties and now the latest testing confirms that MicroSilver also has anti-viral effects.\r\n\r\nMicroSilver BG&#x2122; is manufactured in Bio-Gate’s AG own facilities in Germany. MicroSilver BG&#x2122; is a pure silver powder additive with highly porous and micro-sized particles of silver. The large micro-particles remain on the surface of the skin / mucosa tissue. MicroSilver BG&#x2122; is a natural product certified according to COSMOS/Ecocert and the Natural Product Association (NPA)\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://markets.businessinsider.com/stocks/bio-gate/company-profile\">Marc Lloret-Grau, CEO of Bio-Gate AG:</a></span> \"The Covid-19 pandemic and its rapid spread has shown how important the use of antiviral and antibacterial products has become in daily life. Doctors and virologists point out that, especially after the upcoming relaxation of corona measures, hygiene must be paid more attention to in order to keep new infections as low as possible. Bio-Gate has a variety of products to support the necessary hygienic requirements. The product range extends from antiviral and antibacterial solutions for the end user, through medical devices such as catheters, to supplements to the hygiene strategy in hygiene-sensitive areas such as hospitals and healthcare facilities. By proving the antiviral efficacy, we further round off our product portfolio with MicroSilver BG&#x2122;\".\r\n\r\nFor further information, please contact:\r\n\r\nBio-Gate AG\r\nNeumeyerstr. 28-34\r\n90411 Nuremberg\r\nGermany\r\nwww.bio-gate.de\r\n\r\nNorth America:\r\nKarl Richter\r\nRFH BioTek Inc.\r\nTel: 416-407-6120\r\nrfh@rfhBioTek.com\r\nToronto, Canada\r\n\r\nGerd Rückel\r\nrikutis consulting\r\ngr@rikutis.de\r\npresse@bio-gate.de\r\nTel +49 (0) 6172 807309\r\nMobil +49 (0)152 34221966','Screening test proves effectiveness of various MicroSilver BG&#x2122; products against viruses','','inherit','closed','closed','','4861-revision-v1','','','2020-04-15 13:21:21','2020-04-15 13:21:21','',4861,'https://microbiozindia.com/uncategorized/4861-revision-v1/',0,'revision','',0),(4864,2,'2020-04-15 13:23:01','2020-04-15 13:23:01','Nuremberg, April 15th 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the leading providers of innovative technologies and solutions for health and hygiene, has proven in a screening test in cooperation with a renowned and certified test laboratory in Germany, that MicroSilver BG&#x2122; and various products that contain MicroSilver BG&#x2122; are effective against enveloped viruses.\r\n\r\nThe family of enveloped viruses includes for example the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.msdmanuals.com/professional/infectious-diseases/respiratory-viruses/coronaviruses-and-acute-respiratory-syndromes-covid-19,-mers,-and-sars\">current corona virus (SARS-Cov2), SARS (SARS-Cov), MERS (MERS-CoV) and influenza A.</a></span> Hand sanitizers, hand gels, surface and textile sprays as well as shampoos were successfully tested. In addition, the tests demonstrated synergetic effects between MicroSilver BG&#x2122; and alcohol as well as with surfactants and soaps. All the products tested have been available on the market for some time.\r\n\r\nMicroSilver BG&#x2122; is used in many healthcare and hygiene related products on the market including: skincare, wound care, medical devices (e.g. catheters, dental fillers); products for surfaces for consumer and industrial goods including: hospital chairs, sanitary equipment, door handles and frames, pipes, architectural wall paints, and coatings for equipment and airplanes. MicroSilver BG&#x2122; has been used for many years for its effective broad-spectrum antimicrobial properties and now the latest testing confirms that MicroSilver also has anti-viral effects.\r\n\r\nMicroSilver BG&#x2122; is manufactured in Bio-Gate’s AG own facilities in Germany. MicroSilver BG&#x2122; is a pure silver powder additive with highly porous and micro-sized particles of silver. The large micro-particles remain on the surface of the skin / mucosa tissue. MicroSilver BG&#x2122; is a natural product certified according to COSMOS/Ecocert and the Natural Product Association (NPA)\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://markets.businessinsider.com/stocks/bio-gate/company-profile\">Marc Lloret-Grau, CEO of Bio-Gate AG:</a></span> \"The Covid-19 pandemic and its rapid spread has shown how important the use of antiviral and antibacterial products has become in daily life. Doctors and virologists point out that, especially after the upcoming relaxation of corona measures, hygiene must be paid more attention to in order to keep new infections as low as possible. Bio-Gate has a variety of products to support the necessary hygienic requirements. The product range extends from antiviral and antibacterial solutions for the end user, through medical devices such as catheters, to supplements to the hygiene strategy in hygiene-sensitive areas such as hospitals and healthcare facilities. By proving the antiviral efficacy, we further round off our product portfolio with MicroSilver BG&#x2122;\".\r\n\r\n<span style=\"text-decoration: underline;\">For further information, please contact:</span>\r\n\r\nBio-Gate AG\r\nNeumeyerstr. 28-34\r\n90411 Nuremberg\r\nGermany\r\nwww.bio-gate.de','Screening test proves effectiveness of various MicroSilver BG&#x2122; products against viruses','','inherit','closed','closed','','4861-revision-v1','','','2020-04-15 13:23:01','2020-04-15 13:23:01','',4861,'https://microbiozindia.com/uncategorized/4861-revision-v1/',0,'revision','',0),(4865,2,'2020-04-15 17:10:31','2020-04-15 17:10:31','Abbott Laboratories Inc on Wednesday propelled a coronavirus blood test that could show whether an individual has been tainted and plans to increase assembling to create 20 million tests in June.\r\n\r\nThe test recognizes malady battling antibodies in individuals who have been contaminated yet may have had gentle manifestations or none by any means, making it unique in relation to the current indicative tests that require nasal swabs to affirm dynamic disease.\r\n\r\n[caption id=\"attachment_4867\" align=\"alignnone\" width=\"495\"]<img class=\"wp-image-4867\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/760_main-300x162.jpg\" alt=\"\" width=\"495\" height=\"267\" /> Abbott’s new lab COVID-19 antibody test will run on Abbott’s ARCHITECT i1000SR and i2000SR laboratory instruments.[/caption]\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/companies/abbott-gets-usfda-nod-for-covid-19-diagnostic-test-that-can-deliver-results-in-5-mins-5082421.html\">Abbott has recently won U.S. approval for two coronavirus testing units</a></span>: a mechanized test that can be utilized in labs and a test that can convey results in no time and be utilized in doctors\' workplaces, facilities and emergency clinics.\r\n\r\nCounter acting agent tests are viewed as a potential distinct advantage in the fight to contain diseases and offers the opportunity to recover the economy on target by recognizing individuals who may have invulnerability to the infection and could come back to their occupations.\r\n\r\nThe organization said it intends to petition for FDA endorsement for its test through the crisis use pathway.\r\n\r\nA month ago, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">U.S. Food and Drug Administration</a></span> loosened up the standards on utilization of demonstrative tests by permitting body-liquid tests to continue to showcase without full office survey and endorsement. (https://reut.rs/2RFgway)\r\n\r\nAbbott\'s test distinguishes the IgG immune response, a protein that the body creates in the late phases of disease and may stay for up to months and conceivably years after an individual has recuperated.\r\n\r\nThe organization hopes to promptly transport near 1 million tests this week to U.S. clients, and will send an aggregate of 4 million tests for April.\r\n\r\nThe organization additionally said it would take a shot at extending its testing to distinguish the neutralizer, IgM, made by the body a couple of days after contamination.','Abbott introduced antibody test for coronavirus, plans to convey 20 million tests per month by June 2020','','publish','open','open','','abbott-introduced-antibody-test-for-coronavirus-plans-to-convey-20-million-tests-per-month-by-june-2020','','','2020-04-15 17:10:31','2020-04-15 17:10:31','',0,'https://microbiozindia.com/?p=4865',0,'post','',0),(4866,2,'2020-04-15 17:05:48','2020-04-15 17:05:48','','960x0','','inherit','open','closed','','960x0','','','2020-04-15 17:05:48','2020-04-15 17:05:48','',4865,'https://microbiozindia.com/wp-content/uploads/2020/04/960x0.jpg',0,'attachment','image/jpeg',0),(4867,2,'2020-04-15 17:09:58','2020-04-15 17:09:58','','760_main','','inherit','open','closed','','760_main','','','2020-04-15 17:09:58','2020-04-15 17:09:58','',4865,'https://microbiozindia.com/wp-content/uploads/2020/04/760_main.jpg',0,'attachment','image/jpeg',0),(4868,2,'2020-04-15 17:10:31','2020-04-15 17:10:31','Abbott Laboratories Inc on Wednesday propelled a coronavirus blood test that could show whether an individual has been tainted and plans to increase assembling to create 20 million tests in June.\r\n\r\nThe test recognizes malady battling antibodies in individuals who have been contaminated yet may have had gentle manifestations or none by any means, making it unique in relation to the current indicative tests that require nasal swabs to affirm dynamic disease.\r\n\r\n[caption id=\"attachment_4867\" align=\"alignnone\" width=\"495\"]<img class=\"wp-image-4867\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/760_main-300x162.jpg\" alt=\"\" width=\"495\" height=\"267\" /> Abbott’s new lab COVID-19 antibody test will run on Abbott’s ARCHITECT i1000SR and i2000SR laboratory instruments.[/caption]\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/companies/abbott-gets-usfda-nod-for-covid-19-diagnostic-test-that-can-deliver-results-in-5-mins-5082421.html\">Abbott has recently won U.S. approval for two coronavirus testing units</a></span>: a mechanized test that can be utilized in labs and a test that can convey results in no time and be utilized in doctors\' workplaces, facilities and emergency clinics.\r\n\r\nCounter acting agent tests are viewed as a potential distinct advantage in the fight to contain diseases and offers the opportunity to recover the economy on target by recognizing individuals who may have invulnerability to the infection and could come back to their occupations.\r\n\r\nThe organization said it intends to petition for FDA endorsement for its test through the crisis use pathway.\r\n\r\nA month ago, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">U.S. Food and Drug Administration</a></span> loosened up the standards on utilization of demonstrative tests by permitting body-liquid tests to continue to showcase without full office survey and endorsement. (https://reut.rs/2RFgway)\r\n\r\nAbbott\'s test distinguishes the IgG immune response, a protein that the body creates in the late phases of disease and may stay for up to months and conceivably years after an individual has recuperated.\r\n\r\nThe organization hopes to promptly transport near 1 million tests this week to U.S. clients, and will send an aggregate of 4 million tests for April.\r\n\r\nThe organization additionally said it would take a shot at extending its testing to distinguish the neutralizer, IgM, made by the body a couple of days after contamination.','Abbott introduced antibody test for coronavirus, plans to convey 20 million tests per month by June 2020','','inherit','closed','closed','','4865-revision-v1','','','2020-04-15 17:10:31','2020-04-15 17:10:31','',4865,'https://microbiozindia.com/uncategorized/4865-revision-v1/',0,'revision','',0),(4869,2,'2020-04-16 06:48:32','2020-04-16 06:48:32','The CondenSyn Waterless Air Condenser from Asynt is a proven ‘green’ replacement for water cooled condensers and suitable for greater than 95% of all chemical reflux applications.\r\n\r\nManufactured in the UK, the CondenSyn is a high-performance glass condenser, that requires no cooling water for operation. Unlike traditional Liebig condensers, which are cooled by a circulating fluid such as tap water, CondenSyn eliminates issues with water leakage and potential laboratory flooding. Also, by not using cooling water the environmental impact of your lab is reduced as is the cost of your water usage.\r\n\r\nOffering clear visibility of ongoing experimental reflux, the Asynt CondenSyn is very easy to clean and maintain, whilst the incorporation of a non-roll feature helps prevent accidents if left on a lab bench. Asynt offers a range of CondenSyn to optimally suit different capacity round bottom flasks.\r\n\r\nMany chemistry experiments include a reflux step, making a reflux condenser an essential tool for both research and teaching chemistry. As a result, driven by their ease of use and considerable benefits compared to using traditional water condensers - CondenSyn waterless air condensers have rapidly become a necessity in laboratories all over the world. Not only has the CondenSyn proved itself as a sustainable alternative for reflux reactions but increasingly also for distillation experiments using the CondenSyn Distillation Adapter.\r\n\r\nA typical Chemistry laboratory replacing their standard water condensers with CondenSyn units can expect to see a return on its investment in as little as 6 months.\r\n\r\nFor further information on CondenSyn please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asynt.com/product/asynt-condensyn-air-condenser/\">https://www.asynt.com/product/asynt-condensyn-air-condenser/</a></span> or contact Asynt on +44-1638-781709 / enquiries@asynt.com.\r\n\r\nAsynt is a leading supplier of affordable products, consumables and services for chemists in industry and academia. With staff of trained chemists - Asynt can draw upon this in-depth applications knowledge to provide a high level of customer support for its DrySyn Heating Blocks, Controlled Lab Reactors, Synthesis Tools, Evaporators, Circulators, Temperature Control Systems, Vacuum Pumps and Lab Safety Equipment.','Green Replacement for Water Cooled Condensers','','publish','open','open','','green-replacement-for-water-cooled-condensers','','','2020-04-16 06:48:32','2020-04-16 06:48:32','',0,'https://microbiozindia.com/?p=4869',0,'post','',0),(4870,2,'2020-04-16 06:48:23','2020-04-16 06:48:23','','asyntpr106-image','','inherit','open','closed','','asyntpr106-image','','','2020-04-16 06:48:23','2020-04-16 06:48:23','',4869,'https://microbiozindia.com/wp-content/uploads/2020/04/asyntpr106-image.jpg',0,'attachment','image/jpeg',0),(4871,2,'2020-04-16 06:48:32','2020-04-16 06:48:32','The CondenSyn Waterless Air Condenser from Asynt is a proven ‘green’ replacement for water cooled condensers and suitable for greater than 95% of all chemical reflux applications.\r\n\r\nManufactured in the UK, the CondenSyn is a high-performance glass condenser, that requires no cooling water for operation. Unlike traditional Liebig condensers, which are cooled by a circulating fluid such as tap water, CondenSyn eliminates issues with water leakage and potential laboratory flooding. Also, by not using cooling water the environmental impact of your lab is reduced as is the cost of your water usage.\r\n\r\nOffering clear visibility of ongoing experimental reflux, the Asynt CondenSyn is very easy to clean and maintain, whilst the incorporation of a non-roll feature helps prevent accidents if left on a lab bench. Asynt offers a range of CondenSyn to optimally suit different capacity round bottom flasks.\r\n\r\nMany chemistry experiments include a reflux step, making a reflux condenser an essential tool for both research and teaching chemistry. As a result, driven by their ease of use and considerable benefits compared to using traditional water condensers - CondenSyn waterless air condensers have rapidly become a necessity in laboratories all over the world. Not only has the CondenSyn proved itself as a sustainable alternative for reflux reactions but increasingly also for distillation experiments using the CondenSyn Distillation Adapter.\r\n\r\nA typical Chemistry laboratory replacing their standard water condensers with CondenSyn units can expect to see a return on its investment in as little as 6 months.\r\n\r\nFor further information on CondenSyn please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.asynt.com/product/asynt-condensyn-air-condenser/\">https://www.asynt.com/product/asynt-condensyn-air-condenser/</a></span> or contact Asynt on +44-1638-781709 / enquiries@asynt.com.\r\n\r\nAsynt is a leading supplier of affordable products, consumables and services for chemists in industry and academia. With staff of trained chemists - Asynt can draw upon this in-depth applications knowledge to provide a high level of customer support for its DrySyn Heating Blocks, Controlled Lab Reactors, Synthesis Tools, Evaporators, Circulators, Temperature Control Systems, Vacuum Pumps and Lab Safety Equipment.','Green Replacement for Water Cooled Condensers','','inherit','closed','closed','','4869-revision-v1','','','2020-04-16 06:48:32','2020-04-16 06:48:32','',4869,'https://microbiozindia.com/uncategorized/4869-revision-v1/',0,'revision','',0),(4872,2,'2020-04-16 09:08:57','2020-04-16 09:08:57','Dr Reddy\'s Laboratory has started take a shot at a generic version of Gilead\'s trial coronavirus tranquilize remdesivir, which has demonstrated guarantee with different fundamentally sick patients, <a href=\"https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-medicine-dr-reddys-laboratories-begins-work-on-gilead-drug-clone/articleshow/75169478.cms\">The Economic Times has detailed.</a>\r\n\r\nA source told the paper that however it was early days, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/covid-medicine-dr-reddys-laboratories-begins-work-on-gilead-drug-clone/articleshow/75169478.cms\">Dr Reddy\'s Laboratory had started chip away at building up the medication.</a></span>\r\n\r\nCipla had before said it was working with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Council_of_Scientific_and_Industrial_Research\">Council of Scientific and Industrial Research (CSIR)</a></span> in India to build up a conventional form of the medication.\r\n\r\nInitially created for Ebola, remdesivir has improved the state of 36 basically sick COVID-19 patients out of 53 of every a multi-nation caring use program.\r\n\r\nGilead has said it will increase creation to up to 1 million empathetic dosages, even before endorsement.\r\n\r\nMerciful use program takes into consideration an undertrial or unapproved medication or medication to be utilized for treating basically sick patients without an elective medicine.\r\n\r\nThe issue, in any case, is that Gilead holds the patent for remdesivir in India. A representative for Dr Reddy\'s wouldn\'t remark.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.msfindia.in/\">Médecins Sans Frontières (MSF)</a> </span>or Doctors without Borders are among different gatherings that have requested that nations issue necessary licenses (CL), which permits nonexclusive drugmakers to fabricate even protected medications, for COVID-19 treatment.','Dr Reddy\'s taking a shot at generic version of remdesivir','','publish','open','open','','dr-reddys-taking-a-shot-at-generic-version-of-remdesivir','','','2020-04-16 09:08:57','2020-04-16 09:08:57','',0,'https://microbiozindia.com/?p=4872',0,'post','',0),(4873,2,'2020-04-16 09:00:33','2020-04-16 09:00:33','','Dr-Reddys-750x375','','inherit','open','closed','','dr-reddys-750x375','','','2020-04-16 09:00:33','2020-04-16 09:00:33','',4872,'https://microbiozindia.com/wp-content/uploads/2020/04/Dr-Reddys-750x375-1.jpg',0,'attachment','image/jpeg',0),(4874,2,'2020-04-16 09:08:57','2020-04-16 09:08:57','Dr Reddy\'s Laboratory has started take a shot at a generic version of Gilead\'s trial coronavirus tranquilize remdesivir, which has demonstrated guarantee with different fundamentally sick patients, <a href=\"https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-medicine-dr-reddys-laboratories-begins-work-on-gilead-drug-clone/articleshow/75169478.cms\">The Economic Times has detailed.</a>\r\n\r\nA source told the paper that however it was early days, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/covid-medicine-dr-reddys-laboratories-begins-work-on-gilead-drug-clone/articleshow/75169478.cms\">Dr Reddy\'s Laboratory had started chip away at building up the medication.</a></span>\r\n\r\nCipla had before said it was working with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Council_of_Scientific_and_Industrial_Research\">Council of Scientific and Industrial Research (CSIR)</a></span> in India to build up a conventional form of the medication.\r\n\r\nInitially created for Ebola, remdesivir has improved the state of 36 basically sick COVID-19 patients out of 53 of every a multi-nation caring use program.\r\n\r\nGilead has said it will increase creation to up to 1 million empathetic dosages, even before endorsement.\r\n\r\nMerciful use program takes into consideration an undertrial or unapproved medication or medication to be utilized for treating basically sick patients without an elective medicine.\r\n\r\nThe issue, in any case, is that Gilead holds the patent for remdesivir in India. A representative for Dr Reddy\'s wouldn\'t remark.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.msfindia.in/\">Médecins Sans Frontières (MSF)</a> </span>or Doctors without Borders are among different gatherings that have requested that nations issue necessary licenses (CL), which permits nonexclusive drugmakers to fabricate even protected medications, for COVID-19 treatment.','Dr Reddy\'s taking a shot at generic version of remdesivir','','inherit','closed','closed','','4872-revision-v1','','','2020-04-16 09:08:57','2020-04-16 09:08:57','',4872,'https://microbiozindia.com/uncategorized/4872-revision-v1/',0,'revision','',0),(4875,2,'2020-04-16 12:18:11','2020-04-16 12:18:11','Ziath Ltd is a global leader in manufacturing instruments for tracking large numbers of scientific sample tubes.\r\n\r\n<span style=\"font-family: georgia, palatino, serif;\">Based near Granta Park Research Campus, just outside Cambridge UK, this small business is now gearing up to produce its tube readers faster than ever before. That’s because Ziath tube scanners are a critical part of the procedure for testing Covid-19 samples in the laboratory. With so many samples arriving at the UK Government’s new testing laboratories in Milton Keynes, Alderley Park and Glasgow, together with University labs switching to Covid-19 testing, keeping track of all these samples is a major headache for scientists. </span>\r\n\r\nBy using tubes for these tests which have a small 2D barcode, like a QR code, on the base, scientists can keep track of each patient’s individual swab and their test results. The Ziath instruments can read these 2D codes from the bottom of the tubes, which are held in racks of 100 or 180 tubes, decode them and send the data to the laboratory central computer in just 2 seconds. With the UK government alone reaching for 100,000 tests per day, delivering the ability to track these samples is clearly crucial to the success of the Covid-19 screening campaign.\r\n\r\nHowever, Ziath would not be able to achieve the fast turn around and scale up in their business to meet this challenge without the unwavering support of their key suppliers – many of whom are also small businesses who are experts in their field. Photofab Ltd, headquartered in St. Neots, Cambridgeshire, is one such key supplier. Established in 1971,\r\n\r\nPhotofab is a world leader in chemically etched metal components, having designed &amp; produced more than 70,000 different parts since it started. In their words, “If you can draw it, we can make it, as long as it’s in thin sheet metal.” That, naturally, includes intricately cut and etched metal shields for the Ziath scanners that prevent the on-board computer from interfering with other sensitive instruments in the laboratory.\r\n\r\nSteve Knight, Ziath Commercial Director, commented “Without trusted suppliers such as Photofab in St Neots and our wiring loom supplier, Powerwise Ltd in West Wratting, we would not be able to respond to this global crisis as quickly as we have. Thanks to their efforts and support we are now building and delivering tube scanners for Covid-19 testing not just in the UK, but to Norway, Israel, Germany, Austria, and through a United Nations programme, to Myanmar, Mongolia, Thailand, Vietnam, Nepal, Ethiopia, Kenya, Madagascar, Republic of Congo, Liberia, Ivory Coast, Dominican Republic, Jamaica, Cuba, and El Salvador.”\r\n\r\nFor further information on high performance tube readers to aid labs focusing on screening patient samples for Covid-19 please contact Ziath on +44-1223-855021 / +1 858-880-6920 / info@ziath.com\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ziath.com/\">visit www.ziath.com</a></span>','UK Companies Tackle the Challenge of Large Scale Covid-19 Testing','','publish','open','open','','uk-companies-tackle-the-challenge-of-large-scale-covid-19-testing','','','2020-04-16 12:18:11','2020-04-16 12:18:11','',0,'https://microbiozindia.com/?p=4875',0,'post','',0),(4876,2,'2020-04-16 12:16:25','2020-04-16 12:16:25','','covid-19-4908692_640','','inherit','open','closed','','covid-19-4908692_640','','','2020-04-16 12:16:25','2020-04-16 12:16:25','',4875,'https://microbiozindia.com/wp-content/uploads/2020/04/covid-19-4908692_640.jpg',0,'attachment','image/jpeg',0),(4877,2,'2020-04-16 12:18:11','2020-04-16 12:18:11','Ziath Ltd is a global leader in manufacturing instruments for tracking large numbers of scientific sample tubes.\r\n\r\n<span style=\"font-family: georgia, palatino, serif;\">Based near Granta Park Research Campus, just outside Cambridge UK, this small business is now gearing up to produce its tube readers faster than ever before. That’s because Ziath tube scanners are a critical part of the procedure for testing Covid-19 samples in the laboratory. With so many samples arriving at the UK Government’s new testing laboratories in Milton Keynes, Alderley Park and Glasgow, together with University labs switching to Covid-19 testing, keeping track of all these samples is a major headache for scientists. </span>\r\n\r\nBy using tubes for these tests which have a small 2D barcode, like a QR code, on the base, scientists can keep track of each patient’s individual swab and their test results. The Ziath instruments can read these 2D codes from the bottom of the tubes, which are held in racks of 100 or 180 tubes, decode them and send the data to the laboratory central computer in just 2 seconds. With the UK government alone reaching for 100,000 tests per day, delivering the ability to track these samples is clearly crucial to the success of the Covid-19 screening campaign.\r\n\r\nHowever, Ziath would not be able to achieve the fast turn around and scale up in their business to meet this challenge without the unwavering support of their key suppliers – many of whom are also small businesses who are experts in their field. Photofab Ltd, headquartered in St. Neots, Cambridgeshire, is one such key supplier. Established in 1971,\r\n\r\nPhotofab is a world leader in chemically etched metal components, having designed &amp; produced more than 70,000 different parts since it started. In their words, “If you can draw it, we can make it, as long as it’s in thin sheet metal.” That, naturally, includes intricately cut and etched metal shields for the Ziath scanners that prevent the on-board computer from interfering with other sensitive instruments in the laboratory.\r\n\r\nSteve Knight, Ziath Commercial Director, commented “Without trusted suppliers such as Photofab in St Neots and our wiring loom supplier, Powerwise Ltd in West Wratting, we would not be able to respond to this global crisis as quickly as we have. Thanks to their efforts and support we are now building and delivering tube scanners for Covid-19 testing not just in the UK, but to Norway, Israel, Germany, Austria, and through a United Nations programme, to Myanmar, Mongolia, Thailand, Vietnam, Nepal, Ethiopia, Kenya, Madagascar, Republic of Congo, Liberia, Ivory Coast, Dominican Republic, Jamaica, Cuba, and El Salvador.”\r\n\r\nFor further information on high performance tube readers to aid labs focusing on screening patient samples for Covid-19 please contact Ziath on +44-1223-855021 / +1 858-880-6920 / info@ziath.com\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"http://www.ziath.com/\">visit www.ziath.com</a></span>','UK Companies Tackle the Challenge of Large Scale Covid-19 Testing','','inherit','closed','closed','','4875-revision-v1','','','2020-04-16 12:18:11','2020-04-16 12:18:11','',4875,'https://microbiozindia.com/uncategorized/4875-revision-v1/',0,'revision','',0),(4878,2,'2020-04-16 16:52:16','2020-04-16 16:52:16','Jubilant Life Sciences discredits Karnataka priest\'s case that coronavirus positive representative made a trip to China\r\n\r\nThe inquisitive instance of the coronavirus bunch episode among the representatives of pharmaceutical firm <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Generics</a></span> at its Mysuru plant took a new turn on Thursday, with the organization invalidating charges by Karnataka state specialists that the state\'s COVID-19 patient zero had headed out to China.\r\n\r\nJubilant Generics is a backup of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Life Sciences.</a></span>\r\n\r\nK Sudhakar, Karnataka serve accountable for COVID-19 reaction, had revealed to some news channels on Thursday that that the patient zero, alluded to as \"Tolerant P52\" in Karnataka\'s rundown of positive cases, had made a trip to China.\r\n\r\nState specialists had been examining how the wellbeing emergency had broken out at the pharmaceutical organization, and had likewise sent examples got from China for testing to the National Institute of Virology (NIV) in Pune and the Indian Council of Medical Research.\r\n\r\nAlmost 50 representatives of Jubilant Generics at its Myusru plant and their relatives have tried positive for coronavirus up until this point.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Life Sciences</a></span> Limited said in a press explanation that none of the workers who tried positive for the infection had an abroad travel history in the previous a half year, and included that the examples sent for testing had come out negative for the coronavirus.\r\n\r\n\"No hints of COVID-19 infection have been found in the imported crude material examined from Nanjangud office of its auxiliary – Jubilant Generics Limited. Crude material (imported from China) tried negative for COVID-19 infection by National Institute of Virology, Pune as declared by the specialists of Government of Karnataka,\" the organization said.\r\n\r\n\"Moreover, the organization explained that Patient P52 didn\'t venture out to China or on any abroad outing over the most recent a half year. Further, none of the representatives tried positive so far voyaged abroad over the most recent a half year,\" the announcement said.\r\n\r\nJubilant Generics likewise said that the patient P52 had no contact with any crude material nor had a \"job in getting, moving, taking care of or capacity of crude materials.\"\r\n\r\nKarnataka wellbeing secretary Pankaj Kumar Pandey said in a question and answer session on Thursday that so far tests for bundling material from the organization sent for examining have been negative, yet said he will return on the status of the examples of crude material.\r\n\r\nJubilant Generics is additionally confronting a PIL in the Karnataka High Court asserting carelessness with respect to the organization for the flare-up of the infection.\r\n\r\nThe applicant has guaranteed that the organization got synthetic concoctions at its plant from China in March, which may have been the \"underlying driver\" of the episode. The PIL has required an examination by specialists into the issue and for move to be made against the organization.\r\n\r\n<a href=\"https://www.jubilantpharma.com/\"><span style=\"color: #ff6600;\">Jubilant Generics Limited</span></a> said that at its plant situated at Nanjangud, Mysore, it fabricates <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\">Active Pharmaceutical Ingredients</a></span> (APIs or mass medications) like Azithromycin Dihydrate and Azithromycin Monohydrate, which are required in treatment for patients contaminated with COVID-19.\r\n\r\n\"Along these lines, it was basic for the organization to proceed with its tasks in its endeavors to help battle the worldwide pandemic of COVID-19,\" the organization had prior said.\r\n\r\nThe primary constructive instance of a representative of Jubilant Generics was accounted for on March 26, and specialists have been researching how the individual gotten the infection.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Generics</a> </span>said the worker had quit going to the plant after March 20.\r\n\r\n\"He didn\'t go to office from March 21-26 till he was distinguished positive. He was put under clinical watch at an administration medical clinic and the organization has been getting data from the administration specialists that he is recovering great,\" the organization said.\r\n\r\nBe that as it may, cases before long began ascending in the little sanctuary town of Nanjangud close Mysuru, fundamentally among the workers and their contacts. This incited specialists to ask the more than 1,000-part staff at the pharmaceutical organization to be carefully home isolated.\r\n\r\nSpecialists have likewise been exploring CCTV film and company records with respect to guest subtleties, travel history, material development to recognize the wellspring of the episode.','Jubilant Life Sciences invalidates Karnataka minister\'s claim','','publish','open','open','','jubilant-life-sciences-invalidates-karnataka-ministers-claim','','','2020-04-16 16:52:16','2020-04-16 16:52:16','',0,'https://microbiozindia.com/?p=4878',0,'post','',0),(4879,2,'2020-04-16 15:44:23','2020-04-16 15:44:23','','AAAE','','inherit','open','closed','','aaae','','','2020-04-16 15:44:23','2020-04-16 15:44:23','',4878,'https://microbiozindia.com/wp-content/uploads/2020/04/AAAE.png',0,'attachment','image/png',0),(4880,2,'2020-04-16 16:52:16','2020-04-16 16:52:16','Jubilant Life Sciences discredits Karnataka priest\'s case that coronavirus positive representative made a trip to China\r\n\r\nThe inquisitive instance of the coronavirus bunch episode among the representatives of pharmaceutical firm <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Generics</a></span> at its Mysuru plant took a new turn on Thursday, with the organization invalidating charges by Karnataka state specialists that the state\'s COVID-19 patient zero had headed out to China.\r\n\r\nJubilant Generics is a backup of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Life Sciences.</a></span>\r\n\r\nK Sudhakar, Karnataka serve accountable for COVID-19 reaction, had revealed to some news channels on Thursday that that the patient zero, alluded to as \"Tolerant P52\" in Karnataka\'s rundown of positive cases, had made a trip to China.\r\n\r\nState specialists had been examining how the wellbeing emergency had broken out at the pharmaceutical organization, and had likewise sent examples got from China for testing to the National Institute of Virology (NIV) in Pune and the Indian Council of Medical Research.\r\n\r\nAlmost 50 representatives of Jubilant Generics at its Myusru plant and their relatives have tried positive for coronavirus up until this point.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Life Sciences</a></span> Limited said in a press explanation that none of the workers who tried positive for the infection had an abroad travel history in the previous a half year, and included that the examples sent for testing had come out negative for the coronavirus.\r\n\r\n\"No hints of COVID-19 infection have been found in the imported crude material examined from Nanjangud office of its auxiliary – Jubilant Generics Limited. Crude material (imported from China) tried negative for COVID-19 infection by National Institute of Virology, Pune as declared by the specialists of Government of Karnataka,\" the organization said.\r\n\r\n\"Moreover, the organization explained that Patient P52 didn\'t venture out to China or on any abroad outing over the most recent a half year. Further, none of the representatives tried positive so far voyaged abroad over the most recent a half year,\" the announcement said.\r\n\r\nJubilant Generics likewise said that the patient P52 had no contact with any crude material nor had a \"job in getting, moving, taking care of or capacity of crude materials.\"\r\n\r\nKarnataka wellbeing secretary Pankaj Kumar Pandey said in a question and answer session on Thursday that so far tests for bundling material from the organization sent for examining have been negative, yet said he will return on the status of the examples of crude material.\r\n\r\nJubilant Generics is additionally confronting a PIL in the Karnataka High Court asserting carelessness with respect to the organization for the flare-up of the infection.\r\n\r\nThe applicant has guaranteed that the organization got synthetic concoctions at its plant from China in March, which may have been the \"underlying driver\" of the episode. The PIL has required an examination by specialists into the issue and for move to be made against the organization.\r\n\r\n<a href=\"https://www.jubilantpharma.com/\"><span style=\"color: #ff6600;\">Jubilant Generics Limited</span></a> said that at its plant situated at Nanjangud, Mysore, it fabricates <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\">Active Pharmaceutical Ingredients</a></span> (APIs or mass medications) like Azithromycin Dihydrate and Azithromycin Monohydrate, which are required in treatment for patients contaminated with COVID-19.\r\n\r\n\"Along these lines, it was basic for the organization to proceed with its tasks in its endeavors to help battle the worldwide pandemic of COVID-19,\" the organization had prior said.\r\n\r\nThe primary constructive instance of a representative of Jubilant Generics was accounted for on March 26, and specialists have been researching how the individual gotten the infection.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.jubilantpharma.com/\">Jubilant Generics</a> </span>said the worker had quit going to the plant after March 20.\r\n\r\n\"He didn\'t go to office from March 21-26 till he was distinguished positive. He was put under clinical watch at an administration medical clinic and the organization has been getting data from the administration specialists that he is recovering great,\" the organization said.\r\n\r\nBe that as it may, cases before long began ascending in the little sanctuary town of Nanjangud close Mysuru, fundamentally among the workers and their contacts. This incited specialists to ask the more than 1,000-part staff at the pharmaceutical organization to be carefully home isolated.\r\n\r\nSpecialists have likewise been exploring CCTV film and company records with respect to guest subtleties, travel history, material development to recognize the wellspring of the episode.','Jubilant Life Sciences invalidates Karnataka minister\'s claim','','inherit','closed','closed','','4878-revision-v1','','','2020-04-16 16:52:16','2020-04-16 16:52:16','',4878,'https://microbiozindia.com/uncategorized/4878-revision-v1/',0,'revision','',0),(4881,2,'2020-04-16 16:54:43','2020-04-16 16:54:43','FLIR Systems reports how its thermal cameras have a long history of being used in public spaces as an effective frontline screening tool to non-invasively measure skin surface temperature and identify individuals with Elevated Body Temperature (EBT).\r\n\r\nIn light of the global coronavirus (COVID-19) pandemic, society is deeply concerned about the spread of this infection and is seeking tools to help slow and ultimately stop the spread of the virus. Although no thermal cameras can detect or diagnose the coronavirus, FLIR cameras can be used as an adjunct to other body temperature screening tools for detecting elevated skin temperature in high-traffic public places through quick individual screening.\r\n\r\nIf the temperature of the skin in key areas (especially the corner of the eye and forehead) is above average temperature, then the individual may be selected for additional screening. Identifying individuals with EBT, who should then be further screened with virus-specific diagnostic tests, can help reduce or dramatically slow the spread of viruses and infections.\r\n\r\nAirports around the world are actively employing FLIR thermal cameras as part of their screening measures for passengers and flight crews. The screening procedures implemented at airports and in other public places are just the first step when it comes to detecting a possible infection. FLIR thermal cameras provide a quick way to screen for anyone who might be sick, and must always be followed up with further screening before authorities decide to quarantine a person.\r\n\r\nFor further information on the FLIR T-Series thermal imaging camera please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.flir.co.uk/products/t540/\">https://www.flir.co.uk/products/t540/</a></span>. For further informative on remote, non-invasive measurement of individuals with elevated body temperature please visit www.flir.com/discover/public-safety/thermal-imaging-for-detecting-elevated-body-temperature/ or contact FLIR Systems on research@flir.com or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.flir.com/\">www.flir.com</a></span> and follow @flir.\r\n\r\nWhile governments outside the United States may choose from many different cameras, FLIR has a 510(k) filing (K033967) with the US Food and Drug Administration (FDA) for select camera models for use as an adjunct to other body temperature screening tools to detect differences in skin surface temperatures. These cameras include the FLIR Exx-Series, FLIR T-Series, FLIR A320, and Extech IR200. For more information about ordering FLIR cameras for temperature screening purposes in the United States, please call +1 866.477.3687.','Detecting Elevated Body Temperature using Thermal Imaging','','publish','open','open','','detecting-elevated-body-temperature-using-thermal-imaging','','','2020-04-16 16:54:43','2020-04-16 16:54:43','',0,'https://microbiozindia.com/?p=4881',0,'post','',0),(4882,2,'2020-04-16 16:53:31','2020-04-16 16:53:31','','fliratspr236-imageB','','inherit','open','closed','','fliratspr236-imageb','','','2020-04-16 16:53:31','2020-04-16 16:53:31','',4881,'https://microbiozindia.com/wp-content/uploads/2020/04/fliratspr236-imageB.jpg',0,'attachment','image/jpeg',0),(4883,2,'2020-04-16 16:54:43','2020-04-16 16:54:43','FLIR Systems reports how its thermal cameras have a long history of being used in public spaces as an effective frontline screening tool to non-invasively measure skin surface temperature and identify individuals with Elevated Body Temperature (EBT).\r\n\r\nIn light of the global coronavirus (COVID-19) pandemic, society is deeply concerned about the spread of this infection and is seeking tools to help slow and ultimately stop the spread of the virus. Although no thermal cameras can detect or diagnose the coronavirus, FLIR cameras can be used as an adjunct to other body temperature screening tools for detecting elevated skin temperature in high-traffic public places through quick individual screening.\r\n\r\nIf the temperature of the skin in key areas (especially the corner of the eye and forehead) is above average temperature, then the individual may be selected for additional screening. Identifying individuals with EBT, who should then be further screened with virus-specific diagnostic tests, can help reduce or dramatically slow the spread of viruses and infections.\r\n\r\nAirports around the world are actively employing FLIR thermal cameras as part of their screening measures for passengers and flight crews. The screening procedures implemented at airports and in other public places are just the first step when it comes to detecting a possible infection. FLIR thermal cameras provide a quick way to screen for anyone who might be sick, and must always be followed up with further screening before authorities decide to quarantine a person.\r\n\r\nFor further information on the FLIR T-Series thermal imaging camera please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.flir.co.uk/products/t540/\">https://www.flir.co.uk/products/t540/</a></span>. For further informative on remote, non-invasive measurement of individuals with elevated body temperature please visit www.flir.com/discover/public-safety/thermal-imaging-for-detecting-elevated-body-temperature/ or contact FLIR Systems on research@flir.com or +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.flir.com/\">www.flir.com</a></span> and follow @flir.\r\n\r\nWhile governments outside the United States may choose from many different cameras, FLIR has a 510(k) filing (K033967) with the US Food and Drug Administration (FDA) for select camera models for use as an adjunct to other body temperature screening tools to detect differences in skin surface temperatures. These cameras include the FLIR Exx-Series, FLIR T-Series, FLIR A320, and Extech IR200. For more information about ordering FLIR cameras for temperature screening purposes in the United States, please call +1 866.477.3687.','Detecting Elevated Body Temperature using Thermal Imaging','','inherit','closed','closed','','4881-revision-v1','','','2020-04-16 16:54:43','2020-04-16 16:54:43','',4881,'https://microbiozindia.com/uncategorized/4881-revision-v1/',0,'revision','',0),(4884,2,'2020-04-17 07:25:15','2020-04-17 07:25:15','As of late, specialists have discovered that the body can recuperate itself. Platelet-rich plasma treatment is a type of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nature.com/subjects/regenerative-medicine\">regenerative medication</a></span> that can bridle those capacities and intensify the regular development factors your body uses to recuperate tissue.\r\n<h3>What is plasma and what are platelets?</h3>\r\nPlasma is the fluid part of entire blood. It is made to a great extent out of water and proteins, and it gives a medium to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">red platelets</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">white platelets</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">platelets</a></span> to flow through the body. Platelets, likewise called <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thrombocyte\">thrombocytes</a></span>, are platelets that cause blood clusters and other important development mending capacities.\r\n\r\n[caption id=\"attachment_4885\" align=\"alignnone\" width=\"580\"]<img class=\"wp-image-4885\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4944680_640-300x166.jpg\" alt=\"\" width=\"580\" height=\"321\" /> <span style=\"font-size: 10pt;\"><em>Mask is known for best way to prevent spread of infection. Image Cred: Pixabay</em></span>[/caption]\r\n\r\nPlatelet enactment assumes a key job in the body\'s common recuperating process.\r\n<h3>What is Convalescent plasma treatment?</h3>\r\nGaining strength plasma treatment utilizes a blood segment called plasma - which contains the infection battling antibodies - from individuals who have recuperated from the disease to treat the individuals who are seriously sick with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">Covid-19.</a></span>\r\n\r\nAside from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research</a></span> - India\'s pinnacle wellbeing research body - at any rate two emergency clinics have applied to test the viability of the treatment in Delhi, the conventions for which have been set up .\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ilbs.in/\">Institute of Liver and Biliary Sciences</a></span>, an autonomous Delhi government medical clinic, has just gotten endorsement to direct the preliminaries. The private Max Hospital is anticipating endorsement to dispatch the preliminaries.\r\n\r\n\"As a similar product will be tried over the centers, the endorsements are being given to clinics that accommodate with the ICMR conventions so uniform and practically identical information is created from across focuses,\" said an authority from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/Home/\">Central Drugs Standard Control Organization (CDSCO),</a> </span>the peak medicate controller.\r\n\r\nAt the point when the infection enters the human body, the immune system makes an antibody to battle it. This antibody er stays in an individual considerably after the infection has gotten out of their system. Without different medications, specialists state that utilizing these antibodies from recouped patients can offer a respite to seriously sick Covid-19 patients.\r\n\r\n\"Presently, there are more than 1,000 individuals who have recouped from Covid-19 in the nation and their blood plasma can be utilized to treat the individuals who are basic. The antibodies from the recuperated individual will hypothetically help the basic patients in battling the contamination.<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://in.news.yahoo.com/plasma-therapy-small-ray-hope-220603247.html\"> This is accomplished for other viral sicknesses also,\" said Dr SK Sarin, chief of the Institute of Liver and Biliary Sciences</a></span>\r\n\r\nThe treatment would be offered distinctly to patients in a basic condition - those with a respiratory rate higher than 30 breaths for each moment (the ordinary is 18-20 breaths for every moment), have oxygen immersion of under 90% (typical is 95 to 100%), or have penetrates like discharge in the lungs.\r\n\r\nConcerning givers, just wellbeing people - with no comorbidities like diabetes, hypertension, or coronary illness and under 60 years old - who have recuperated from the disease would be chosen.\r\n<h3>When was this thought imagined?</h3>\r\nThe idea of this treatment goes back over a century, in 1890, when Emil von Behring, a German physiologist, found that the serum got from a hare contaminated with diphtheria was compelling in forestalling the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/diphtheria/symptoms-causes/syc-20351897\">diphtheria disease</a></span>. Behring was granted the first-since forever Nobel prize for medication in 1901.\r\n\r\nComparable medications have been endeavored during a few episodes before, including the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html\">Spanish influenza pandemic</a></span> of 1918, the diphtheria flare-up during the 1920s, a substance eating microscopic organisms plague during the 1930s. In those days, gaining strength serum treatment was less powerful and had significant symptoms. It took numerous years prior to the counter acting agent portion could be isolated. All things considered, the unintended antibodies and pollutions caused symptoms.\r\n<h3>Where first acted in Quite a while ??</h3>\r\nKerala is the main state to start the convention for plasma treatment. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Sree_Chitra_Tirunal_Institute_for_Medical_Sciences_and_Technology\">The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)</a></span> under the Department of Science and Technology, was given an approval on April 11 by ICMR.\r\n\r\nIn any case, endorsement from the DCGI is pending as there are rules like the blood benefactor ought not have voyage abroad in the previous three months.\r\n\r\n[caption id=\"attachment_4786\" align=\"alignnone\" width=\"524\"]<img class=\"wp-image-4786\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/AAA-300x200.jpg\" alt=\"\" width=\"524\" height=\"349\" /> <em><span style=\"font-size: 10pt;\">Image Credit: Pixabay</span></em>[/caption]\r\n\r\n<span style=\"text-decoration: underline;\">\"We have applied to the Drug Controller General of India (DCGI) for consents to loosen up the standards for blood gift,\" said Dr Asha Kishore Director, SCTIMST.</span>\r\n\r\nKerala had started research and conventions for the plasma treatment even before the US Food and Drug Administration (FDA) affirmed it on April 3. ICMR sources said it would take a couple of days to find out what number of preliminaries have been permitted, since the official letter of goal was promoted just two or three days back.\r\n<h3>Different nations attempting a similar methodology</h3>\r\nChina has now loosened up the lockdown after their cases have gone down definitely to single digits. Then, the USA has dominated. The quantity of cases in the US are a lot higher than they ever were in China.\r\n\r\nThe US has additionally joined the plasma treatment temporary fad and has started clinical preliminaries for plasma. They have likewise started clinical preliminaries for potential antibodies, however we should sit tight and watch for the outcomes.\r\n\r\n<span style=\"text-decoration: underline;\">Turkey, South Korea, Italy, the United Kingdom, are a portion of the couple of nations that are additionally taking a gander at plasma treatment to help manage the coronavirus emergency that has held the world.</span>','Here\'s what you need to know about Plasma therapy for CORONA virus','','publish','open','open','','heres-what-you-need-to-know-about-plasma-therapy-for-corona-virus','','','2020-04-17 07:25:15','2020-04-17 07:25:15','',0,'https://microbiozindia.com/?p=4884',0,'post','',0),(4885,2,'2020-04-17 07:12:51','2020-04-17 07:12:51','','coronavirus-4944680_640','','inherit','open','closed','','coronavirus-4944680_640','','','2020-04-17 07:12:51','2020-04-17 07:12:51','',4884,'https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4944680_640.jpg',0,'attachment','image/jpeg',0),(4886,2,'2020-04-17 07:12:54','2020-04-17 07:12:54','','red-blood-cell-4302093_640 (1)','','inherit','open','closed','','red-blood-cell-4302093_640-1','','','2020-04-17 07:12:54','2020-04-17 07:12:54','',4884,'https://microbiozindia.com/wp-content/uploads/2020/04/red-blood-cell-4302093_640-1.jpg',0,'attachment','image/jpeg',0),(4887,2,'2020-04-17 07:25:15','2020-04-17 07:25:15','As of late, specialists have discovered that the body can recuperate itself. Platelet-rich plasma treatment is a type of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nature.com/subjects/regenerative-medicine\">regenerative medication</a></span> that can bridle those capacities and intensify the regular development factors your body uses to recuperate tissue.\r\n<h3>What is plasma and what are platelets?</h3>\r\nPlasma is the fluid part of entire blood. It is made to a great extent out of water and proteins, and it gives a medium to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">red platelets</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">white platelets</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=160&amp;ContentID=36\">platelets</a></span> to flow through the body. Platelets, likewise called <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thrombocyte\">thrombocytes</a></span>, are platelets that cause blood clusters and other important development mending capacities.\r\n\r\n[caption id=\"attachment_4885\" align=\"alignnone\" width=\"580\"]<img class=\"wp-image-4885\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4944680_640-300x166.jpg\" alt=\"\" width=\"580\" height=\"321\" /> <span style=\"font-size: 10pt;\"><em>Mask is known for best way to prevent spread of infection. Image Cred: Pixabay</em></span>[/caption]\r\n\r\nPlatelet enactment assumes a key job in the body\'s common recuperating process.\r\n<h3>What is Convalescent plasma treatment?</h3>\r\nGaining strength plasma treatment utilizes a blood segment called plasma - which contains the infection battling antibodies - from individuals who have recuperated from the disease to treat the individuals who are seriously sick with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">Covid-19.</a></span>\r\n\r\nAside from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research</a></span> - India\'s pinnacle wellbeing research body - at any rate two emergency clinics have applied to test the viability of the treatment in Delhi, the conventions for which have been set up .\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ilbs.in/\">Institute of Liver and Biliary Sciences</a></span>, an autonomous Delhi government medical clinic, has just gotten endorsement to direct the preliminaries. The private Max Hospital is anticipating endorsement to dispatch the preliminaries.\r\n\r\n\"As a similar product will be tried over the centers, the endorsements are being given to clinics that accommodate with the ICMR conventions so uniform and practically identical information is created from across focuses,\" said an authority from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/Home/\">Central Drugs Standard Control Organization (CDSCO),</a> </span>the peak medicate controller.\r\n\r\nAt the point when the infection enters the human body, the immune system makes an antibody to battle it. This antibody er stays in an individual considerably after the infection has gotten out of their system. Without different medications, specialists state that utilizing these antibodies from recouped patients can offer a respite to seriously sick Covid-19 patients.\r\n\r\n\"Presently, there are more than 1,000 individuals who have recouped from Covid-19 in the nation and their blood plasma can be utilized to treat the individuals who are basic. The antibodies from the recuperated individual will hypothetically help the basic patients in battling the contamination.<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://in.news.yahoo.com/plasma-therapy-small-ray-hope-220603247.html\"> This is accomplished for other viral sicknesses also,\" said Dr SK Sarin, chief of the Institute of Liver and Biliary Sciences</a></span>\r\n\r\nThe treatment would be offered distinctly to patients in a basic condition - those with a respiratory rate higher than 30 breaths for each moment (the ordinary is 18-20 breaths for every moment), have oxygen immersion of under 90% (typical is 95 to 100%), or have penetrates like discharge in the lungs.\r\n\r\nConcerning givers, just wellbeing people - with no comorbidities like diabetes, hypertension, or coronary illness and under 60 years old - who have recuperated from the disease would be chosen.\r\n<h3>When was this thought imagined?</h3>\r\nThe idea of this treatment goes back over a century, in 1890, when Emil von Behring, a German physiologist, found that the serum got from a hare contaminated with diphtheria was compelling in forestalling the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/diphtheria/symptoms-causes/syc-20351897\">diphtheria disease</a></span>. Behring was granted the first-since forever Nobel prize for medication in 1901.\r\n\r\nComparable medications have been endeavored during a few episodes before, including the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html\">Spanish influenza pandemic</a></span> of 1918, the diphtheria flare-up during the 1920s, a substance eating microscopic organisms plague during the 1930s. In those days, gaining strength serum treatment was less powerful and had significant symptoms. It took numerous years prior to the counter acting agent portion could be isolated. All things considered, the unintended antibodies and pollutions caused symptoms.\r\n<h3>Where first acted in Quite a while ??</h3>\r\nKerala is the main state to start the convention for plasma treatment. <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Sree_Chitra_Tirunal_Institute_for_Medical_Sciences_and_Technology\">The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)</a></span> under the Department of Science and Technology, was given an approval on April 11 by ICMR.\r\n\r\nIn any case, endorsement from the DCGI is pending as there are rules like the blood benefactor ought not have voyage abroad in the previous three months.\r\n\r\n[caption id=\"attachment_4786\" align=\"alignnone\" width=\"524\"]<img class=\"wp-image-4786\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/AAA-300x200.jpg\" alt=\"\" width=\"524\" height=\"349\" /> <em><span style=\"font-size: 10pt;\">Image Credit: Pixabay</span></em>[/caption]\r\n\r\n<span style=\"text-decoration: underline;\">\"We have applied to the Drug Controller General of India (DCGI) for consents to loosen up the standards for blood gift,\" said Dr Asha Kishore Director, SCTIMST.</span>\r\n\r\nKerala had started research and conventions for the plasma treatment even before the US Food and Drug Administration (FDA) affirmed it on April 3. ICMR sources said it would take a couple of days to find out what number of preliminaries have been permitted, since the official letter of goal was promoted just two or three days back.\r\n<h3>Different nations attempting a similar methodology</h3>\r\nChina has now loosened up the lockdown after their cases have gone down definitely to single digits. Then, the USA has dominated. The quantity of cases in the US are a lot higher than they ever were in China.\r\n\r\nThe US has additionally joined the plasma treatment temporary fad and has started clinical preliminaries for plasma. They have likewise started clinical preliminaries for potential antibodies, however we should sit tight and watch for the outcomes.\r\n\r\n<span style=\"text-decoration: underline;\">Turkey, South Korea, Italy, the United Kingdom, are a portion of the couple of nations that are additionally taking a gander at plasma treatment to help manage the coronavirus emergency that has held the world.</span>','Here\'s what you need to know about Plasma therapy for CORONA virus','','inherit','closed','closed','','4884-revision-v1','','','2020-04-17 07:25:15','2020-04-17 07:25:15','',4884,'https://microbiozindia.com/uncategorized/4884-revision-v1/',0,'revision','',0),(4888,2,'2020-04-17 08:23:04','2020-04-17 08:23:04','The U.S. Food and Drug Administration said on Thursday spun manufactured swabs could be utilized for coronavirus testing by gathering an example from the front of the nose.\r\n\r\nThis kind of testing would permit self-assortment by patients, in this way constraining introduction of human services suppliers, FDA said.\r\n\r\nThe United States has recorded more fatalities from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span>, the respiratory illness brought about by the new coronavirus, than some other nation, with 30,961 passings and 636,937 affirmed cases.\r\n\r\nU.S. Cotton, the biggest maker of cotton swabs in the nation, built up a polyester-based Q-tip-type swab that is completely similarity with COVID-19 testing, FDA said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://bit.ly/3cnfEz4\">https://bit.ly/3cnfEz4</a></span>.\r\n\r\n\"U.S. Cotton intends to deliver these new polyester swabs in enormous amounts to help address the issues for coronavirus indicative testing,\" the controller said in an announcement.\r\n\r\nThe finding that spun manufactured swabs could be utilized for testing depends on results from a clinical examination by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">FDA</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unitedhealthgroup.com/\">UnitedHealth Group,</a></span> the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gatesfoundation.org/\">Gates Foundation</a></span>, and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.quantigen.com/\">Quantigen.</a></span>\r\n\r\nThis story has been distributed from a wire organization feed without alterations to the content. Just the feature has been changed','USFDA favors engineered swabs for coronavirus testing','','publish','open','open','','usfda-favors-engineered-swabs-for-coronavirus-testing','','','2020-04-17 08:23:04','2020-04-17 08:23:04','',0,'https://microbiozindia.com/?p=4888',0,'post','',0),(4889,2,'2020-04-17 08:21:06','2020-04-17 08:21:06','','test-5027031_640','','inherit','open','closed','','test-5027031_640','','','2020-04-17 08:21:06','2020-04-17 08:21:06','',4888,'https://microbiozindia.com/wp-content/uploads/2020/04/test-5027031_640.jpg',0,'attachment','image/jpeg',0),(4890,2,'2020-04-17 08:23:04','2020-04-17 08:23:04','The U.S. Food and Drug Administration said on Thursday spun manufactured swabs could be utilized for coronavirus testing by gathering an example from the front of the nose.\r\n\r\nThis kind of testing would permit self-assortment by patients, in this way constraining introduction of human services suppliers, FDA said.\r\n\r\nThe United States has recorded more fatalities from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19</a></span>, the respiratory illness brought about by the new coronavirus, than some other nation, with 30,961 passings and 636,937 affirmed cases.\r\n\r\nU.S. Cotton, the biggest maker of cotton swabs in the nation, built up a polyester-based Q-tip-type swab that is completely similarity with COVID-19 testing, FDA said <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://bit.ly/3cnfEz4\">https://bit.ly/3cnfEz4</a></span>.\r\n\r\n\"U.S. Cotton intends to deliver these new polyester swabs in enormous amounts to help address the issues for coronavirus indicative testing,\" the controller said in an announcement.\r\n\r\nThe finding that spun manufactured swabs could be utilized for testing depends on results from a clinical examination by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">FDA</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.unitedhealthgroup.com/\">UnitedHealth Group,</a></span> the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gatesfoundation.org/\">Gates Foundation</a></span>, and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.quantigen.com/\">Quantigen.</a></span>\r\n\r\nThis story has been distributed from a wire organization feed without alterations to the content. Just the feature has been changed','USFDA favors engineered swabs for coronavirus testing','','inherit','closed','closed','','4888-revision-v1','','','2020-04-17 08:23:04','2020-04-17 08:23:04','',4888,'https://microbiozindia.com/uncategorized/4888-revision-v1/',0,'revision','',0),(4891,2,'2020-04-17 12:08:24','2020-04-17 12:08:24','Swiss Pharmaceutical Company Roche today reported the turn of events and up and coming dispatch of its <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Elecsys® Anti-SARS-CoV-2</a></span> serology test to recognize antibodies in individuals who have been presented to the <a href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2</a>) that causes the COVID-19 infection.\r\n\r\nCounter acting agent testing is fundamental to help distinguish individuals who have been tainted by the infection, particularly the individuals who may have been contaminated yet didn\'t show symptoms.³ Additionally, the test can bolster need screening of high hazard gatherings, for example, social insurance laborers, nourishment supply laborers who may as of now have built up a specific degree of invulnerability and can keep serving as well as come back to work. When we see increasingly about the resistance of COVID-19, it could likewise assist society with returning quicker to ordinariness.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/person/7542591\">Severin Schwan, CEO Roche Group:</a></span> \"Following the dispatch of our high-volume PCR test in mid-March to recognize dynamic contamination of the infection, we are currently going to dispatch another counter acting agent test toward the beginning of May. Each dependable test available fills its need for social insurance frameworks to assist us with beating this pandemic. Roche is teaming up intimately with wellbeing specialists and increase creation to guarantee quick accessibility of the test all inclusive.\"\r\n\r\n\"Roche is profoundly dedicated to supporting the worldwide reaction to the COVID-19 pandemic,\" said Thomas Schinecker, CEO Roche Diagnostics. \"Auspicious accessibility and quick access to dependable, top notch tests are fundamental for human services frameworks. The immunizer test is a significant following stage in the battle against COVID-19. Roche\'s immune response test can be immediately scaled and made extensively accessible around the globe as our instrument framework is as of now set up.\"\r\n\r\n<img class=\"alignnone  wp-image-4893\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Roche-740x520-1-300x211.jpg\" alt=\"\" width=\"582\" height=\"409\" />\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Elecsys Anti-SARS-CoV-2 immunoassay</a> </span>is an in vitro test, utilizing human serum and plasma drawn from a blood test, to distinguish antibodies and decide the body\'s invulnerable response to SARS-CoV-2. The test might be utilized in epidemiological research to assist better with understanding the spread of the ailment and may likewise be utilized together with sub-atomic tests to help in the finding of suspected COVID-19 patients. Clinics and reference research facilities can run the test on Roche\'s cobas e analysers, which are generally accessible in labs around the globe.\r\n\r\nRoche plans to have the immunizer test accessible by early May in nations tolerating the CE mark and is effectively working with the FDA for an Emergency Use Authorisation. Roche is anticipating a quickened increase of month to month creation to high twofold digit million tests by June and will additionally scale up creation as quick as could be expected under the circumstances.','New serology test to identify COVID-19 antibodies by Roche','','publish','open','open','','new-serology-test-to-identify-covid-19-antibodies-by-roche','','','2020-04-17 12:08:24','2020-04-17 12:08:24','',0,'https://microbiozindia.com/?p=4891',0,'post','',0),(4892,2,'2020-04-17 11:49:51','2020-04-17 11:49:51','','FDA-Approves-Roche-Coronavirus-Test-BioSpace-3-13-20','','inherit','open','closed','','fda-approves-roche-coronavirus-test-biospace-3-13-20','','','2020-04-17 11:49:51','2020-04-17 11:49:51','',4891,'https://microbiozindia.com/wp-content/uploads/2020/04/FDA-Approves-Roche-Coronavirus-Test-BioSpace-3-13-20.jpeg',0,'attachment','image/jpeg',0),(4893,2,'2020-04-17 12:07:37','2020-04-17 12:07:37','','Roche-740x520','','inherit','open','closed','','roche-740x520','','','2020-04-17 12:07:37','2020-04-17 12:07:37','',4891,'https://microbiozindia.com/wp-content/uploads/2020/04/Roche-740x520-1.jpg',0,'attachment','image/jpeg',0),(4894,2,'2020-04-17 12:08:24','2020-04-17 12:08:24','Swiss Pharmaceutical Company Roche today reported the turn of events and up and coming dispatch of its <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Elecsys® Anti-SARS-CoV-2</a></span> serology test to recognize antibodies in individuals who have been presented to the <a href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2</a>) that causes the COVID-19 infection.\r\n\r\nCounter acting agent testing is fundamental to help distinguish individuals who have been tainted by the infection, particularly the individuals who may have been contaminated yet didn\'t show symptoms.³ Additionally, the test can bolster need screening of high hazard gatherings, for example, social insurance laborers, nourishment supply laborers who may as of now have built up a specific degree of invulnerability and can keep serving as well as come back to work. When we see increasingly about the resistance of COVID-19, it could likewise assist society with returning quicker to ordinariness.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/person/7542591\">Severin Schwan, CEO Roche Group:</a></span> \"Following the dispatch of our high-volume PCR test in mid-March to recognize dynamic contamination of the infection, we are currently going to dispatch another counter acting agent test toward the beginning of May. Each dependable test available fills its need for social insurance frameworks to assist us with beating this pandemic. Roche is teaming up intimately with wellbeing specialists and increase creation to guarantee quick accessibility of the test all inclusive.\"\r\n\r\n\"Roche is profoundly dedicated to supporting the worldwide reaction to the COVID-19 pandemic,\" said Thomas Schinecker, CEO Roche Diagnostics. \"Auspicious accessibility and quick access to dependable, top notch tests are fundamental for human services frameworks. The immunizer test is a significant following stage in the battle against COVID-19. Roche\'s immune response test can be immediately scaled and made extensively accessible around the globe as our instrument framework is as of now set up.\"\r\n\r\n<img class=\"alignnone  wp-image-4893\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Roche-740x520-1-300x211.jpg\" alt=\"\" width=\"582\" height=\"409\" />\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/media/releases/med-cor-2020-04-17.htm\">Elecsys Anti-SARS-CoV-2 immunoassay</a> </span>is an in vitro test, utilizing human serum and plasma drawn from a blood test, to distinguish antibodies and decide the body\'s invulnerable response to SARS-CoV-2. The test might be utilized in epidemiological research to assist better with understanding the spread of the ailment and may likewise be utilized together with sub-atomic tests to help in the finding of suspected COVID-19 patients. Clinics and reference research facilities can run the test on Roche\'s cobas e analysers, which are generally accessible in labs around the globe.\r\n\r\nRoche plans to have the immunizer test accessible by early May in nations tolerating the CE mark and is effectively working with the FDA for an Emergency Use Authorisation. Roche is anticipating a quickened increase of month to month creation to high twofold digit million tests by June and will additionally scale up creation as quick as could be expected under the circumstances.','New serology test to identify COVID-19 antibodies by Roche','','inherit','closed','closed','','4891-revision-v1','','','2020-04-17 12:08:24','2020-04-17 12:08:24','',4891,'https://microbiozindia.com/uncategorized/4891-revision-v1/',0,'revision','',0),(4895,2,'2020-04-17 12:52:46','2020-04-17 12:52:46','One more establishment of the Council of Scientific and Industrial Research (CSIR) has begun entire genome sequencing of the novel coronavirus.\r\n\r\nThis organization is Chandigarh-based <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://twitter.com/CSIR_IMTECH?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Institute of Microbial Technology (IMTech)</a></span> and it has taken up the assignment of enormous scope genome sequencing of the infection.\r\n\r\nInfections have a higher transformation rate contrasted with that of organisms and their hereditary material continues changing rapidly as they imitate quickly.\r\n\r\nThese genome sequencing tests will be submitted to the global perceived store,\" said IMTech chief <span style=\"text-decoration: underline;\">Dr Sanjeev Khosla.</span>\r\n\r\n[caption id=\"attachment_4896\" align=\"alignnone\" width=\"427\"]<img class=\"wp-image-4896\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/3c35bdbb3a6073111de95a2d122d74b0-300x225.jpg\" alt=\"\" width=\"427\" height=\"320\" /> <span style=\"font-size: 10pt;\"><em>CSIR-IMTECH, Chandigarh India</em></span>[/caption]\r\n\r\n\"The total genome succession data will empower scientists to pick up bits of knowledge about the starting points of the infection, the various sorts of strains flowing in India and how it has spread over the length and broadness of our nation,\" he said.\r\n\r\n\"The genomic asset acquired from this sequencing will likewise permit distinguishing proof of new focuses for determination and medications for COVID-19,\" he further included.\r\n\r\nEntire genome sequencing is a technique used to decide the total DNA succession of a particular life form\'s genome.\r\n\r\nAs the Institute is known for its specialization in microbial and genomic examine, CSIR-IMTech will perform sequencing of the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/\"> SARS-Cov-2 RNA genom</a></span>e segregated from clinical examples.\r\n\r\nUp until this point, 9000 examples have been sequenced universally according to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gisaid.org/about-us/mission/\">worldwide Initiative on Sharing All Influenza Data (GISAID)</a></span> — an open stage began by the WHO in 2008 for nations to share genome arrangements.\r\n\r\nThe genomic asset acquired from this sequencing will likewise permit the recognizable proof of new focuses of analysis and medications for COVID-19.\r\n\r\n\"We have just begun clinical testing of tests and now by leaving on this crucial succession viral strains, we will be better prepared to comprehend the idea of this infection, which has caused a worldwide pandemic,\" Dr Khosla included.\r\n\r\nCSIR-IMTech will utilize its involvement with compact, ongoing and direct genome sequencing to consider the concoction change in SARS-Cov-2 strains from India.','CSIR lab to begin genome sequencing of novel coronavirus','','publish','open','open','','csir-lab-to-begin-genome-sequencing-of-novel-coronavirus','','','2020-04-17 12:52:46','2020-04-17 12:52:46','',0,'https://microbiozindia.com/?p=4895',0,'post','',0),(4896,2,'2020-04-17 12:48:54','2020-04-17 12:48:54','','3c35bdbb3a6073111de95a2d122d74b0','','inherit','open','closed','','3c35bdbb3a6073111de95a2d122d74b0','','','2020-04-17 12:48:54','2020-04-17 12:48:54','',4895,'https://microbiozindia.com/wp-content/uploads/2020/04/3c35bdbb3a6073111de95a2d122d74b0.jpg',0,'attachment','image/jpeg',0),(4897,2,'2020-04-17 12:48:55','2020-04-17 12:48:55','','dna-4334173_640','','inherit','open','closed','','dna-4334173_640','','','2020-04-17 12:48:55','2020-04-17 12:48:55','',4895,'https://microbiozindia.com/wp-content/uploads/2020/04/dna-4334173_640.jpg',0,'attachment','image/jpeg',0),(4898,2,'2020-04-17 12:52:46','2020-04-17 12:52:46','One more establishment of the Council of Scientific and Industrial Research (CSIR) has begun entire genome sequencing of the novel coronavirus.\r\n\r\nThis organization is Chandigarh-based <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://twitter.com/CSIR_IMTECH?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Institute of Microbial Technology (IMTech)</a></span> and it has taken up the assignment of enormous scope genome sequencing of the infection.\r\n\r\nInfections have a higher transformation rate contrasted with that of organisms and their hereditary material continues changing rapidly as they imitate quickly.\r\n\r\nThese genome sequencing tests will be submitted to the global perceived store,\" said IMTech chief <span style=\"text-decoration: underline;\">Dr Sanjeev Khosla.</span>\r\n\r\n[caption id=\"attachment_4896\" align=\"alignnone\" width=\"427\"]<img class=\"wp-image-4896\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/3c35bdbb3a6073111de95a2d122d74b0-300x225.jpg\" alt=\"\" width=\"427\" height=\"320\" /> <span style=\"font-size: 10pt;\"><em>CSIR-IMTECH, Chandigarh India</em></span>[/caption]\r\n\r\n\"The total genome succession data will empower scientists to pick up bits of knowledge about the starting points of the infection, the various sorts of strains flowing in India and how it has spread over the length and broadness of our nation,\" he said.\r\n\r\n\"The genomic asset acquired from this sequencing will likewise permit distinguishing proof of new focuses for determination and medications for COVID-19,\" he further included.\r\n\r\nEntire genome sequencing is a technique used to decide the total DNA succession of a particular life form\'s genome.\r\n\r\nAs the Institute is known for its specialization in microbial and genomic examine, CSIR-IMTech will perform sequencing of the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/\"> SARS-Cov-2 RNA genom</a></span>e segregated from clinical examples.\r\n\r\nUp until this point, 9000 examples have been sequenced universally according to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gisaid.org/about-us/mission/\">worldwide Initiative on Sharing All Influenza Data (GISAID)</a></span> — an open stage began by the WHO in 2008 for nations to share genome arrangements.\r\n\r\nThe genomic asset acquired from this sequencing will likewise permit the recognizable proof of new focuses of analysis and medications for COVID-19.\r\n\r\n\"We have just begun clinical testing of tests and now by leaving on this crucial succession viral strains, we will be better prepared to comprehend the idea of this infection, which has caused a worldwide pandemic,\" Dr Khosla included.\r\n\r\nCSIR-IMTech will utilize its involvement with compact, ongoing and direct genome sequencing to consider the concoction change in SARS-Cov-2 strains from India.','CSIR lab to begin genome sequencing of novel coronavirus','','inherit','closed','closed','','4895-revision-v1','','','2020-04-17 12:52:46','2020-04-17 12:52:46','',4895,'https://microbiozindia.com/uncategorized/4895-revision-v1/',0,'revision','',0),(4899,2,'2020-04-17 16:16:03','2020-04-17 16:16:03','Researchers at Georgia State University have found that auranofin, a drug authorize for rheumatoid arthritis, may be a ground-breaking system contrary to the coronavirus.\r\n\r\nThe group set out to survey how medicine previously affirmed by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">Foods and Drug Administration</a></span> interface with the infection, known as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span> between specialists.\r\n\r\n\"Medication repurposing is the quickest method to get a solution for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span>, fundamentally in light of the fact that it is at this point been demonstrated that these meds are sheltered to use in people,\" says <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">Mukesh Kumar,</a></span> direct author of the analyze, in an official statement on <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">GSU\'s web webpage. Kumar and his partners shared</a> </span>their capacity on <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.biorxiv.org/content/10.1101/2020.04.14.041228v1?__cf_chl_jschl_tk__=47bedd6132d8a34d6fec9dbc7e8592967ccbde98-1587139922-0-ATd_KP47ayit0vmemC-1STS4TfI6hjgkrOzjQyoT-MUsSF0sSWG_vJhVky76ueaTzWQeiXxGt3xT5a82-kYGpxp_J0l0Fqsx8pfJYGbi6ixpepsSthbkDtYsLVKFAXxIcAfyciTXimqt7fWwgLy692wGbDHBp6AxYbiHAmCfKrAWOYWuF5WTTNsFcz7xt1z11_P6fd-Shb9CVycP3YXHmedUmK3lPoHOM61R7vcxMkxXo3H1JoruB65MJen3G-T9zlUpDnjw1mrgukztJlUuKaPkVWP7XgejLf2kpZSX813jCrDS5ocsqhKVz1E5yGyItQ\">bioRxiv for peer scrutinize.</a></span>\r\n\r\nLike all infections, COVID-19 essentially can\'t self-repeat. It wants have cells — creature or human — in get the chance to make duplicates of alone.\r\n\r\n\"Compelling medications should meddle with this replication procedure, closing down the infection\'s way to multiply inside the host,\" recommends Hussin Rothan, a co-maker of the investigation.\r\n\r\nWith auranofin, the coronavirus was drop somewhere near 95% in human cells inside 48 hours, and growing activated by the ailment was fundamentally relieved.\r\n\r\n1 of the essential realizes of death toll in COVID-19 sufferers is a disorder named a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext\">\"cytokine storm,\"</a> </span>whereby the body\'s remedial reaction to ailment goes haywire, activating insusceptible cells to ambush adjusted tissue, primary to organ disappointment. Cells dealt with auranofin, having said that, saw a huge drop in cytokines, the proteins that sign invulnerable cells to ambush.\r\n\r\n[caption id=\"attachment_4901\" align=\"alignnone\" width=\"500\"]<img class=\"wp-image-4901\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Rothan-768x576-1-300x225.jpg\" alt=\"\" width=\"500\" height=\"375\" /> <span style=\"font-size: 10pt;\">Hussin Rothan, post-doctoral researcher at Georgia State and co-author of the study, at work in the lab.</span>[/caption]\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">\"This shows the medication not exclusively could repress replication of SARS-CoV-2, moderating the disease, yet in addition bring down the subsidiary lung injury that commonly prospects to basic respiratory misery and even demise,\" says Kumar.</a></span>\r\n\r\nAuranofin, which incorporates the model-name sedate Ridaura, was acknowledged by the Fda in 1985. The medication is uncommon for getting in part made out of gold particles, which have been utilized for many years for their mitigating houses. Treatment alternatives including gold mixes have likewise been hypothesized for use contrary to HIV, most tumors, neurodegenerative issues, and parasitic and bacterial diseases.\r\n\r\nThe group at Ga Condition University says they get ready to go on their audit on how auranofin impacts the coronavirus in creature variants.','Scientists Find Rheumatoid Arthritis Drug Is Effective Against Coronavirus','','publish','open','open','','scientists-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus','','','2020-04-17 16:16:03','2020-04-17 16:16:03','',0,'https://microbiozindia.com/?p=4899',0,'post','',0),(4900,2,'2020-04-17 16:10:31','2020-04-17 16:10:31','','abstract-4999190_640','','inherit','open','closed','','abstract-4999190_640','','','2020-04-17 16:10:31','2020-04-17 16:10:31','',4899,'https://microbiozindia.com/wp-content/uploads/2020/04/abstract-4999190_640.jpg',0,'attachment','image/jpeg',0),(4901,2,'2020-04-17 16:11:03','2020-04-17 16:11:03','','Rothan-768x576','','inherit','open','closed','','rothan-768x576','','','2020-04-17 16:11:03','2020-04-17 16:11:03','',4899,'https://microbiozindia.com/wp-content/uploads/2020/04/Rothan-768x576-1.jpg',0,'attachment','image/jpeg',0),(4902,2,'2020-04-17 16:16:03','2020-04-17 16:16:03','Researchers at Georgia State University have found that auranofin, a drug authorize for rheumatoid arthritis, may be a ground-breaking system contrary to the coronavirus.\r\n\r\nThe group set out to survey how medicine previously affirmed by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">Foods and Drug Administration</a></span> interface with the infection, known as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span> between specialists.\r\n\r\n\"Medication repurposing is the quickest method to get a solution for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">SARS-CoV-2</a></span>, fundamentally in light of the fact that it is at this point been demonstrated that these meds are sheltered to use in people,\" says <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">Mukesh Kumar,</a></span> direct author of the analyze, in an official statement on <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">GSU\'s web webpage. Kumar and his partners shared</a> </span>their capacity on <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.biorxiv.org/content/10.1101/2020.04.14.041228v1?__cf_chl_jschl_tk__=47bedd6132d8a34d6fec9dbc7e8592967ccbde98-1587139922-0-ATd_KP47ayit0vmemC-1STS4TfI6hjgkrOzjQyoT-MUsSF0sSWG_vJhVky76ueaTzWQeiXxGt3xT5a82-kYGpxp_J0l0Fqsx8pfJYGbi6ixpepsSthbkDtYsLVKFAXxIcAfyciTXimqt7fWwgLy692wGbDHBp6AxYbiHAmCfKrAWOYWuF5WTTNsFcz7xt1z11_P6fd-Shb9CVycP3YXHmedUmK3lPoHOM61R7vcxMkxXo3H1JoruB65MJen3G-T9zlUpDnjw1mrgukztJlUuKaPkVWP7XgejLf2kpZSX813jCrDS5ocsqhKVz1E5yGyItQ\">bioRxiv for peer scrutinize.</a></span>\r\n\r\nLike all infections, COVID-19 essentially can\'t self-repeat. It wants have cells — creature or human — in get the chance to make duplicates of alone.\r\n\r\n\"Compelling medications should meddle with this replication procedure, closing down the infection\'s way to multiply inside the host,\" recommends Hussin Rothan, a co-maker of the investigation.\r\n\r\nWith auranofin, the coronavirus was drop somewhere near 95% in human cells inside 48 hours, and growing activated by the ailment was fundamentally relieved.\r\n\r\n1 of the essential realizes of death toll in COVID-19 sufferers is a disorder named a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext\">\"cytokine storm,\"</a> </span>whereby the body\'s remedial reaction to ailment goes haywire, activating insusceptible cells to ambush adjusted tissue, primary to organ disappointment. Cells dealt with auranofin, having said that, saw a huge drop in cytokines, the proteins that sign invulnerable cells to ambush.\r\n\r\n[caption id=\"attachment_4901\" align=\"alignnone\" width=\"500\"]<img class=\"wp-image-4901\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Rothan-768x576-1-300x225.jpg\" alt=\"\" width=\"500\" height=\"375\" /> <span style=\"font-size: 10pt;\">Hussin Rothan, post-doctoral researcher at Georgia State and co-author of the study, at work in the lab.</span>[/caption]\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.gsu.edu/2020/04/15/georgia-state-researchers-find-rheumatoid-arthritis-drug-is-effective-against-coronavirus/\">\"This shows the medication not exclusively could repress replication of SARS-CoV-2, moderating the disease, yet in addition bring down the subsidiary lung injury that commonly prospects to basic respiratory misery and even demise,\" says Kumar.</a></span>\r\n\r\nAuranofin, which incorporates the model-name sedate Ridaura, was acknowledged by the Fda in 1985. The medication is uncommon for getting in part made out of gold particles, which have been utilized for many years for their mitigating houses. Treatment alternatives including gold mixes have likewise been hypothesized for use contrary to HIV, most tumors, neurodegenerative issues, and parasitic and bacterial diseases.\r\n\r\nThe group at Ga Condition University says they get ready to go on their audit on how auranofin impacts the coronavirus in creature variants.','Scientists Find Rheumatoid Arthritis Drug Is Effective Against Coronavirus','','inherit','closed','closed','','4899-revision-v1','','','2020-04-17 16:16:03','2020-04-17 16:16:03','',4899,'https://microbiozindia.com/uncategorized/4899-revision-v1/',0,'revision','',0),(4903,2,'2020-04-18 10:09:58','2020-04-18 10:09:58','While stem cell treatment is not a technique to eradicate or fix Coronavirus completely, there is proof to help the idea that infected patients might be more receptive to survive the disease. Because, stem cells oppose viral infection due to the presence of specific qualities known as interferon gamma invigorated qualities (ISGs). These are present in stem cells before their separation process happens. Thus, stem cells can be expected to survive even if they are transferred into a patient with positive Coronavirus confirmation.\r\nEven medical science has determined how Influenza virus A/H5N1, with a history of causing intense lung injury, was destroyed by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413017/\">human mesenchymal stromal cells (MSCs)</a></span> in a mouse. Going back to basics has only expanded the chances of positive outcome.\r\nMesenchymal stromal cells (MSCs) are those stem cells which can separate into an assortment of cell types. There are several other properties of MSCs which make them suitable for clinical trials, such as they have ability to reduce inflammation thus regulating the immune system back to healthy and an extraordinary capacity to find the damaged tissues in human body. They can even fasten the recovery of those damaged tissues.\r\n\r\nTo achieve desired outcome, specialists have used enormous quantities of MSCs with one patient in Baoshan who got 3 implantations of 50 million umbilical blood cord derived MSCs, while every Beijing patients got 1 mixture of 1 million cells for every kilogram of weight. MSCs can be acquired from fat, which implies that everybody can use his/her cells, abolishing any contamination or fatalities. In any case, extending them to the amount required for implantation, takes 2 to 3 weeks which is why it is valuable to cryo-conserve (process of preserving cells prone to damage) an individual reservoir of MSCs, that would permit to get to an early and progressively beneficial treatment.\r\n\r\nAbout 14 trials have been conducted using stem cells to treat coronavirus patients in China. They recommended stem cells may be the option to fix the extreme organ damage brought about by the virus. MSCs can lessen the overproduction of immunity cells caused as a response to the virus and lower down the levels of inflammatory substances. Thus, bringing the weak framework and the whole body back to its ordinary state. What can be securely said at this stage following this spearheading study, is that MSCs demonstrate extraordinary potential to turn into an important part of eradicating something so huge Coronavirus itself.','Stem cells may give a respite to COVID-19 infected','','publish','open','open','','stem-cells-may-give-a-respite-to-covid-19-infected','','','2020-04-18 10:09:58','2020-04-18 10:09:58','',0,'https://microbiozindia.com/?p=4903',0,'post','',0),(4904,2,'2020-04-18 10:07:49','2020-04-18 10:07:49','','coronavirus-4914026_640','','inherit','open','closed','','coronavirus-4914026_640','','','2020-04-18 10:07:49','2020-04-18 10:07:49','',4903,'https://microbiozindia.com/wp-content/uploads/2020/04/coronavirus-4914026_640.jpg',0,'attachment','image/jpeg',0),(4905,2,'2020-04-18 10:09:58','2020-04-18 10:09:58','While stem cell treatment is not a technique to eradicate or fix Coronavirus completely, there is proof to help the idea that infected patients might be more receptive to survive the disease. Because, stem cells oppose viral infection due to the presence of specific qualities known as interferon gamma invigorated qualities (ISGs). These are present in stem cells before their separation process happens. Thus, stem cells can be expected to survive even if they are transferred into a patient with positive Coronavirus confirmation.\r\nEven medical science has determined how Influenza virus A/H5N1, with a history of causing intense lung injury, was destroyed by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413017/\">human mesenchymal stromal cells (MSCs)</a></span> in a mouse. Going back to basics has only expanded the chances of positive outcome.\r\nMesenchymal stromal cells (MSCs) are those stem cells which can separate into an assortment of cell types. There are several other properties of MSCs which make them suitable for clinical trials, such as they have ability to reduce inflammation thus regulating the immune system back to healthy and an extraordinary capacity to find the damaged tissues in human body. They can even fasten the recovery of those damaged tissues.\r\n\r\nTo achieve desired outcome, specialists have used enormous quantities of MSCs with one patient in Baoshan who got 3 implantations of 50 million umbilical blood cord derived MSCs, while every Beijing patients got 1 mixture of 1 million cells for every kilogram of weight. MSCs can be acquired from fat, which implies that everybody can use his/her cells, abolishing any contamination or fatalities. In any case, extending them to the amount required for implantation, takes 2 to 3 weeks which is why it is valuable to cryo-conserve (process of preserving cells prone to damage) an individual reservoir of MSCs, that would permit to get to an early and progressively beneficial treatment.\r\n\r\nAbout 14 trials have been conducted using stem cells to treat coronavirus patients in China. They recommended stem cells may be the option to fix the extreme organ damage brought about by the virus. MSCs can lessen the overproduction of immunity cells caused as a response to the virus and lower down the levels of inflammatory substances. Thus, bringing the weak framework and the whole body back to its ordinary state. What can be securely said at this stage following this spearheading study, is that MSCs demonstrate extraordinary potential to turn into an important part of eradicating something so huge Coronavirus itself.','Stem cells may give a respite to COVID-19 infected','','inherit','closed','closed','','4903-revision-v1','','','2020-04-18 10:09:58','2020-04-18 10:09:58','',4903,'https://microbiozindia.com/uncategorized/4903-revision-v1/',0,'revision','',0),(4906,2,'2020-04-18 10:44:04','2020-04-18 10:44:04','Sanofi has started working with California startup <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://luminostics.com/\">Luminostics</a></span> to construct an at-home test for COVID-19 that would utilize an example peruser fueled by a client\'s close to home cell phone.\r\n\r\nUtilizing a connector that cuts via telephone\'s camera and flashbulb, Luminostics\' minimal effort, reusable gadget contains synthetic substances that faintly shine in obscurity when certain objectives are available. The camera and a downloaded application would then be able to be utilized to distinguish microscopic organisms from respiratory swabs or, as Sanofi trusts, the sub-atomic arrangements related with the novel coronavirus.\r\n\r\n[caption id=\"attachment_4908\" align=\"alignnone\" width=\"555\"]<img class=\"wp-image-4908 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/960x0-1-300x200.jpg\" alt=\"\" width=\"555\" height=\"370\" /> <span style=\"font-size: 10pt;\">On the off chance that Sanofi and Luminostics arrange it, we could have a cell phone based COVID-19 test before the end of 2020.</span>[/caption]\r\n\r\n\"The improvement of a self-testing arrangement with Luminostics could help give lucidity to a person—in minutes—on whether they are contaminated,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.sanofi.com/en/media-room/press-releases/2020/2020-04-16-14-00-00\">said Alan Main</a></span>, leader of Sanofi\'s buyer social insurance division, which will give clinical research and testing backing to the exertion.\r\n\r\nA definitive objective is to give an over-the-counter test before the year\'s end. The two organizations said they hope to start improvement work in the coming weeks, with a future understanding covering the required assembling abilities on the off chance that they are effective. Budgetary subtleties were not unveiled.\r\n\r\nIndependently, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-gates-foundation-unitedhealth-group-quantigen-and-us-cotton\">FDA declared that it would perceive spun manufactured swabs—like the universal cotton Q-tip, however made out of polyester—as a potential choice for home COVID-19 testing.</a></span>\r\n\r\nThese new swabs could be utilized to accumulate tests from the front of the nose without expecting to get to its more profound breaks—an overwhelming, difficult procedure that the organization has generally endowed to prepared social insurance experts over self-use, where a clean nasopharyngeal example is required for a touchy sub-atomic test.\r\n\r\nAs of April 17, over 3.4 million individuals have been tried for the novel coronavirus in the U.S., or simply over 1% of the populace as indicated by insights accumulated by The Johns Hopkins University, yet there are right now no FDA-approved self-performed or locally situated tests accessible.','Sanofi and Luminostics to create cell-phone based test for Covid-19','','publish','open','open','','sanofi-and-luminostics-to-create-cell-phone-based-test-for-covid-19','','','2020-04-18 10:44:04','2020-04-18 10:44:04','',0,'https://microbiozindia.com/?p=4906',0,'post','',0),(4907,2,'2020-04-18 10:38:48','2020-04-18 10:38:48','','30274abc-dbab-444c-aea1-9787c6990fad','','inherit','open','closed','','30274abc-dbab-444c-aea1-9787c6990fad','','','2020-04-18 10:38:48','2020-04-18 10:38:48','',4906,'https://microbiozindia.com/wp-content/uploads/2020/04/30274abc-dbab-444c-aea1-9787c6990fad.jpg',0,'attachment','image/jpeg',0),(4908,2,'2020-04-18 10:41:10','2020-04-18 10:41:10','','960x0','','inherit','open','closed','','960x0-2','','','2020-04-18 10:41:10','2020-04-18 10:41:10','',4906,'https://microbiozindia.com/wp-content/uploads/2020/04/960x0-1.jpg',0,'attachment','image/jpeg',0),(4909,2,'2020-04-18 10:44:04','2020-04-18 10:44:04','Sanofi has started working with California startup <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://luminostics.com/\">Luminostics</a></span> to construct an at-home test for COVID-19 that would utilize an example peruser fueled by a client\'s close to home cell phone.\r\n\r\nUtilizing a connector that cuts via telephone\'s camera and flashbulb, Luminostics\' minimal effort, reusable gadget contains synthetic substances that faintly shine in obscurity when certain objectives are available. The camera and a downloaded application would then be able to be utilized to distinguish microscopic organisms from respiratory swabs or, as Sanofi trusts, the sub-atomic arrangements related with the novel coronavirus.\r\n\r\n[caption id=\"attachment_4908\" align=\"alignnone\" width=\"555\"]<img class=\"wp-image-4908 \" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/960x0-1-300x200.jpg\" alt=\"\" width=\"555\" height=\"370\" /> <span style=\"font-size: 10pt;\">On the off chance that Sanofi and Luminostics arrange it, we could have a cell phone based COVID-19 test before the end of 2020.</span>[/caption]\r\n\r\n\"The improvement of a self-testing arrangement with Luminostics could help give lucidity to a person—in minutes—on whether they are contaminated,\" <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.sanofi.com/en/media-room/press-releases/2020/2020-04-16-14-00-00\">said Alan Main</a></span>, leader of Sanofi\'s buyer social insurance division, which will give clinical research and testing backing to the exertion.\r\n\r\nA definitive objective is to give an over-the-counter test before the year\'s end. The two organizations said they hope to start improvement work in the coming weeks, with a future understanding covering the required assembling abilities on the off chance that they are effective. Budgetary subtleties were not unveiled.\r\n\r\nIndependently, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-gates-foundation-unitedhealth-group-quantigen-and-us-cotton\">FDA declared that it would perceive spun manufactured swabs—like the universal cotton Q-tip, however made out of polyester—as a potential choice for home COVID-19 testing.</a></span>\r\n\r\nThese new swabs could be utilized to accumulate tests from the front of the nose without expecting to get to its more profound breaks—an overwhelming, difficult procedure that the organization has generally endowed to prepared social insurance experts over self-use, where a clean nasopharyngeal example is required for a touchy sub-atomic test.\r\n\r\nAs of April 17, over 3.4 million individuals have been tried for the novel coronavirus in the U.S., or simply over 1% of the populace as indicated by insights accumulated by The Johns Hopkins University, yet there are right now no FDA-approved self-performed or locally situated tests accessible.','Sanofi and Luminostics to create cell-phone based test for Covid-19','','inherit','closed','closed','','4906-revision-v1','','','2020-04-18 10:44:04','2020-04-18 10:44:04','',4906,'https://microbiozindia.com/uncategorized/4906-revision-v1/',0,'revision','',0),(4910,2,'2020-04-18 12:16:12','2020-04-18 12:16:12','USA-based Eli Lilly has joined a huge and quickly developing rundown of drugmakers chipping away at treatments to battle COVID-19, with the consideration of Olumiant (baricitinib) in a National Institutes of Health (NIH)- supported preliminary.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://investor.lilly.com/news-releases/news-release-details/lilly-begins-clinical-testing-therapies-covid-19\">Olumiant will presently be incorporated as an arm in the Adaptive COVID-19 Treatment Trial.</a></span> The investigation will test the item as a potential treatment for individuals who have been hospitalized with COVID-19.\r\n\r\nThe investigation will start this month in the USA, with an arranged development to extra destinations including Europe and Asia. Results are normal inside the following two months.\r\n\r\n[caption id=\"attachment_4912\" align=\"alignnone\" width=\"549\"]<img class=\"wp-image-4912\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/1585506478-4481-300x225.jpg\" alt=\"\" width=\"549\" height=\"412\" /> <span style=\"font-size: 10pt;\">Doctors with COVID-19 patients</span>[/caption]\r\n\r\nThe organization accepts that the calming movement of the rheumatoid joint pain medication could be advantageous for these individuals.\r\n\r\nLilly is additionally propelling its <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cmaxinsight.com/blog/tag/ly3127804/\">investigational biologic LY3127804</a></span> into Phase II preliminaries for individuals with pneumonia and COVID-19 in danger of advancing to intense respiratory trouble disorder (ARDS). This preliminary will start not long from now at a few US communities.\r\n\r\n<strong>Immunologicals against COVID-19</strong>\r\n\r\nReports show that thought of Olumiant as a COVID-19 treatment was prodded by look into from UK-based computerized reasoning think-tank BenevolentAI, which demonstrated a potential advantage.\r\n\r\nLilly is presently one of different organizations testing joint inflammation drugs for the novel coronavirus, most strikingly Sanofi (Euronext: SAN) and Regeneron (Nasdaq: REGN), who have commenced numerous worldwide preliminaries for their choice Kevzara (sarilumab).\r\n\r\nDifferent choices viable incorporate <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.pfizer.com/products\">Pfizer\'s</a></span> (NYSE: PFE) <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://ra.xeljanz.com/\">Xeljanz</a></span> (tofacitinib) and A<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rxlist.com/actemra-drug.htm\">ctemra (tocilizumab)</a></span>, from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/investors/shares.htm\">Swiss oncology goliath Roche (ROG: SIX).</a></span>\r\n\r\nThe firm noted it didn\'t envision deficiencies for any of its meds, including Olumiant, which remains generally accessible in nations where it is affirmed.','Lilly collaborates with NIH to test Olumiant in patients hospitalized with COVID-19','','publish','open','open','','lilly-collaborates-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19','','','2020-04-18 12:16:12','2020-04-18 12:16:12','',0,'https://microbiozindia.com/?p=4910',0,'post','',0),(4911,2,'2020-04-18 12:05:43','2020-04-18 12:05:43','','IMAGE','','inherit','open','closed','','image','','','2020-04-18 12:05:43','2020-04-18 12:05:43','',4910,'https://microbiozindia.com/wp-content/uploads/2020/04/IMAGE.png',0,'attachment','image/png',0),(4912,2,'2020-04-18 12:10:40','2020-04-18 12:10:40','','1585506478-4481','','inherit','open','closed','','1585506478-4481','','','2020-04-18 12:10:40','2020-04-18 12:10:40','',4910,'https://microbiozindia.com/wp-content/uploads/2020/04/1585506478-4481.jpg',0,'attachment','image/jpeg',0),(4913,2,'2020-04-18 12:16:12','2020-04-18 12:16:12','USA-based Eli Lilly has joined a huge and quickly developing rundown of drugmakers chipping away at treatments to battle COVID-19, with the consideration of Olumiant (baricitinib) in a National Institutes of Health (NIH)- supported preliminary.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://investor.lilly.com/news-releases/news-release-details/lilly-begins-clinical-testing-therapies-covid-19\">Olumiant will presently be incorporated as an arm in the Adaptive COVID-19 Treatment Trial.</a></span> The investigation will test the item as a potential treatment for individuals who have been hospitalized with COVID-19.\r\n\r\nThe investigation will start this month in the USA, with an arranged development to extra destinations including Europe and Asia. Results are normal inside the following two months.\r\n\r\n[caption id=\"attachment_4912\" align=\"alignnone\" width=\"549\"]<img class=\"wp-image-4912\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/1585506478-4481-300x225.jpg\" alt=\"\" width=\"549\" height=\"412\" /> <span style=\"font-size: 10pt;\">Doctors with COVID-19 patients</span>[/caption]\r\n\r\nThe organization accepts that the calming movement of the rheumatoid joint pain medication could be advantageous for these individuals.\r\n\r\nLilly is additionally propelling its <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cmaxinsight.com/blog/tag/ly3127804/\">investigational biologic LY3127804</a></span> into Phase II preliminaries for individuals with pneumonia and COVID-19 in danger of advancing to intense respiratory trouble disorder (ARDS). This preliminary will start not long from now at a few US communities.\r\n\r\n<strong>Immunologicals against COVID-19</strong>\r\n\r\nReports show that thought of Olumiant as a COVID-19 treatment was prodded by look into from UK-based computerized reasoning think-tank BenevolentAI, which demonstrated a potential advantage.\r\n\r\nLilly is presently one of different organizations testing joint inflammation drugs for the novel coronavirus, most strikingly Sanofi (Euronext: SAN) and Regeneron (Nasdaq: REGN), who have commenced numerous worldwide preliminaries for their choice Kevzara (sarilumab).\r\n\r\nDifferent choices viable incorporate <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.pfizer.com/products\">Pfizer\'s</a></span> (NYSE: PFE) <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://ra.xeljanz.com/\">Xeljanz</a></span> (tofacitinib) and A<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rxlist.com/actemra-drug.htm\">ctemra (tocilizumab)</a></span>, from <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.roche.com/investors/shares.htm\">Swiss oncology goliath Roche (ROG: SIX).</a></span>\r\n\r\nThe firm noted it didn\'t envision deficiencies for any of its meds, including Olumiant, which remains generally accessible in nations where it is affirmed.','Lilly collaborates with NIH to test Olumiant in patients hospitalized with COVID-19','','inherit','closed','closed','','4910-revision-v1','','','2020-04-18 12:16:12','2020-04-18 12:16:12','',4910,'https://microbiozindia.com/uncategorized/4910-revision-v1/',0,'revision','',0),(4914,2,'2020-04-18 12:38:59','2020-04-18 12:38:59','The Central Drugs Standard Control Organization (CDSCO) has given a green sign to intrigued foundations to direct the clinical preliminary with gaining strength plasma in COVID-19 patients, according to the convention created by Indian Council of Medical Research (ICMR).\r\n\r\nIn a notification in regards to the clinical preliminary of healing plasma in COVID-19 patients, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.newslivetv.com/india/icmr-directs-all-states-to-follow-key-protocols-for-rapid-testing-of-covid-19/\">the CDSCO stated</a></span>: \"It is to educate that in light regarding open intrigue the proposition of ICMR for directing the said preliminary has been audited through the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cliniexperts.com/india-regulatory-services/drug/for-manufacturer/sec-meetings/\">Subject Expert Committee (SEC) </a></span>in its gathering hung on April 13 under quickened endorsement process considering the present circumstance of COVID-19 and dependent on the suggestion of the advisory group.\r\n\r\nThe CDSCO has passed on it has no complaint for the lead of the clinical preliminary subject to specific changes in the convention and different conditions under the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.iscr.org/wp-content/uploads/2019/05/New-Rules-2019_ISCR-RC_21Apr2019_GMupdates-1.pdf\">New Drugs and Clinical Trial Rules 2019.</a></span>\r\n\r\nIt said that the ICMR has given a rundown of foundations to CDSCO which have demonstrated enthusiasm for the lead of the said preliminary.\r\n\r\nWhile thinking the clinical preliminary conventions of different candidates for the direct of clinical preliminary with gaining strength plasma in COVID-19 patients, the SEC in the said gathering opined that ICMR has built up a convention for a controlled clinical preliminary with healing plasma in moderate COVID-19 patients which has been assessed by the board of trustees and the equivalent may likewise be considered by the candidates as proper.<img class=\"alignnone  wp-image-4727\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/200407072712_1_900x600-300x169.jpg\" alt=\"\" width=\"552\" height=\"311\" />\r\n\r\nAny individual or establishment association intrigued by the direct of the preliminary of recovering plasma according to the convention created by ICMR and endorsed by CDSCO, may do as such in conference with ICMR and in like manner, the candidate may approach ICMR for the lead of the clinical preliminary, the notification undersigned by Drugs Controller General VG Somani read.\r\n\r\nIndia\'s all out number of coronavirus positive cases has ascended to 13,835, including 1767 restored and released and 452 passings, according to the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://twitter.com/MoHFW_INDIA?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Union Health Ministry.</a></span>','CDSCO supports foundations to direct clinical preliminaries in COVID-19 Patients','','publish','open','open','','cdsco-supports-foundations-to-direct-clinical-preliminaries-in-covid-19-patients','','','2020-04-18 12:38:59','2020-04-18 12:38:59','',0,'https://microbiozindia.com/?p=4914',0,'post','',0),(4915,2,'2020-04-18 12:33:43','2020-04-18 12:33:43','','virus-4976408_640','','inherit','open','closed','','virus-4976408_640','','','2020-04-18 12:33:43','2020-04-18 12:33:43','',4914,'https://microbiozindia.com/wp-content/uploads/2020/04/virus-4976408_640.jpg',0,'attachment','image/jpeg',0),(4916,2,'2020-04-18 12:38:59','2020-04-18 12:38:59','The Central Drugs Standard Control Organization (CDSCO) has given a green sign to intrigued foundations to direct the clinical preliminary with gaining strength plasma in COVID-19 patients, according to the convention created by Indian Council of Medical Research (ICMR).\r\n\r\nIn a notification in regards to the clinical preliminary of healing plasma in COVID-19 patients, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.newslivetv.com/india/icmr-directs-all-states-to-follow-key-protocols-for-rapid-testing-of-covid-19/\">the CDSCO stated</a></span>: \"It is to educate that in light regarding open intrigue the proposition of ICMR for directing the said preliminary has been audited through the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cliniexperts.com/india-regulatory-services/drug/for-manufacturer/sec-meetings/\">Subject Expert Committee (SEC) </a></span>in its gathering hung on April 13 under quickened endorsement process considering the present circumstance of COVID-19 and dependent on the suggestion of the advisory group.\r\n\r\nThe CDSCO has passed on it has no complaint for the lead of the clinical preliminary subject to specific changes in the convention and different conditions under the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.iscr.org/wp-content/uploads/2019/05/New-Rules-2019_ISCR-RC_21Apr2019_GMupdates-1.pdf\">New Drugs and Clinical Trial Rules 2019.</a></span>\r\n\r\nIt said that the ICMR has given a rundown of foundations to CDSCO which have demonstrated enthusiasm for the lead of the said preliminary.\r\n\r\nWhile thinking the clinical preliminary conventions of different candidates for the direct of clinical preliminary with gaining strength plasma in COVID-19 patients, the SEC in the said gathering opined that ICMR has built up a convention for a controlled clinical preliminary with healing plasma in moderate COVID-19 patients which has been assessed by the board of trustees and the equivalent may likewise be considered by the candidates as proper.<img class=\"alignnone  wp-image-4727\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/200407072712_1_900x600-300x169.jpg\" alt=\"\" width=\"552\" height=\"311\" />\r\n\r\nAny individual or establishment association intrigued by the direct of the preliminary of recovering plasma according to the convention created by ICMR and endorsed by CDSCO, may do as such in conference with ICMR and in like manner, the candidate may approach ICMR for the lead of the clinical preliminary, the notification undersigned by Drugs Controller General VG Somani read.\r\n\r\nIndia\'s all out number of coronavirus positive cases has ascended to 13,835, including 1767 restored and released and 452 passings, according to the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://twitter.com/MoHFW_INDIA?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Union Health Ministry.</a></span>','CDSCO supports foundations to direct clinical preliminaries in COVID-19 Patients','','inherit','closed','closed','','4914-revision-v1','','','2020-04-18 12:38:59','2020-04-18 12:38:59','',4914,'https://microbiozindia.com/uncategorized/4914-revision-v1/',0,'revision','',0),(4917,2,'2020-04-18 14:43:26','2020-04-18 14:43:26','Zydus Cadila on Saturday said it has gotten last gesture from the US wellbeing controller to advertise Baclofen tablets, utilized for treatment of muscle fits brought about by certain conditions, in the American market.\r\n\r\nThe organization has gotten last endorsement from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://in.finance.yahoo.com/news/zydus-cadila-gets-usfda-nod-074355597.html\">United States Food and Drug Administration (USFDA) to showcase Baclofen</a> </span>tablets in the quality of 5 mg, Zydus Cadila said in an announcement.\r\n\r\nThe item will be fabricated at the gathering\'s plans producing office at Baddi, it included.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-8615/baclofen-oral/details\">Baclofen is utilized to treat muscle fits</a></span> brought about by specific conditions, for example, different sclerosis and spinal string injury/ailment. It works by assisting with loosening up the muscles, Zydus Cadila said.\r\n\r\nThe gathering presently has 288 endorsements and has so far documented more than 386 shortened new medication applications (ANDAs) since the beginning of its recording procedure.','Zydus Cadila gets USFDA gesture to advertise muscle fits tablets','','publish','open','open','','zydus-cadila-gets-usfda-gesture-to-advertise-muscle-fits-tablets','','','2020-04-18 14:43:26','2020-04-18 14:43:26','',0,'https://microbiozindia.com/?p=4917',0,'post','',0),(4918,2,'2020-04-18 14:43:26','2020-04-18 14:43:26','Zydus Cadila on Saturday said it has gotten last gesture from the US wellbeing controller to advertise Baclofen tablets, utilized for treatment of muscle fits brought about by certain conditions, in the American market.\r\n\r\nThe organization has gotten last endorsement from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://in.finance.yahoo.com/news/zydus-cadila-gets-usfda-nod-074355597.html\">United States Food and Drug Administration (USFDA) to showcase Baclofen</a> </span>tablets in the quality of 5 mg, Zydus Cadila said in an announcement.\r\n\r\nThe item will be fabricated at the gathering\'s plans producing office at Baddi, it included.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-8615/baclofen-oral/details\">Baclofen is utilized to treat muscle fits</a></span> brought about by specific conditions, for example, different sclerosis and spinal string injury/ailment. It works by assisting with loosening up the muscles, Zydus Cadila said.\r\n\r\nThe gathering presently has 288 endorsements and has so far documented more than 386 shortened new medication applications (ANDAs) since the beginning of its recording procedure.','Zydus Cadila gets USFDA gesture to advertise muscle fits tablets','','inherit','closed','closed','','4917-revision-v1','','','2020-04-18 14:43:26','2020-04-18 14:43:26','',4917,'https://microbiozindia.com/uncategorized/4917-revision-v1/',0,'revision','',0),(4919,2,'2020-04-19 07:27:15','2020-04-19 07:27:15','Having the option to test for coronavirus contaminations is a basic segment to reviving society — even a smidgen — after the underlying flood of COVID-19. So there is a dire requirement for quicker, less expensive tests than the ones accessible at present.\r\n\r\nOne way to deal with the up and coming age of tests is being created by the <span style=\"color: #ff6600;\">U<a style=\"color: #ff6600;\" href=\"https://www.ucsf.edu/news/2020/04/417181/new-crispr-based-covid-19-test-kit-can-diagnose-infection-less-hour\"><span style=\"color: #ff6600;\">niv</span>ersity of California, San Francisco Medical School and Mammoth Biosciences.</a> </span>In a paper discharged Thursday in the diary <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nature.com/articles/s41587-020-0513-4\">Nature Biotechnology</a></span>, scientists portray a test dependent on another innovation known as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/CRISPR\">CRISPR.</a></span>\r\n\r\nCRISPR frameworks have been broadly utilized by scientists to change the hereditary material in living cells. For this situation, a framework known as CRISPR-Cas12 is utilized to perceive hereditary marks of the coronavirus that causes COVID-19 and afterward make slices in it to discharge a fluorescent atom that will show whether the infection is available.\r\n\r\nLike the test created by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.statnews.com/2020/04/16/coronavirus-test-crispr-mammoth-biosciences/\">Centers for Disease Control and Prevention, this CRISPR-based test can run various examples without a moment\'s delay.</a></span> And keeping in mind that the CDC variant conveys answers in hours, the test from UCSF and Mammoth Biosciences is quicker — giving outcomes in 30-45 minutes.\r\n\r\nThe test is independent, so it doesn\'t require complex, costly hardware that is utilized in different tests for the infection.\r\n\r\n\"I can run it now myself at home,\" clarifies <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://bms.ucsf.edu/people/charles-chiu-md-phd\">Dr. Charles Chiu, teacher of research center medication at UCSF</a></span> and co-lead designer of the new test — despite the fact that he notes it requires some mastery to direct it. He says he and his partners plan to present the present form of their test one week from now for FDA endorsement. Be that as it may, it likely won\'t be the last emphasis.\r\n\r\n\"What we truly need to create is something like a handheld, pocket-sized gadget utilizing expendable cartridges,\" says Chiu — something that could even be utilized by nonexperts as a locally established test. Chiu is certain such tests could be fabricated at a scale that would be broadly accessible.\r\n\r\n[caption id=\"attachment_4922\" align=\"alignnone\" width=\"507\"]<img class=\"wp-image-4922\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/img_3092_custom-ad4e5250eae71203e239906250c3867c90ea5dc1-s1500-c85-300x225.jpg\" alt=\"\" width=\"507\" height=\"380\" /> <span style=\"font-size: 10pt;\">Mammoth Biosciences and researchers at the University of California, San Francisco are working on a coronavirus test that could run multiple samples at once, with results in 35-40 minutes. Even better, they say, it doesn\'t require the sophisticated, expensive equipment used in other tests for the virus. Mammoth Biosciences</span>[/caption]\r\n\r\nDifferent labs, remembering two at the Broad Institute for Cambridge, Mass., are additionally chipping away at CRISPR-based demonstrative tests.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://sawyerlab.colorado.edu/\">Sara Sawyer, a virologist at the University of Colorado</a></span>, is attempting to go above and beyond in the testing scene. She\'s attempting to build up a minimal effort test individuals could use at home that would uncover whether they are tainted — days before they show any side effects.\r\n\r\n\"For a long time, we\'ve been dealing with attempting to build up a symptomatic that can get on the soonest phases of basic respiratory maladies,\" Sawyer says. Her test doesn\'t search for the infection itself. Rather, it searches for a reaction to the infection by the cells of an individual who is contaminated.\r\n\r\nThe thought is that once cells in the nose and throat are contaminated, certain qualities are turned on that aren\'t ordinarily turned on. Sawyer says it\'s conceivable to recognize those \"up-controlled\" qualities in spit — rather than the nasal swab different coronavirus tests depend on. The inquiry is, would she be able to recognize the new coronavirus from different infections. She wants to.\r\n\r\n<strong>Be that as it may, do others concur?</strong>\r\n\r\n\"The appropriate response is perhaps,\" says Benjamin tenOever, a virologist at the Icahn School of Medicine at Mount Sinai in New York City. He says truly, disease by the infection that causes COVID-19 outcomes in various qualities being up-managed, contrasted and influenza or different infections. He\'s simply doubtful the innovation exists to have the option to distinguish those distinctions.\r\n\r\n\"I\'d state hypothetically it is conceivable,\" tenOever says. \"She\'s a savvy researcher. Thus in the event that she says she can do it, I would assume the best about her.\"\r\n\r\nSawyer has shaped an organization to construct her test unit. In the event that society is to revive, she says, there should be simple ways for individuals to check their disease status. She\'s planning and fund-raising for an investigation to approve her test\'s precision.\r\n\r\n\"We think salivation is the way to moving these tests out of the specialist\'s office,\" Sawyer says, since all individuals would need to do to gather an example is spit in a cup. No blood draws, no nasal swabs.','CRISPR and Spit Might Be Keys to faster and cheaper tests For The Coronavirus','','publish','open','open','','crispr-and-spit-might-be-keys-to-faster-and-cheaper-tests-for-the-coronavirus','','','2020-04-19 07:27:15','2020-04-19 07:27:15','',0,'https://microbiozindia.com/?p=4919',0,'post','',0),(4920,2,'2020-04-19 07:20:29','2020-04-19 07:20:29','','crispr-cartoon','','inherit','open','closed','','crispr-cartoon','','','2020-04-19 07:20:29','2020-04-19 07:20:29','',4919,'https://microbiozindia.com/wp-content/uploads/2020/04/crispr-cartoon.jpg',0,'attachment','image/jpeg',0),(4921,2,'2020-04-19 07:20:33','2020-04-19 07:20:33','','Feluda','','inherit','open','closed','','feluda','','','2020-04-19 07:20:33','2020-04-19 07:20:33','',4919,'https://microbiozindia.com/wp-content/uploads/2020/04/Feluda.jpg',0,'attachment','image/jpeg',0),(4922,2,'2020-04-19 07:20:56','2020-04-19 07:20:56','','img_3092_custom-ad4e5250eae71203e239906250c3867c90ea5dc1-s1500-c85','','inherit','open','closed','','img_3092_custom-ad4e5250eae71203e239906250c3867c90ea5dc1-s1500-c85','','','2020-04-19 07:20:56','2020-04-19 07:20:56','',4919,'https://microbiozindia.com/wp-content/uploads/2020/04/img_3092_custom-ad4e5250eae71203e239906250c3867c90ea5dc1-s1500-c85.jpg',0,'attachment','image/jpeg',0),(4923,2,'2020-04-19 07:27:15','2020-04-19 07:27:15','Having the option to test for coronavirus contaminations is a basic segment to reviving society — even a smidgen — after the underlying flood of COVID-19. So there is a dire requirement for quicker, less expensive tests than the ones accessible at present.\r\n\r\nOne way to deal with the up and coming age of tests is being created by the <span style=\"color: #ff6600;\">U<a style=\"color: #ff6600;\" href=\"https://www.ucsf.edu/news/2020/04/417181/new-crispr-based-covid-19-test-kit-can-diagnose-infection-less-hour\"><span style=\"color: #ff6600;\">niv</span>ersity of California, San Francisco Medical School and Mammoth Biosciences.</a> </span>In a paper discharged Thursday in the diary <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nature.com/articles/s41587-020-0513-4\">Nature Biotechnology</a></span>, scientists portray a test dependent on another innovation known as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/CRISPR\">CRISPR.</a></span>\r\n\r\nCRISPR frameworks have been broadly utilized by scientists to change the hereditary material in living cells. For this situation, a framework known as CRISPR-Cas12 is utilized to perceive hereditary marks of the coronavirus that causes COVID-19 and afterward make slices in it to discharge a fluorescent atom that will show whether the infection is available.\r\n\r\nLike the test created by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.statnews.com/2020/04/16/coronavirus-test-crispr-mammoth-biosciences/\">Centers for Disease Control and Prevention, this CRISPR-based test can run various examples without a moment\'s delay.</a></span> And keeping in mind that the CDC variant conveys answers in hours, the test from UCSF and Mammoth Biosciences is quicker — giving outcomes in 30-45 minutes.\r\n\r\nThe test is independent, so it doesn\'t require complex, costly hardware that is utilized in different tests for the infection.\r\n\r\n\"I can run it now myself at home,\" clarifies <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://bms.ucsf.edu/people/charles-chiu-md-phd\">Dr. Charles Chiu, teacher of research center medication at UCSF</a></span> and co-lead designer of the new test — despite the fact that he notes it requires some mastery to direct it. He says he and his partners plan to present the present form of their test one week from now for FDA endorsement. Be that as it may, it likely won\'t be the last emphasis.\r\n\r\n\"What we truly need to create is something like a handheld, pocket-sized gadget utilizing expendable cartridges,\" says Chiu — something that could even be utilized by nonexperts as a locally established test. Chiu is certain such tests could be fabricated at a scale that would be broadly accessible.\r\n\r\n[caption id=\"attachment_4922\" align=\"alignnone\" width=\"507\"]<img class=\"wp-image-4922\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/img_3092_custom-ad4e5250eae71203e239906250c3867c90ea5dc1-s1500-c85-300x225.jpg\" alt=\"\" width=\"507\" height=\"380\" /> <span style=\"font-size: 10pt;\">Mammoth Biosciences and researchers at the University of California, San Francisco are working on a coronavirus test that could run multiple samples at once, with results in 35-40 minutes. Even better, they say, it doesn\'t require the sophisticated, expensive equipment used in other tests for the virus. Mammoth Biosciences</span>[/caption]\r\n\r\nDifferent labs, remembering two at the Broad Institute for Cambridge, Mass., are additionally chipping away at CRISPR-based demonstrative tests.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://sawyerlab.colorado.edu/\">Sara Sawyer, a virologist at the University of Colorado</a></span>, is attempting to go above and beyond in the testing scene. She\'s attempting to build up a minimal effort test individuals could use at home that would uncover whether they are tainted — days before they show any side effects.\r\n\r\n\"For a long time, we\'ve been dealing with attempting to build up a symptomatic that can get on the soonest phases of basic respiratory maladies,\" Sawyer says. Her test doesn\'t search for the infection itself. Rather, it searches for a reaction to the infection by the cells of an individual who is contaminated.\r\n\r\nThe thought is that once cells in the nose and throat are contaminated, certain qualities are turned on that aren\'t ordinarily turned on. Sawyer says it\'s conceivable to recognize those \"up-controlled\" qualities in spit — rather than the nasal swab different coronavirus tests depend on. The inquiry is, would she be able to recognize the new coronavirus from different infections. She wants to.\r\n\r\n<strong>Be that as it may, do others concur?</strong>\r\n\r\n\"The appropriate response is perhaps,\" says Benjamin tenOever, a virologist at the Icahn School of Medicine at Mount Sinai in New York City. He says truly, disease by the infection that causes COVID-19 outcomes in various qualities being up-managed, contrasted and influenza or different infections. He\'s simply doubtful the innovation exists to have the option to distinguish those distinctions.\r\n\r\n\"I\'d state hypothetically it is conceivable,\" tenOever says. \"She\'s a savvy researcher. Thus in the event that she says she can do it, I would assume the best about her.\"\r\n\r\nSawyer has shaped an organization to construct her test unit. In the event that society is to revive, she says, there should be simple ways for individuals to check their disease status. She\'s planning and fund-raising for an investigation to approve her test\'s precision.\r\n\r\n\"We think salivation is the way to moving these tests out of the specialist\'s office,\" Sawyer says, since all individuals would need to do to gather an example is spit in a cup. No blood draws, no nasal swabs.','CRISPR and Spit Might Be Keys to faster and cheaper tests For The Coronavirus','','inherit','closed','closed','','4919-revision-v1','','','2020-04-19 07:27:15','2020-04-19 07:27:15','',4919,'https://microbiozindia.com/uncategorized/4919-revision-v1/',0,'revision','',0),(4924,2,'2020-04-19 07:40:48','2020-04-19 07:40:48','Feluda, the investigator specialist will presently recognize in minutes on the off chance that you are contaminated with COVID19.\r\n\r\nIn the midst of the developing interest for fast test pack for COVID19, another paper-based test strip has been found by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.igib.res.in/\">Institute of Genomics and Integrative Biology (IGIB) in New Delhi.</a></span>\r\n\r\nDriven by two Bengali-talking researchers — <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rnabiologylab.com/\">Debojyoti Chakraborty</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.researchgate.net/scientific-contributions/38539601_Souvik_Maiti\">Souvik Maiti</a></span>, the test strip has been named after Feluda, the distinguished analyst character made by notorious producer <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://theprint.in/science/satyajit-rays-feluda-will-soon-detect-coronavirus-in-minutes-thanks-to-csir-scientists/404057/\">Satyajit Ray</a></span>.\r\n\r\n[caption id=\"attachment_4921\" align=\"alignnone\" width=\"449\"]<img class=\"wp-image-4921\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Feluda-300x177.jpg\" alt=\"\" width=\"449\" height=\"265\" /> Feluda[/caption]\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.igib.res.in/\">Institute of Genomics and Integrative Biology (IGIB) in New Delhi</a></span> is a unit of the Council of Scientific and Industrial Research (CSIR).\r\n\r\nBoth Maiti and Chakraborty are certain that the straightforward paper-based test strip would lessen expenses of testing for COVID19 in India.\r\n\r\nAt present, the continuous polymerase chain response test (RT-PCR) costs Rs 4,500 in private labs.\r\n\r\nBe that as it may, the Feluda test will be a lot less expensive. It would cost just Rs 500.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.csir.res.in/dgcsir/dr-shekhar-c-mande\">Shekhar C. Mande, the Director-General of CSIR</a> <a style=\"color: #ff6600;\" href=\"https://theprint.in/science/satyajit-rays-feluda-will-soon-detect-coronavirus-in-minutes-thanks-to-csir-scientists/404057/\">disclosed to The Print that the Feluda is as basic as pregnancy test strips.</a></span>\r\n\r\nThe Feluda test would not require any particular ability and machines to perform, Mande said.\r\n\r\nThe Feluda strip will simply change shading, and can be utilized in a basic neurotic lab.\r\n\r\nFurthermore, the test is 100 percent exact, Mande stated, including that researchers by and large take a very long time to build up this sort of units. Be that as it may, the IGIB researchers did it in a record time.\r\n\r\nHe said CSIR is among the three or four nations driving the path in creating it, close by Stanford University and the MIT.\r\n\r\nBoth Chakraborty and Maiti have been investigating sickle cell iron deficiency throughout the previous two years.\r\n\r\nWhat\'s more, when COVID19 brought its head up in China, they began to examination to perceive how transformations happen in the coronavirus, and found the Feluda test strips.\r\n\r\nDuring the most recent two months, they have been working 20 hours per day to create it.\r\n\r\nChakraborty said the test is as speedy and immaculate like Feluda, and that is the manner by which the name came up.\r\n\r\nWhile administrative approval is in process, the IGIB researchers are confident that the innovation move for business creation may begin in hardly any weeks.','Paper based “Feluda test” to detect COVID19 in minutes','','publish','open','open','','paper-based-feluda-test-to-detect-covid19-in-minutes','','','2020-04-19 07:40:48','2020-04-19 07:40:48','',0,'https://microbiozindia.com/?p=4924',0,'post','',0),(4925,2,'2020-04-19 07:34:39','2020-04-19 07:34:39','','corona-4924608_640','','inherit','open','closed','','corona-4924608_640','','','2020-04-19 07:34:39','2020-04-19 07:34:39','',4924,'https://microbiozindia.com/wp-content/uploads/2020/04/corona-4924608_640.png',0,'attachment','image/png',0),(4926,2,'2020-04-19 07:40:48','2020-04-19 07:40:48','Feluda, the investigator specialist will presently recognize in minutes on the off chance that you are contaminated with COVID19.\r\n\r\nIn the midst of the developing interest for fast test pack for COVID19, another paper-based test strip has been found by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.igib.res.in/\">Institute of Genomics and Integrative Biology (IGIB) in New Delhi.</a></span>\r\n\r\nDriven by two Bengali-talking researchers — <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.rnabiologylab.com/\">Debojyoti Chakraborty</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.researchgate.net/scientific-contributions/38539601_Souvik_Maiti\">Souvik Maiti</a></span>, the test strip has been named after Feluda, the distinguished analyst character made by notorious producer <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://theprint.in/science/satyajit-rays-feluda-will-soon-detect-coronavirus-in-minutes-thanks-to-csir-scientists/404057/\">Satyajit Ray</a></span>.\r\n\r\n[caption id=\"attachment_4921\" align=\"alignnone\" width=\"449\"]<img class=\"wp-image-4921\" src=\"https://microbiozindia.com/wp-content/uploads/2020/04/Feluda-300x177.jpg\" alt=\"\" width=\"449\" height=\"265\" /> Feluda[/caption]\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.igib.res.in/\">Institute of Genomics and Integrative Biology (IGIB) in New Delhi</a></span> is a unit of the Council of Scientific and Industrial Research (CSIR).\r\n\r\nBoth Maiti and Chakraborty are certain that the straightforward paper-based test strip would lessen expenses of testing for COVID19 in India.\r\n\r\nAt present, the continuous polymerase chain response test (RT-PCR) costs Rs 4,500 in private labs.\r\n\r\nBe that as it may, the Feluda test will be a lot less expensive. It would cost just Rs 500.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.csir.res.in/dgcsir/dr-shekhar-c-mande\">Shekhar C. Mande, the Director-General of CSIR</a> <a style=\"color: #ff6600;\" href=\"https://theprint.in/science/satyajit-rays-feluda-will-soon-detect-coronavirus-in-minutes-thanks-to-csir-scientists/404057/\">disclosed to The Print that the Feluda is as basic as pregnancy test strips.</a></span>\r\n\r\nThe Feluda test would not require any particular ability and machines to perform, Mande said.\r\n\r\nThe Feluda strip will simply change shading, and can be utilized in a basic neurotic lab.\r\n\r\nFurthermore, the test is 100 percent exact, Mande stated, including that researchers by and large take a very long time to build up this sort of units. Be that as it may, the IGIB researchers did it in a record time.\r\n\r\nHe said CSIR is among the three or four nations driving the path in creating it, close by Stanford University and the MIT.\r\n\r\nBoth Chakraborty and Maiti have been investigating sickle cell iron deficiency throughout the previous two years.\r\n\r\nWhat\'s more, when COVID19 brought its head up in China, they began to examination to perceive how transformations happen in the coronavirus, and found the Feluda test strips.\r\n\r\nDuring the most recent two months, they have been working 20 hours per day to create it.\r\n\r\nChakraborty said the test is as speedy and immaculate like Feluda, and that is the manner by which the name came up.\r\n\r\nWhile administrative approval is in process, the IGIB researchers are confident that the innovation move for business creation may begin in hardly any weeks.','Paper based “Feluda test” to detect COVID19 in minutes','','inherit','closed','closed','','4924-revision-v1','','','2020-04-19 07:40:48','2020-04-19 07:40:48','',4924,'https://microbiozindia.com/uncategorized/4924-revision-v1/',0,'revision','',0),